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1 Introduction 
“At the interior of our cells, driving them, providing the oxidative energy that sends us out for the 
improvement of each shining day, are the mitochondria, and … without them, we would not move a 
muscle, drum a finger, think a thought.” Lewis Thomas, 1974 (1) 
 
1.1 Affective disorders 
Affective disorders such as major depression (MDD) and bipolar disorder (BD) are among the 
most prevalent forms of mental illness and affect more than 350 million people worldwide (2). 
These major neuropsychiatric disorders are chronic, multifaceted, and heterogeneous diseases 
with shared symptomatic features, also including schizophrenia and autism (3). BD has a 
lifetime prevalence of 3.9% and is characterized by episodes of mania or hypomania and 
depression, which typically occur in a cyclical course (4). The manic phase involves symptoms 
of elevated mood and over-activity (2). Mood stabilizers, such as lithium, antipsychotics, and 
anticonvulsants, form the basis of BD pharmacotherapy (5). With a lifetime risk of 16.6%, MDD 
is the more frequent affective disorder and its characteristic symptoms comprise loss of 
interest, sadness, feelings of guilt, sleep disturbances, and poor concentration (2, 4). Currently 
available pharmacological treatments are targeted against monoaminergic neurotransmitter 
imbalances and their main classes include tricyclic antidepressants as well as selective 
serotonin reuptake inhibitors (6). However, it is estimated that over one-third of MDD patients 
are resistant to antidepressant therapy (7). In fact, despite being among the leading causes of 
disability worldwide, their underlying pathophysiology still remains poorly understood (8). 
Therefore, a better understanding of the neurobiology underlying MDD and BD is highly 
warranted to improve treatment outcome and to provide greater and sustained rates of 
remission in the future. Established current neurobiological theories attempting to elucidate 
the pathophysiology of these complex psychiatric disorders mainly focus on genetic and 
environmental risk factors, and ,in particular, their interactions (9). The pronounced 
heritability of affective disorders suggests that genetic influences play a key role in disease 
pathogenesis (10). Indeed, the heritability ranges from 40-50% in MDD to 80-85% in BD, and 
family studies indicate for MDD a two- to threefold and for BD a nearly tenfold increase in 
lifetime risk among first-degree relatives (11, 12). 
 
1.1.1 Psychiatric risk gene CACNA1C 
During the past decade, several genome wide association studies (GWAS) have identified 
CACNA1C as one of the strongest and most replicable genetic risk factors for the development 
of affective disorders (13–15). CACNA1C codes for the pore-forming α1C subunit of CaV1.2, the 
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major L-type voltage-gated calcium channel in the brain. L-type calcium channels (LTCC) are 
heteromultimeric protein complexes consisting of a pore-forming α1 as well as auxiliary β and 
α2δ subunits, which are required for functional expression and cell surface trafficking (16). 
However, the major channel characteristics including voltage sensor, ion selectivity, and 
pharmacological drug binding domains reside in the transmembrane α1 subunit (17). LTCCs 
exhibit long-lasting calcium currents upon strong membrane depolarization and are sensitive 
to blockade by dihydropyridines (DHP) such as nimodipine (18). There exist four different 
LTCC isoforms, two of them are expressed in the mammalian brain: CaV1.3, its α1 subunit is 
encoded by CACNA1D, accounts for ~20% of the brain LTCCs and the more abundant CaV1.2 
for approximately 80% (19–21). In the central nervous system (CNS), CaV1.2 is mainly localized 
in neuronal cell bodies, dendrites, and postsynaptic regions (22, 23). Brain CaV1.2 channels 
couple Ca2+ influx to neuronal gene transcription and play a pivotal role in regulating neuronal 
excitability, synaptic plasticity, dendritic development, and cell survival (17, 24).  
To date, several psychiatric risk-associated single nucleotide polymorphisms (SNP) in 
CACNA1C have been found in its intronic regions, thereby likely affecting CaV1.2 channel 
expression rather than function. Such genetic changes increase the disease probability, but are 
not deterministic. So far, both decreased and increased CaV1.2 levels have been associated with 
the main non-coding risk SNP rs1006737, suggesting that alternations in CACNA1C expression 
may be developmental-stage-, brain-region-, as well as cell-type-specific (25–28). In this 
context, it has been shown that Cacna1c depletion in forebrain glutamatergic neurons, either 
during development or adulthood, differentially modulates synaptic plasticity, stress 
susceptibility, and cognition in mice (29). These findings indicate an essential role for CaV1.2 
in memory formation during development, whereas CaV1.2 activation during adulthood is 
even detrimental for synaptic plasticity. Additionally, a number of studies provide convincing 
evidence that the common risk haplotype rs1006737 is related to impaired calcium signaling 
as well as compromised structure and function of brain regions relevant for characteristic 
behavioral changes observed in psychiatric patients (17, 30, 31). Particularly affected brain 
regions include the prefrontal cortex (PFC) and the hippocampus (HC), which are essential for 
stress regulation, emotion, cognition, learning, and memory (32). Supportive findings from 
transgenic animal models confirm the impact of the cross-disorder risk gene Cacna1c on PFC- 
and HC-dependent behaviors. For instance, constitutive Cacna1c haploinsufficiency leads to 
increased anxiety, antidepressant-like effects, and resilience to chronic stress in adult mice (33–
36) and causes deficits in social behavior and affective communication in juvenile rats (37). 
Furthermore, embryonic deletion of Cacna1c in mouse forebrain glutamatergic neurons results 
in diminished synaptic plasticity, cognitive decline, and reduced sociability (29). However, the 
underlying cellular and molecular mechanisms explaining how genetic CACNA1C risk 
variants contribute to the pathophysiology of neuropsychiatric disorders remain largely 
unknown (38, 39). 
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1.1.2 Environmental risk factors 
Vulnerability to affective disorders is not only based on genetic predisposition, but also 
involves diverse environmental risk factors such as intrauterine infections of the embryo, 
perinatal brain injuries attributed to birth complications, childhood maltreatment, migration, 
chronic stress and other adverse pathophysiological and psychosocial life events (40–42). 
There is accumulating evidence that such psychosocial stressors activate oxidative stress 
pathways, thereby disrupting the oxidant-antioxidant balance within the brain and causing 
oxidative damage to DNA, mitochondria, lipids, and proteins. Mitochondrial impairment, in 
turn, can accelerate the production of reactive oxygen species (ROS), which further modifies 
biological macromolecules and alters cellular functions (43). The brain is especially vulnerable 
to oxidative stress due to its high metabolic rate coupled with high oxygen consumption and 
limited levels of antioxidants (44). Additionally, the brain is particularly susceptible to lipid 
peroxidation because of the large amounts of polyunsaturated fatty acids present in neuronal 
membranes (45, 46). In the CNS, the accumulation of oxidative damage may result in loss of 
neuronal plasticity and function, and ultimately in apoptotic cell death, processes that have 
also been implicated as underlying mechanisms in the neuropathology of affective disorders 
(47, 48). 
Stress is also associated with the activation of the innate immune system and stressful 
experiences such as adverse childhood events induce long-term alterations of the immune 
response, lead to elevated levels of pro-inflammatory cytokines in blood and brain, and 
increase the susceptibility to develop psychiatric disorders later in life (7, 49–51). The early 
years of life constitute an important and sensitive developmental period in which 
physiological and behavioral responses to the environment are shaped (52). In line with the 
effects of psychiatric risk gene variants, early-life adverse experiences are also closely linked 
to detrimental morphological brain alterations, in this case PFC and HC volume loss (53, 54). 
Physical and emotional neglect during childhood can be simulated in rodents by post-weaning 
social isolation, which induces behavioral phenotypes related to various neuropsychiatric 
disorders including social withdrawal and cognitive inflexibility (55). Moreover, these 
prominent impairments due to juvenile social deprivation are accompanied by reduced PFC 
volume and decreased hippocampal synaptic plasticity (56). On the contrary, social and 
physical environmental enrichment, mimicking positive and protective life experiences, 
promotes HC neurogenesis, improves learning and memory, reduces depression-related 
behavior, and has beneficial effects on affective communication through ultrasonic 
vocalizations in rats (57, 58). 
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1.1.3 Mitochondrial dysfunction 
Various epidemiologic studies indicate that a single risk factor is not sufficient for the 
development of a certain psychiatric disorder. These complex diseases rather result from 
multiple interdependent processes involving the interaction of different genetic and 
environmental factors (9). At the cellular level, the substantial impact of genetic and 
environmental risks as well as their interplay on neuroplasticity and behavior might be 
mediated by mitochondrial dysfunction, which has been frequently associated with 
psychiatric disorders (59). Intra- and intercellular mechanisms of stress adaptation in the brain 
such as in the course of MDD and BD lead to a significant increase in energy demand (60). 
Mitochondria are the key organelles of cellular energy metabolism and play a crucial role in 
regulating calcium homeostasis, redox balance, synaptic plasticity, and cell viability, thereby 
influencing neural circuits that control high-order functions of the brain such as mood, 
cognition, and social behavior (61). In this context, emerging evidence strongly suggests 
impaired mitochondrial bioenergetics as possible underlying mechanism of regional brain 
abnormalities in mood disorders by compromising energy-dependent processes such as 
neuronal plasticity and the brain’s ability to resist or adapt to genetic and environmental 
stressors (62). 
While affective disorders are not considered as classic mitochondrial diseases, numerous 
studies propose a substantial link between mitochondrial dysfunction and these disorders in 
genetic and behavioral animal models, as well as in patients (63, 64). For example, patients 
suffering from mitochondrial diseases caused by genetic alterations affecting mitochondrial 
metabolism frequently develop symptoms of MDD, BD, psychosis, and personality changes 
(65, 66). Further, psychiatric symptoms are often prevalent years before the onset of cognitive 
and motor impairments in patients later diagnosed with neurodegenerative diseases, such as 
Alzheimer’s, Parkinson’s or Huntington’s disease (67), which all feature mitochondrial 
dysfunction in neurons as a major hallmark of their underlying pathology (68–70). Concurrent 
findings from neuro-imaging, post-mortem brain analyses, GWAS, and studies on peripheral 
biomarkers suggest that psychiatric disorders are accompanied by mitochondrial dysfunction 
(59, 71). These investigations revealed reduced complex I activity, increased ROS levels, 
decreased ATP production, downregulated expression of anti-apoptotic proteins, and 
upregulated expression of pro-apoptotic proteins in patients suffering from affective disorders 
or schizophrenia, all indicating impaired mitochondrial function. 
Mitochondria are highly dynamic and undergo permanent fission and fusion processes 
allowing for the transport, reorganization, and regeneration of these organelles within the cell. 
Intact mitochondrial fission and fusion dynamics are important for proper cristae formation, 
respiratory functions, and quality control through mitophagy. Perturbations in the structural 
dynamics lead to reduced energy supply, accumulation of dysfunctional mitochondria, and 
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increased ROS production. These phenomena are closely associated with both, enhanced 
inflammatory responses and the risk of psychiatric disorders including MDD and BD (72, 73). 
Overall, accumulating evidence suggests that mitochondrial dysfunction contributes to 
disease neuropathology and may therefore represent a converging point of alterations in 
complex interdependent processes involved in energy metabolism, cellular stress and calcium 
homeostasis (74). Furthermore, mitochondrial dysfunction is currently being discussed as a 
potential biomarker for affective disorders supporting early diagnosis, control of disease 
progression, and evaluation of treatment response (75). 
 
1.1.4 Neuroinflammation 
A growing body of evidence suggests the involvement of neuroinflammation and its primary 
mediators, the brain-resident microglia, in the neurobiology of psychiatric disorders including 
MDD, BD, schizophrenia, and autism (76–79). Several postmortem brain analyses have shown 
increased activation of microglia in depressed patients (80) as well as in subjects who 
committed suicide (81). Concordantly, recent in vivo positron emission tomography (PET) 
imaging studies, using microglial 18 kDa translocator protein (TSPO) radio ligands, identified 
elevated microglial activation in cortical areas of MDD and BD patients, which directly 
correlates with disease severity and duration (82–85). 
Microglia represent 10-15% of the total cell population within the CNS (86) and originate from 
hematopoietic stem cells in the yolk sac (87). They invade the brain early in development, 
differentiate into a highly ramified phenotype, and continuously survey their micro-
environment for signs of damage or pathogens (84). As the resident macrophages of the CNS, 
microglia regulate innate immunity in the brain and initiate inflammatory responses, which 
are essential for neuronal survival and maintenance during infection and sterile injury (88). 
However, excessive or prolonged neuroinflammation is associated with detrimental neuronal 
degeneration, synaptic deficits, and impaired cognition, thus eventually contributing to the 
development of psychiatric disorders (89). In response to changes in brain homeostasis 
microglial cells transform, morphologically and functionally, from a resting into an activated 
state. ROS production, metabolic reprogramming, and related glycolytic activity play a major 
role in coordinating these adaptive processes (90). Upon classical M1-like activation, microglia 
initiate signal transduction cascades resulting in the release of pro-inflammatory cytokines, 
chemokines and nitric oxide (NO) (87). Alternative M2-like polarization induces an anti-
inflammatory microglial phenotype, which promotes debris clearance and wound repair (88, 
91). Importantly, this classification system oversimplifies the existing diversity of microglial 
phenotypes and does not reflect the complexity of activation patterns (87). Microglia share 
phenotypic characteristics and immunological functions with circulating peripheral blood 
monocytes and, indeed, also their number is increased in patients with affective disorders 
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accompanied by a rise in plasma cytokines including pro-inflammatory interleukin 1β (IL-1β), 
IL-6, and tumor necrosis factor α (TNF-α) (92–94). 
A wide variety of studies indicate that exposure to chronic psychological stress causes 
microglial activation resulting in elevated pro-inflammatory cytokine release (77, 95). These 
can, in turn, reduce mitochondrial density and impair oxidative phosphorylation, which leads 
to increased ROS production and oxidative stress, thereby highlighting the close 
interconnection between different pathogenic processes (96–98). In addition, pro-
inflammatory cytokines modulate the tryptophan-kynurenine pathway and enhance 
microglial synthesis of the neurotoxic N-methyl-D-aspartate (NMDA) receptor agonist 
quinolinic acid contributing to hippocampal atrophy observed in depression as well as linking 
inflammation and excitotoxicity, which is also implicated in the pathogenesis of psychiatric 
disorders (92, 99, 100). 
 
1.1.5 Peripheral blood mononuclear cells as potential biomarker 
Human peripheral blood mononuclear cells (PBMCs) are a heterogeneous population of 
circulating immune cells including lymphocytes (T, B, and natural killer cells), monocytes, and 
dendritic cells. The frequencies of these populations vary across individuals, but are typically 
in the range of 70-90% for lymphocytes and 10-30% for monocytes, while the rarer dendritic 
cells only account for 1-2% (101). About 70% of circulating lymphocytes are T cells, 15% B cells 
and the remaining 15% consist of natural killer (NK) cells (102). The cytokine-producing, 
cytotoxic T and the antibody-producing B cells constitute the major cellular components of the 
adaptive immune response. NK cells are part of the innate immune system and destroy virally 
infected and tumor cells. Monocytes are phagocytic cells which screen the body for sites of 
inflammation and play an important role in innate immunity (103). Once migrated into tissues, 
they differentiate into macrophages. Dendritic cells are antigen-presenting cells, which 
interact with T and B cells to initiate adaptive immune responses (104). 
Besides comprising the main mediators of cellular immunity, PBMCs also provide an 
accessible source of mitochondria. Furthermore, it has been shown recently in nonhuman 
primates that the mitochondrial bioenergetics profile of blood monocytes and platelets is 
positively related to frontal cortex mitochondrial function and metabolism (105). Brain 
mitochondrial dysfunction, in turn, is significantly involved in the pathophysiology of 
psychiatric disorders as supported by substantial and growing literature (63, 106). In addition, 
a few studies already assessed mitochondrial function in circulating blood cells of psychiatric 
patients (107–109). Mitochondria isolated from PBMCs of patients with chronic schizophrenia 
showed decreased complex I activity, but no changes in complex II and III compared to healthy 
individuals (107). Basal and maximal mitochondrial respiration was significantly lower in 
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platelets (108) as well as PBMCs (109) of depressed patients versus healthy controls. 
Collectively, these findings indicate that PBMCs may be a valuable surrogate of brain function 
and establish mitochondrial perturbations in PBMCs as biomarker for neuropsychiatric 
illnesses. 
Previous research has investigated mitochondrial alterations mostly in patients, however, 
whether mitochondrial dysfunction precedes the onset of psychiatric disorders has not been 
investigated in detail so far. Therefore, it remains to be elucidated, if changes in mitochondrial 
bioenergetics are already present in healthy individuals with psychiatric disease-relevant 
genetic or environmental risk factors and can, thus, serve as prognostic marker before clinical 
symptoms manifest. 
 
1.2 In vitro stress models 
Defined cell model systems are optimally suited to investigate signaling pathways likely 
involved in the pathophysiology of neuropsychiatric disorders and associated mitochondrial 
perturbations as well as metabolic impairments. Further, these in vitro models allow for 
controlled manipulations facilitating systematic studies of gene-environment interactions and 
their impact on mitochondrial morphology, integrity and function. 
 
1.2.1 Glutamate-induced oxytosis in HT22 cells 
Oxidative stress has been frequently linked to the pathophysiology of affective disorders. In 
MDD patients and in animal models, decreased levels of antioxidants and antioxidant 
enzymes were detected, suggesting an impaired antioxidant defense associated with 
depressive behavior (44, 110). The immortalized mouse hippocampal HT22 cell line serves as 
a well-established model system to investigate oxidative stress, which reflects a common 
cellular response to environmental stress, and allows for the targeted, e.g. siRNA-mediated, 
manipulation of gene expression (111, 112). 
Since neuronal HT22 cells do not express functional ionotropic glutamate receptors, 
glutamate-induced cell death is mediated by a caspase-independent, oxidative stress-
dependent pathway called oxytosis, a term first introduced by Tan et al. in 2001 (113). As 
summarized in Figure 1, millimolar extracellular concentrations of glutamate inhibit cystine 
uptake via the plasma membrane-localized cystine/glutamate antiporter (XCˉ), which is, after 
reduction to cysteine, essential for the synthesis of the main brain antioxidant glutathione 
(GSH) (114). Cellular GSH depletion, in turn, involves reduced glutathione peroxidase 4 
(GPX4) and enhanced 12/15 lipoxygenase (12/15-LOX) activities (112, 115). In HT22 cells, this 
consecutively leads to an increase in ROS formation and lipid peroxidation initiating the 
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activation and mitochondrial translocation of pro-apoptotic BH3-interacting domain death 
agonist (BID) and the fission-inducing guanosine triphosphatase dynamin-related protein 1 
(Drp1) (111, 116, 117). Upon mitochondrial transactivation, these proteins then mediate, at the 
level of mitochondria, fission, Ca2+ overload, ROS production, loss of membrane potential 
(ΔΨm), ATP depletion, and respiratory dysfunction (118). Finally, these fatal mitochondrial 
perturbations result in disruption of the mitochondrial membrane and release of apoptosis 
inducing factor (AIF) causing nuclear DNA fragmentation and ultimately neuronal cell death 
(119, 120). 
 
 
Figure 1. Molecular mechanisms of glutamate-induced oxidative stress in HT22 cells 
The scheme illustrates the major hallmarks of oxytosis in immortalized hippocampal HT22 cells. XCˉ, 
cystine/glutamate antiporter; GPX4, glutathione peroxidase 4; 12/15-LOX, 12/15 lipoxygenase; ROS, 
reactive oxygen species; BID, BH3-interacting domain death agonist; Drp1, dynamin-related protein 1; 
ΔΨm, mitochondrial membrane potential; ATP, adenosine triphosphate; AIF, apoptosis inducing factor. 
 
1.2.2 Glutamate-induced excitotoxicity in primary cortical neurons 
First described by Olney in 1986 (121), excitotoxicity refers to the toxic effect of prolonged 
neuronal over-activation by excitatory amino acids and plays a central role in a wide variety 
of neurological diseases including ischemic stroke, epilepsy as well as psychiatric disorders 
(99). Glutamate is the primary excitatory neurotransmitter in the CNS and binds, amongst 
others, to ionotropic glutamate receptors. These ligated-gated ion channels are classified into 
three subtypes: N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionate (AMPA), and kainate receptors (122). Under pathological conditions, 
excessive extracellular glutamate concentrations are primarily associated with a massive 
influx of calcium in particular via the over-stimulation of highly Ca2+-permeable NMDA 
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receptors as well as voltage-gated Ca2+ channels, which are indirectly activated by glutamate-
induced depolarization (123) (Figure 2). In neurons, intracellular calcium overload 
subsequently triggers mitochondrial Ca2+ accumulation, a critical step in glutamate 
excitotoxicity. Mitochondrial Ca2+ loading, in turn, promotes mitochondrial membrane 
depolarization (ΔΨm), superoxide generation, respiratory inhibition, and ATP depletion (124). 
The resulting mitochondrial dysfunction ultimately induces the opening of the mitochondrial 
permeability transition pore (mPTP), thus causing the disruption of metabolic gradients 
between mitochondria and cytosol and the release of pro-apoptotic cytochrome c (CytC), 
which mediates caspase activation and DNA damage (99).  
 
 
Figure 2. Molecular mechanisms of glutamate-induced neuronal excitotoxicity 
The schematic shows the main molecular mechanisms involved in excitotoxic cell death in neurons. 
NMDAR, N-methyl-D-aspartate receptor; LTCC, L-type calcium channel; ΔΨ, membrane potential; 
[Ca2+]i, intracellular calcium concentration; ΔΨm, mitochondrial membrane potential; ATP, adenosine 
triphosphate; ROS, reactive oxygen species; nNOS, neuronal nitric oxide synthase; NO, nitric oxide; 
O2• ‾, superoxide anion; ONOO-, peroxynitrite; mPTP, mitochondrial permeability transition pore; CytC, 
cytochrome c; DNA, deoxyribonucleic acid. 
 
Additionally, Ca2+ entry through NMDA receptors stimulates neuronal nitric oxide synthase 
(nNOS). Activation of nNOS leads to NO production, which inhibits the mitochondrial 
electron transport chain (ETC) and reacts with superoxide anions (O2•ˉ) to form toxic 
peroxynitrites, thereby further contributing to excitotoxic neuronal cell death (122, 125). It is 
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generally agreed that glutamate-induced cell death is not a uniform event, but rather a mixed 
form of necrosis and apoptosis with the severity of the excitotoxic insult determining the 
prevalent of both pathways (122, 126). Characterized by loss of plasma membrane integrity, 
vacuolization and cell swelling, necrosis predominates after intense glutamate insults, 
whereas mild glutamate exposure results in apoptotic cell death featuring chromatin 
condensation, nuclear shrinkage, and DNA oligonucleosomal degradation (127, 128). 
 
1.2.3 LPS-induced inflammation in primary microglia 
Microglial activation plays a prominent role in the pathogenesis of affective disorders (76, 129) 
and its underlying molecular pathways can be systematically studied in an in vitro model of 
lipopolysaccharide-stimulated primary cultures (Figure 3). As integral part of gram-negative 
bacterial cell walls, lipopolysaccharide (LPS) represents a highly immunogenic antigen and 
polarizes microglia towards a M1-like phenotype. Microglial cells express intracellular or 
membrane-bound pattern recognition receptors (PRR), including nucleotide-binding 
oligomerization domain (NOD)-like receptors (NLR) or Toll-like receptors (TLR), and thus 
recognize pathogen-associated molecular patterns (PAMPs) such as the TLR4 ligand LPS. 
Upon PRR activation, microglia acquire an amoeboid-like phenotype, migrate to 
inflammatory sites and promote innate immune responses (130, 131). Even in the absence of 
overt pathogenic infection, cell damage or stress responses may activate microglia via 
endogenous damage-associated molecular patterns (DAMPs) such as ATP or mitochondrial 
DNA (mtDNA), which also bind to PRRs (132, 133). This triggers the assembly of NOD-, LRR- 
and pyrin domain-containing 3 (NLRP3) and caspase-1 to form the inflammasome, a multi-
protein signaling complex, leading to the processing of pro-IL-1β as well as pro-IL-18 to active 
IL-1β and IL-18 respectively (134). In addition, a particular role has been described for oxidized 
mtDNA and mitochondria-derived ROS in pathways that activate the inflammasome (135–
138). 
The binding of LPS to TLR4 further leads to the activation of redox-sensitive transcription 
factors, such as nuclear factor κB (NF-κB), and subsequently to an increased expression of pro-
inflammatory TNF-α, IL-6, inducible nitric oxide synthase (iNOS) as well as inflammasome 
components (139). The oxidation of L-arginine (L-Arg) by iNOS produces neurotoxic NO, 
which, in turn, inhibits oxidative phosphorylation (OXPHOS), thereby shifting the energy 
metabolism of the cell towards glycolysis (140). Recent studies demonstrated that ATP-
mediated Ca2+ influx through the purinoceptor P2X7 is required for sustained reduction of the 
mitochondrial membrane potential (ΔΨm) and generation of mitochondrial ROS upstream of 
NLRP3 inflammasome formation (141, 142). The elevation in intracellular Ca2+ levels 
constitutes a central element in microglial activation (143) and emerging evidence suggests 
LTCCs to be involved in [Ca2+]i increase after LPS stimulation (144). 
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Figure 3. Molecular mechanisms of LPS-induced microglial activation 
The scheme provides an overview of the major intracellular mechanisms contributing to the inflammatory 
activation of microglia. PAMPs, pathogen-associated molecular patterns; LPS, lipopolysaccharide; 
DAMPs, damage-associated molecular patterns; PRR, pattern recognition receptor; NLR, nucleotide-
binding oligomerization domain (NOD)-like receptor; TLR, Toll-like receptor; ox-mtDNA, oxidized 
mitochondrial DNA; ROS, reactive oxygen species; NLRP3, NOD-, leucine-rich repeat (LRR)- and pyrin 
domain-containing 3; NF-κB, nuclear factor κB; IL, interleukin; TNF-α, tumor necrosis factor α; ΔΨm, 
mitochondrial membrane potential; OXPHOS, oxidative phosphorylation; L-Arg, L-arginine; iNOS, 
inducible nitric oxide synthase; NO, nitric oxide; LTCC, L-type calcium channels; P2X7, ATP-binding 
purinoceptor; ATP, adenosine triphosphate. 
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2 Aim and objectives 
As part of the DFG Research Group FOR 2107 “Neurobiology of affective disorders: A 
translational perspective on brain structure and function” (145) this project focused, in a 
translational setting, on the effects of defined gene-environment interactions on brain 
mitochondrial integrity and function in order to provide new insights into pathophysiological 
mechanisms of affective disorders and to identify novel therapeutic targets with potential 
relevance for future treatment strategies. 
The specific research objectives of the present work were as follows: 
(1) To study the impact of reduced Cacna1c gene expression in combination with glutamate-
induced oxidative stress on GSH levels, lipid peroxidation, mitochondrial morphology and 
function, Ca2+ homeostasis, and cell viability in mouse hippocampal HT22 cells. 
(2) To evaluate the effect of Cacna1c haploinsufficiency on [Ca2+]i, mitochondrial bioenergetics, 
ATP levels, and cell viability following glutamate-mediated excitotoxicity in primary neuronal 
cultures of rat cortex. 
(3) To examine the impact of Cacna1c+/- deficiency and LPS stimulation on cell morphology, 
metabolism as well as inflammatory cytokine, chemokine, and NO release in primary rat 
microglial cultures. 
(4) To assess the effects of gene-environment interactions on mitochondrial bioenergetics, 
membrane potential, ROS production, and respiratory chain complex levels in isolated 
mitochondria from PFC and HC, both representing particularly susceptible brain regions in 
neuropsychiatric disorders, using a constitutive heterozygous Cacna1c rat model in 
combination with a four-week exposure to either social isolation, standard housing, or social 
and physical environmental enrichment during the juvenile developmental period. 
(5) To investigate the impact of psychiatric disease-relevant genetic and environmental risk 
factors on mitochondrial function in human PBMCs of healthy subjects by analyzing 
mitochondrial ROS levels and respiration profiles. 
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3 Materials and methods 
Cell culture sterile plastic ware was obtained from Sarstedt (Nümbrecht, Germany) and 
Greiner (Frickenhausen, Germany). Unless otherwise stated, all reagents were purchased from 
Sigma-Aldrich (Munich, Germany). All buffers and solutions were prepared with 
demineralized, ultrapure water using SG Ultra Clear UV Plus Pure Water System (VWR, 
Darmstadt, Germany). Demineralized water for aseptic preparations was sterilized by a steam 
autoclave (Systec V-40; Systec GmbH, Wettenberg, Germany) or sterile filtration (0.22 µm pore 
size; Sarstedt, Nümbrecht, Germany). DNA/RNA oligonucleotide synthesis and DNA 
sequencing were performed by Eurofins (Hamburg, Germany). 
 
3.1 HT22 cells 
HT22 cells were generated by Prof. David Schubert (Salk Institute, San Diego, CA, USA) and 
obtained from Prof. Gerald Thiel (University of Saarland, Homburg, Germany). HT22 cells 
were originally immortalized from primary hippocampal neurons using a temperature-
sensitive SV-40 T antigen and selected from HT4 cells based on sensitivity to glutamate (146, 
147). HT22 cells were cultured at 37°C and 5% CO2 in Dulbecco’s Modified Eagle’s Medium 
(DMEM High Glucose; Sigma-Aldrich, Munich, Germany) supplemented with 10% fetal 
bovine serum (FBS; Biochrom, Berlin, Germany), 20 mM HEPES, 100 units/ml penicillin, 
100 µg/ml streptomycin, and 2 mM glutamine. HT22 cell cultures were split twice a week at a 
ratio of 1:10-1:20. For cell detachment 0.05% trypsin/0.02% EDTA in isotonic phosphate 
buffered saline (PBS) was used. 
The cells were transfected with an optimized concentration of 40 nM siRNA using 
Lipofectamine RNAiMAX (Thermo Fisher Scientific, Darmstadt, Germany) in antibiotic-free 
growth medium. The siRNA sequences were as follows: scrambled Cacna1c siRNA (siScr, 5‘-
AUU GGC GCA CUA UUA GAC U-3‘), Cacna1c siRNAs (siCacna1c 1, 5’-GGA AAG CUC 
UAU ACC UGU U-3‘; siCacna1c 2, 5‘-CUA GUA UCU UUA CAU UAG A-3‘; siCacna1c 3, 5‘-
GUG CCA CCG UAU UGU CAA U-3‘). The plated cells were treated with millimolar 
concentrations of glutamate for 15 to 18 hours unless otherwise stated and assayed 30 to 48 
hours after transfection. The LTCC blocker nimodipine (100 mM stock solution in DMSO; 
Cayman Chemical, Ann Arbor, MI, USA) was used in a final concentration of 100 µM and 
applied together with 6 to 8 mM glutamate for 16 hours (see Figure 8 for chemical structure). 
 
3.1.1 Reverse transcription PCR 
HT22 cells were seeded at a density of 180,000 cells/well in 6-well plates. Total RNA was 
isolated with the InviTrap Spin Universal RNA Mini Kit (Stratec Biomedical, Birkenfeld, 
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Germany) 24 h after siRNA transfection. Reverse transcription polymerase chain reaction (RT-
PCR) was performed using SuperScript III One-Step RT-PCR system with platinum Taq DNA 
polymerase (Thermo Fisher Scientific, Darmstadt, Germany) and the following primers: 
Cacna1c (502 bp) forward 5‘-CAA CGC AAC CAT CTC TAC CG-3‘ and reverse 5‘-CAG TGC 
CTT CAC GTC GAA TC-3‘; Gapdh (399 bp) forward 5‘-CGT CTT CAC CAC CAT GGA GAA 
GGC-3‘ and reverse 5‘-AAG GCC ATG CCA GTG AGC TTC CC-3‘. The PCR protocol 
included: Cacna1c 30 min 45°C cDNA synthesis, 2 min 94°C denaturation, 29x [15 sec 94°C 
denaturation, 45 sec 55°C annealing, 45 sec 68°C extension], 5 min 68°C final extension; Gapdh 
30 min 60°C, 2 min 95°C, 26x [30 sec 95°C, 1 min 57°C, 2 min 70°C], 10 min 70°C (T-personal 
thermocycler; Biometra GmbH, Göttingen, Germany). The amplified products were loaded on 
a 1.5% agarose gel (Biozym Scientific GmbH, Hessisch Oldendorf, Germany) stained with 
ethidium bromide. Electrophoresis was performed at 70 V for ~30 min in 40 mM Tris-
acetate/0.1 mM EDTA buffer. GeneRuler 100 bp Plus DNA Ladder (Thermo Fisher Scientific, 
Darmstadt, Germany) served as size standard. The resulting DNA bands were visualized 
under UV light using a ChemiDoc XRS system (Bio-Rad Laboratories, Hercules, CA, USA). 
 
3.1.2 Protein analysis 
Protein extraction and Western blot were performed according to established protocols (119). 
Briefly, cells were seeded at a density of 180,000 cells/well in 6-well plates and lysed 48 h after 
siRNA transfection in 0.25 M D-mannitol, 0.05 M Tris base, 1 mM EDTA, 1 mM EGTA, 1 mM 
DTT, and 1% Triton X-100 supplemented with protease and phosphatase inhibitor cocktail 
tablets (Roche Diagnostics, Mannheim, Germany). Total protein amounts were determined 
using the Pierce bicinchoninic acid (BCA) Protein Assay Kit (Thermo Fisher Scientific, 
Darmstadt, Germany). Under alkaline conditions, the containing Cu2+ is concentration-
dependently reduced by protein to Cu+, which forms a water-soluble, purple-colored complex 
with BCA. The resulting absorbance was detected at 595 nm with a FLUOstar OPTIMA reader 
(BMG Labtech, Ortenberg, Germany). Protein concentrations were calculated with reference 
to a standard curve of 0-2 µg/µl bovine serum albumin (BSA). 
Subsequently, proteins contained were separated by size using sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). Therefore, 50 to 60 µg protein in sample 
buffer (60 mM Tris HCl, 2% SDS, 10% glycerol, 5% β-mercaptoethanol, and 0.01% 
bromophenol blue) were loaded on 7.5% and 12.5% SDS-polyacrylamide gels respectively. 
Spectra Multicolor High Range Protein Ladder (Thermo Fisher Scientific, Darmstadt, 
Germany) was used as molecular weight (MW) marker. Gel electrophoresis was performed at 
60 V for ~30 min followed by further separation at 120 V for ~1.5 h in running buffer (0.2 M 
glycine, 24.8 mM Tris base, 3.5 mM SDS). After electrophoresis, the proteins were transferred 
from the gel onto a polyvinylidene difluoride (PVDF) membrane (Roche Diagnostics, 
  Materials and methods 
15 
Mannheim, Germany) by wet blot at 65 V for ~3.5 h in transfer buffer containing 0.2 M glycine, 
24.8 mM Tris base, and 20% (v/v) methanol. Next, the membranes were blocked in blocking 
buffer (5% (w/v) skim milk powder, 0.5 M NaCl, 12 mM Tris base, 0.05% (v/v) Tween 20) and 
incubated with the respective antibodies overnight at 4°C (Table 1). Protein detection was 
realized using peroxidase labeled secondary antibodies (Vector Laboratories, Burlingame, CA, 
USA) and luminol based HRP-Juice Plus (PJK GmbH, Kleinblittersdorf, Germany). The 
resulting chemiluminescence was imaged with a ChemiDoc XRS system (Bio-Rad 
Laboratories, Hercules, California, USA). Densitometric protein quantification was performed 
using the Bio-Rad Image Lab Software. 
Table 1. Antibody specifications 
Antibody Dilution MW (kDa) Host Company 
CaV1.2 1:200 240 Rabbit Alomone Labs 
Vinculin 1:20,000 116 Mouse Sigma-Aldrich 
PGC1α 1:1,000 91 Rabbit Rockland 
Drp1 1:500 80 Mouse BD Bioscience 
Mfn2 1:1,000 80 Rabbit Cell Signaling 
p62 1:1,000 62 Rabbit Cell Signaling 
α-Tubulin 1:10,000 55 Mouse Sigma-Aldrich 
MCU 1:1,000 30 Rabbit Cell Signaling 
Fis1 1:500 17 Rabbit Enzo Life Science 
LC3B 1:500 14-16 Rabbit Cell Signaling 
 
3.1.3 Mitochondrial isolation 
Mitochondria were isolated using a pump-controlled cell homogenizer (Isobiotec, Heidelberg, 
Germany) with a clearance of 10 µm and a constant pump flow rate of 700 µl/min according 
to existing protocols (148). In brief, the trypsinized HT22 cell suspension was filled in a 1 ml 
gas tight glass syringe (Supelco, Munich, Germany) and homogenized with three strokes 
through the cell homogenizer. Subsequently, the homogenate was centrifuged at 800 xg for 
10 min at 4°C. The supernatant, referred to as total lysate, was transferred to a new tube and 
centrifuged at 9,000 xg, again for 10 min at 4°C (Heraeus fresco 17; Thermo Fisher Scientific, 
Darmstadt, Germany). The resulting supernatant contains the cytosolic fraction and the 
emerging pellet represents the crude mitochondrial fraction, which was slowly resuspended 
in 150 µl mitochondrial isolation buffer (70 mM sucrose, 210 mM mannitol, 5 mM HEPES, 
1 mM EGTA, 0.5% (w/v) BSA; pH 7.2). All steps were performed on ice. The total protein 
concentration was determined using the Pierce BCA Protein Assay Kit (Thermo Scientific, 
Darmstadt, Germany) with BSA standards based on mitochondrial isolation buffer. Sixty 
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microgram protein per fraction were separated on a two-phase SDS-polyacrylamide gel 
(7.5/15%). The following antibodies were used: CaV1.2 (1:200; Alomone Labs, Jerusalem, 
Israel), α-tubulin (1:10,000), and Tim23 (1:2,000; BD Biosciences, Franklin Lakes, NJ, USA). 
 
3.1.4 Determination of total glutathione 
The amount of total glutathione in HT22 cells was quantified using the luminescence-based 
GSH/GSSG-Glo Assay (Promega, Mannheim, Germany) in accordance with the 
manufacturer’s instructions. The assay is based on the GSH-dependent conversion of luciferin-
NT to luciferin by glutathione S-transferase coupled to a firefly luciferase reaction. The 
produced light depends on the amount of luciferin formed, which, in turn, is depending on 
the amount of GSH present. HT22 cells were plated at a density of 6,000 cells/well in white-
with-clear-bottom 96-well plates. Twenty-four hours after seeding, the cells were incubated 
for 2, 4, and 6 hours with 10 mM glutamate. The resulting luminescence, which is proportional 
to the amount of GSH, was detected with a FLUOstar OPTIMA reader (BMG Labtech, 
Ortenberg, Germany). Absolute glutathione concentrations were calculated from a GSH 
standard curve. 
 
3.1.5 Mitochondrial morphology 
The evaluation of mitochondrial morphology was carried out as reported and validated 
previously with minor modifications (111). In brief, 14,000 cells/well were seeded in 8-well 
ibiTreat plates (Ibidi, Martinsried, Germany). To visualize mitochondria, cells were incubated 
with 0.2 µM MitoTracker Deep Red (Thermo Fisher Scientific, Darmstadt, Germany) for 
30 min before adding glutamate. After the fixation with 4% paraformaldehyde (PFA), images 
were acquired using a fluorescence microscope (DMI6000 B; Leica Microsystems, Wetzlar, 
Germany) at 63x magnification. To generate reliable results according to previous validation, 
500 cells per condition were counted and classified by their mitochondrial morphology into 
three different categories. Category 1 is defined by elongated and equally distributed 
mitochondria. Category 2 is characterized by partially fragmented mitochondria that are still 
distributed throughout the cytosol. Finally, Category 3 is represented by strongly fragmented 
mitochondria that are located around the nucleus. Three independent experiments were 
performed and the investigator was always blinded to the treatment history. 
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3.1.6 ATP measurement 
The determination of ATP levels was performed using the ViaLight Plus Kit (Lonza, Verviers, 
Belgium) according to the manufacturer’s protocol. Briefly, cells were lysed, transferred to a 
white-walled 96-well plate and the luciferase-containing ATP monitoring reagent was added. 
Luciferase catalyzes the formation of light from ATP and the substrate luciferin. The emitted 
luminescence intensity is linearly related to the cellular ATP concentration and was measured 
using a FLUOstar OPTIMA reader (BMG Labtech, Ortenberg, Germany). 
 
3.1.7 Measurement of the oxygen consumption rate 
The oxygen consumption rate (OCR) as an indicator of mitochondrial respiration was 
identified with a Seahorse XFe96 Analyzer (Agilent Technologies, Waldbronn, Germany). 
 
 
Figure 4. Seahorse assay principle 
The scheme illustrates the substrates (media supplements) and compounds used in the Seahorse 
assays (highlighted in red) and their respective function/effect on cell metabolism. OCR, oxygen 
consumption rate; ECAR, extracellular acidification rate; 2-DG, 2-deoxy-D-glucose (hexokinase 
inhibitor); OXPHOS, oxidative phosphorylation; TCA, tricarboxylic acid cycle; Rot, rotenone (complex I 
inhibitor); AA, antimycin A (complex III inhibitor); Oligo, oligomycin (ATP synthase inhibitor); FCCP, 
carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (protonophore). 
Materials and methods 
18 
The extracellular flux analyzer simultaneously measures the two major energy pathways of 
the cell, mitochondrial respiration and glycolysis, in real time as oxygen consumption rate 
(OCR) and extracellular acidification rate (ECAR) respectively (Figure 4). Changes to the 
concentrations of dissolved oxygen and free protons are assessed in a transient microchamber 
using inert optical micro sensors. The system allows for the consecutive injection of different 
modulators of the ETC. The compounds and final concentrations used are as follows: 
oligomycin 3 µM, FCCP 0.5 µM, rotenone 0.1 µM, and antimycin A 1 µM. Three basal and 
three measurements after each injection were recorded. HT22 cells were assayed in DMEM 
containing 143 mM NaCl, 25 mM D-glucose, 2 mM glutamine, and 1 mM sodium pyruvate 
with an adjusted pH of 7.35. 
 
3.1.8 Flow cytometry 
Several parameters associated with glutamate-induced oxidative stress, such as lipid 
peroxidation, mitochondrial ROS formation, mitochondrial membrane potential, 
mitochondrial Ca2+ levels, and cell death, were analyzed with a Guava easyCyte 6-2L flow 
cytometer (Merck Millipore, Darmstadt, Germany) using different fluorescent dyes. HT22 cells 
were plated at 30,000-55,000 cells/well in a 24-well format. Measurements were performed in 
triplicates, each with a total count of 10,000 cells, and are representative of a least three 
independent experiments. 
Lipid peroxidation 
BODIPY 581/591 C11 (4,4-difluoro-5-(4-phenyl-1,3-butadienyl)-4-bora-3a,4a-diaza-s-
indacene-3-undecanoic acid; Thermo Fisher Scientific, Darmstadt, Germany) was utilized as a 
sensor for the oxidation of lipids and membranes. Oxidation of the polyunsaturated 
butadienyl portion of the dye results in a shift of the fluorescence emission peak from red 
(690/50 nm) to green (525/30 nm). Here, HT22 cells were treated with 9 mM glutamate 24 h 
after siRNA transfection. Following 8 h of glutamate treatment, the cells were stained with 
2 µM BODIPY dye for 1 h at 37°C. 
Mitochondrial superoxide formation 
Superoxides are the predominant reactive oxygen species in mitochondria and were detected 
by incubation of the cells with 1.25 µM MitoSOX Red indicator (Thermo Fisher Scientific, 
Darmstadt, Germany) for 30 min at 37°C (117). MitoSOX is selectively hydroxylated by 
superoxides leading to an increase in red fluorescence. Fluorescence signals were excited at 
488 nm with emission detection at 690/50 nm. 
Mitochondrial membrane potential 
Mitochondrial membrane depolarization was determined using the MitoPT TMRE Kit 
(ImmunoChemistry Technologies, Hamburg, Germany) following the recommendations of 
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the manufacturer. Tetramethylrhodamine ethyl ester (TMRE) is a cationic, potential-sensitive 
fluorescent dye and accumulates, under physiological conditions, in negatively charged 
mitochondria resulting in the emission of red fluorescence. If the mitochondrial membrane 
potential collapses, e.g. in apoptotic or metabolically stressed cells, TMRE is dispersed 
throughout the cell cytosol indicated by a loss in 690/50 nm fluorescence. HT22 cells were 
collected and stained with 0.2 µM TMRE for 30 min at 37°C. The depolarizing reagent CCCP 
(carbonyl cyanide 3-chlorophenylhydrazone) was used in a final concentration of 50 µM and 
served as additional positive control. 
Mitochondrial calcium concentration 
To selectively study mitochondrial calcium levels, the cell-permeant Rhod-2 AM (rhodamine-
2 acetoxymethyl ester; Thermo Fisher Scientific, Darmstadt, Germany) was reduced to the 
colorless, non-fluorescent Dihydrorhod-2 AM with sodium borohydride (NaBH4). 
Dihydrorhod-2 AM exhibits Ca2+-dependent increase in red fluorescence after re-oxidation 
and cleavage of the acetoxymethyl ester, processes that occur rapidly in the mitochondrial 
environment. HT22 cells were harvested and incubated with 2 µM of the reduced dye in 
DMEM without serum for 30 min. 
Cell death 
Cell death was evaluated using the Annexin V-FITC Detection Kit (Promokine, Heidelberg, 
Germany) in accordance with the manufacturer’s instructions. The two containing dyes 
Annexin V and propidium iodide (PI) stain early apoptotic and dead cells respectively. In early 
apoptotic cells phosphatidyl serine is translocated from the inner to the outer site of the plasma 
membrane. Once on the cell surface, phosphatidyl serine is detected by the FITC-labeled 
phospholipid-binding protein Annexin V (green, 525/30 nm). Late apoptotic and necrotic cells 
are characterized by a loss of membrane integrity and are, thus, permeable to propidium 
iodide, which intercalates into DNA showing red staining (690/50 nm). Shortly, HT22 cells 
were trypsinized and the cell suspensions incubated with 5 µl/ml of each dye for 5 min at room 
temperature. 
 
3.1.9 Cell viability 
Metabolic activity as correlate for cell viability was assessed by a colorimetric assay where 
yellow MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) is NADH-
dependently reduced to a water-insoluble, purple-colored formazan product. After incubation 
with 0.5 mg/ml MTT for 1 h at 37°C, the medium was removed and the plates were frozen at  
-80°C for at least 1 h. The formazan crystals were solved in DMSO and incubated at 37°C for 
30 min, followed by quantitative absorbance measurement at 570 nm with a reference filter at 
630 nm (FLUOstar OPTIMA reader; BMG Labtech, Ortenberg, Germany). 
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As described previously, the xCELLigence Real-Time Cell Analysis (RTCA; Roche 
Diagnostics, Mannheim, Germany) system allows cell viability to be measured continuously 
in real time via electrical impedance readout (149). Briefly, attached and proliferating cells 
cause a high and further increasing impedance signal, whereas the detachment of dying cells 
leads to a decrease in electrical impedance. Changes in the impedance are depicted as 
normalized cell index. For both assays HT22 cells were seeded in 96-well plates at 6,000-8,000 
cells per well. 
 
3.1.10 Statistical analysis 
All data are presented as mean values with standard deviation (SD). Multiple comparisons 
were performed by one-way analysis of variance (one-way ANOVA) followed by Scheffé’s 
post-hoc test. All experiments were performed in 3 to 8 replicates per treatment condition, as 
indicated, and were independently repeated at least twice for confirmation of the results. The 
parameters presented were calculated using the WinSTAT statistics Add-In for Microsoft 
Excel (R. Fitch Software, Bad Krozingen, Germany). A statistical significant difference was 
assumed at p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***). 
 
3.2 Cacna1c rat knockout model 
Constitutive heterozygous Cacna1c+/- rats were generated by SAGE Labs (now Horizon 
Discovery Ltd., Cambridge, UK) on a Sprague-Dawley background via zinc-finger nucleases 
following a previously established protocol (150). Cacna1c+/- rats carry a 4 base pair (bp) 
deletion at 460649-460652 bp in the genomic sequence resulting in an early stop codon in exon 
6. Since a homozygous knockout is embryonically lethal (151), wildtype females (Charles 
River, Sulzfeld, Germany) and heterozygous Cacna1c+/- males were paired for breeding to 
obtain offspring from both genotypes. Breeding was performed by Theresa Kisko and Moria 
Braun (research group of Prof. Rainer Schwarting, Markus Wöhr) at the Faculty of Psychology, 
University of Marburg, Germany. All animal procedures were conducted in strict accordance 
with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals 
and the relevant local or national rules and regulations of Germany and were subject to prior 
authorization by the local government (MR 20/35 Nr. 19/2014; Tierschutzbehörde, 
Regierungspräsdium Gießen, Germany). 
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3.3 Primary rat neurons 
One or two days prior to dissection, the respective cell culture plates were coated with 
polyethyleneimine solution (0.005% (w/v) PEI, 50 mM boric acid, 24 mM sodiumtetraborate 
decahydrate; pH 8.4) for 3 h at 37°C. After 3x washing with aqua bidest and 30 min UV 
treatment, the plates were filled with Minimum Essential Medium (MEM; Thermo Fisher 
Scientific, Darmstadt, Germany) supplemented with 0.9 mM HEPES sodium salt, 56 mM 
glucose, 26 mM sodium bicarbonate, 16 mM potassium chloride, 1 mM sodium pyruvate, 
2 mM glutamine, 10 U/ml penicillin, 10 µg/ml streptomycin, and 10% (v/v) FBS (Biochrom, 
Berlin, Germany), adjusted to pH 7.2 and stored at 37°C, 5% CO2. 
 
 
Figure 5. Preparation of cortical tissue from E18 rat embryos 
a First, the embryo’s head was cut off using scissors. b Then, the brain was carefully dissected out of 
the skull. c Subsequently, the isolated brain was placed ventral side up and the meningeal tissue was 
completely removed from the fore- and midbrain region using forceps. d The brain was then turned on 
its dorsal side to make a sagittal incision (dashed line) between the two hemispheres. Finally, this cut 
allowed to unfold (arrow) and separate (e, dashed line) the cortical tissue (f, dashed mark) from the 
hippocampus, thalamus, and hypothalamus. 
 
Primary cultures of cortical neurons were prepared from embryonic day 18 (E18) Sprague-
Dawley rats. To this end, pregnant rats were deeply anesthetized with isoflurane (Baxter, 
Unterschleißheim, Germany), then decapitated, and the embryos quickly removed. Cortices 
of both brain hemispheres were dissected as detailed in Figure 5 and transferred to separate 
tubes for each embryo filled with 1 ml ice-cold Hank’s Balanced Salt Solution (HBSS; Thermo 
Fisher Scientific, Darmstadt, Germany; supplemented with 9 mM HEPES sodium salt, 
100 U/ml penicillin, and 100 µg/ml streptomycin; pH 7.2). Additionally, the remaining brain 
tissue of each embryo was collected for genotyping. After washing once with HBSS, the 
cortices were incubated with pre-warmed trypsin solution (1 mg/ml in HBSS) for 15 min in the 
Materials and methods 
22 
water bath. Next, deoxyribonuclease I (100 µg/ml) was added for 30 sec, followed by two 
washing steps with HBSS and a 2 min-incubation with pre-warmed trypsin inhibitor (1 mg/ml 
in HBSS) at room temperature. After washing twice with HBSS, the cortical cells were 
mechanically dissociated by slow trituration (15-20x) with a P1000 pipette before adding 1 ml 
NB+ (Neurobasal medium plus B-27 Supplement; Thermo Fisher Scientific, Darmstadt, 
Germany; complemented by 2 mM glutamine, 100 U/ml penicillin, and 100 µg/ml 
streptomycin). Subsequently, each cell suspension was centrifuged at 1000 rpm for 5 min 
(Heraeus fresco 17; Thermo Fisher Scientific, Darmstadt, Germany) and the emerging pellet 
was resuspended in 8 ml NB+. Cell numbers were determined using a counting chamber 
(Neubauer Zählkammer; Brand, Wertheim, Germany). Primary cells were seeded on PEI-
coated plates at a density of 80-140 ×103 cells/cm2 and cultured in a humidified incubator at 
37°C, 5% CO2. Final volumes per well were as follows: 100 µl for 96-well, 500 µl for 24-well, 
and 2 ml for 6-well plates. After 3 days in vitro (DIV) one-tenth fresh, warm NB+ was added 
to each well. Then, a half media change was performed every three days. As shown by 
immunostaining, 90-95% of the cells were neurons under these culture conditions (Figure 6). 
 
 
Figure 6. Primary dissociated neuronal cultures from cortex of E18 rat embryos 
An exemplary brightfield image (20x; left picture) of a 10-day-old primary culture is shown. Scale bar, 
50 µm. Further, PFA-fixated cultures were immunostained for the neuronal marker microtubule-
associated protein 2 (MAP2, green, A488), the astrocyte marker glial fibrillary acidic protein (GFAP, red, 
A650), and the nucleus (DAPI, blue). The composite image section (10x, right picture) was captured at 
a Leica DMI6000 B microscope. Scale bar, 100 µm. 
 
3.3.1 Genotyping 
In order to identify the genotypes of the individual neuronal cultures, DNA was isolated from 
the remaining embryonal brain tissue and PCR of the deletion site was performed using RED 
Extract-N-Amp Tissue PCR Kit according to the manufacturer’s instructions and the following 
primers: forward 5’-GCT GCT GAG CCT TTT ATT GG-3’, reverse 5’-CCT CCT GGA TAG 
CTG CTG AC-3’. The PCR protocol included 5 min 95°C, 35x [30 sec 95°C, 30 sec 60°C, 40 sec 
68°C], 5 min 68°C (T-personal thermocycler; Biometra GmbH, Göttingen, Germany) resulting 
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in an expected wildtype product of 369 bp as confirmed by 1.5% agarose gel electrophoresis 
(Figure 7a). PCR products were treated with ExoSAP-IT (Thermo Fisher Scientific, Darmstadt, 
Germany) and sent directly to sequencing (Eurofins Genomics, Ebersberg, Germany) for 
mutation analysis. Exemplary results for wildtype and heterozygous Cacna1c rats are 
illustrated in Figure 7. Genotyping was mainly performed with the help of Katharina Elsässer. 
 
 
Figure 7. Genotyping to identify wildtype and heterozygous Cacna1c animals 
a As expected, PCR of both, wildtype and heterozygous Cacna1c brain DNA resulted in defined PCR 
products, which were each visualized as a single band between 300 and 400 base pairs (bp). GeneRuler 
100 bp Plus DNA Ladder (Thermo Fisher Scientific, Darmstadt, Germany) was used as marker on a 
1.5% agarose gel. Exemplary sequencing results of the amplified PCR products comprising the deletion 
site: b wildtype Cacna1c+/+ sequence and c overlapping pattern of the nucleotide sequence after the 
deletion site illustrating the presence of two PCR amplification products characteristic for the 
heterozygous Cacna1c+/- genotype. 
 
3.3.2 Treatment with glutamate and different LTCC modulators 
Since primary neurons develop functional NMDA receptors after 7 DIV (152), experiments 
were performed with 10-day-old cultures following a 24 h-treatment with 25 µM glutamate in 
Earle’s Balanced Salt Solution (EBSS). The L-type calcium channel activator (±)-Bay K8644 
(10 µM; Biomol, Hamburg, Germany), the dihydropyridine LTCC blockers isradipine (10, 
20 µM; Biozol, Eching, Germany) and nimodipine (12.5, 25 µM; Cayman Chemical, Ann 
Arbor, MI, USA), and the NMDA receptor antagonist MK-801 (10 µM) were all dissolved in 
dimethyl sulfoxide (DMSO) and applied as co-treatment together with glutamate (for chemical 
structures see Figure 8). 
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Figure 8. Chemical structures of the L-type calcium channel modulators used 
a Bay K8644, b isradipine, c nimodipine. 
 
3.3.3 Quantitative PCR 
Two-step reverse transcription quantitative PCR (qPCR) experiments were conducted with 
the help of Helena Martins in the lab of Prof. Gerhard Schratt (Institute of Physiological 
Chemistry, University of Marburg, Germany). In brief, 900,000 cells/well were seeded in 6-
well plates. RNA was isolated from 10 DIV neuronal cultures using the InviTrap Spin 
Universal RNA Mini Kit (Stratec Biomedical, Birkenfeld, Germany) according to the 
manufacturer’s protocol. To remove contaminating genomic DNA from the preparation, 
500 ng-1 µg RNA per sample were treated with the DNase containing Turbo DNA-free Kit 
(Thermo Fisher Scientific, Darmstadt, Germany). After determining the RNA concentration 
with a NanoPhotometer (Implen, Munich, Germany), reverse transcription of 200 ng DNase-
treated RNA was achieved utilizing the iScript cDNA Synthesis Kit (Bio-Rad Laboratories, 
Hercules, CA, USA) and the following thermocycler program: 5 min 25°C, 30 min 42°C, and 
5 min 85°C. The resulting cDNA was diluted 1:5 with aqua bidest before 4 µl were carefully 
transferred to each appropriate well of a MicroAmp Fast Optical 96-well Reaction Plate 
(Thermo Fisher Scientific, Darmstadt, Germany). Then, iTaq Universal SYBR Green Supermix 
(Bio-Rad Laboratories, Hercules, CA, USA) and one of the below-mentioned primer pairs were 
added: Cacna1c forward 5’-AGG CTG AGC GAA GAA GTT GA-3’ and reverse 5’-AGA CAG 
GTC AGT TGT CGG TTT-3’; Cacna1d forward 5’-GGG GGA ATC ACC GAA ACC AT-3’ and 
reverse 5’-CGT ACA CAC CGG AAC ACA GA-3’; U6 forward 5’-CTC GCT TCG GCA GCA 
CA-3’ and reverse 5’-AAC GCT TCA CGA ATT TGC GT-3’. Subsequently, the plate was 
tightly sealed with MicroAmp Optical Adhesive Film (Thermo Fisher Scientific, Darmstadt, 
Germany) to reduce sample contamination and evaporation during the qPCR performed with 
a StepOnePlus Real-Time PCR System (Fisher Scientific GmbH, Schwerte, Germany). The 
following program was used: 10 min 95°C, 40-50x [15 sec 95°C, 1 min 60°C], 15 sec 95°C, 1 min 
60°C, 15 sec 95°C. Data were assessed in triplicates and analysis was realized using the 
StepOnePlus Software v2.3. For comparative quantitation, ΔCT values were calculated by 
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subtracting the CT values of the gene of interest from the respective CT of the reference gene 
U6. Relative mRNA expression levels were presented as 2^ (- average ΔCT). 
 
3.3.4 Protein analysis 
Protein isolation and Western blot were performed in accordance with the standard 
procedures described in Chapter 3.1.2. To analyze changes in protein expression, 60 µg protein 
per sample were loaded on 7.5% SDS-polyacrylamide gels. After transfer onto PVDF 
membranes, these were incubated with anti-CaV1.2 (1:1,000; Alomone Labs, Jerusalem, Israel) 
and anti-Vinculin (1:20,000) antibodies. 
 
3.3.5 MTT and ATP assays 
Primary cortical neurons were seeded with a density of 25,000-40,000 cells per well in PEI-
coated 96-well plates. Both assays were conducted as described previously (Chapter 3.1.6 and 
3.1.9). 
 
3.3.6 Mitochondrial stress test assay 
OCR and ECAR of primary cortical neurons were assayed in DMEM supplemented with 
143 mM sodium chloride, 15 mM glucose, 10 mM sodium pyruvate, 2 mM glutamine, 0.04% 
(w/v) BSA and an adjusted pH of 7.35 using a Seahorse XFe96 Analyzer (Agilent Technologies, 
Waldbronn, Germany). The following 4 injections were applied: 2 µM oligomycin, 2 µM 
FCCP, 1 µM rotenone together with 1 µM antimycin A, and 150 mM 2-DG (Figure 4). Three 
basal and 3 measurements after each injection were recorded and the data was subsequently 
normalized to total protein amount per well. Thus, after the measurement, the cells were 
carefully washed once with PBS before adding 50 µl lysis buffer (10 mM Tris base, 0.1% (v/v) 
Triton X-100) per well and freezing the plate at -80°C. Relative protein absorbance levels were 
determined using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Darmstadt, 
Germany) and a FLUOstar OPTIMA reader (Abs 595 nm; BMG Labtech, Ortenberg, Germany). 
 
3.3.7 Calcium imaging 
Changes in intracellular free Ca2+ concentration in neuronal cell soma were evaluated with the 
membrane-permeable, high-affinity, dual-excitation ratiometric calcium indicator Fura 2-AM. 
The peak excitation wavelength for the Ca2+-free form of Fura 2 is 380 nm, whereas the Ca2+-
bound Fura 2 has one of 340 nm. By using the ratio of fluorescence intensities produced by 
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excitation at the two wavelengths 340 and 380 nm, factors such as uneven dye distribution, 
leakage of dye and photobleaching are minimized allowing accurate measurements of 
intracellular Ca2+ levels (153). Primary cortical neurons were incubated with 3 µM Fura 2-AM 
for 30 min at 37°C in HEPES-Ringer buffer (136.4 mM NaCl, 5.6 mM KCl, 1 mM MgCl2, 2.2 mM 
CaCl2, 10 mM HEPES, 5 mM glucose, and 0.1% (w/v) freshly added BSA; pH 7.4) followed by 
a further 30-min incubation with buffer only to enable complete de-esterification of the 
intracellular AM esters. Glutamate (25 µM) and potassium chloride (KCl; 50 mM) were diluted 
in HEPES-Ringer buffer and applied as bolus injection. Images were acquired every 500 ms 
with a CCD Imaging SensiCam and an Olympus UplanApo 20x/0.80 oil objective at a Ix70 
fluorescence microscope (Olympus, Hamburg, Germany) and 37°C. Regions of interest (ROI) 
selection and data collection were performed using Till Visions 4.50 software (Till Photonics, 
Martinsried, Germany) and the open-source software application ImageJ (National Institutes 
of Health, Bethesda, MD, USA). Data are presented as Fura 2 ratio (340/380 nm). 
 
3.3.8 Immunocytochemistry 
In 24-well plates, 100,000 cells per well were seeded on glass coverslips (Ø 12 mm). After 
10 DIV, the cells were fixed with 4% PFA for 30 min and permeabilized with 0.4% Triton X-
100 in PBS for 5 min, blocked with 3% goat serum in PBS for 30 min, and labeled with the 
respective primary antibodies over night at 4°C. The following antibodies were used: anti-
MAP2 (1:200; Cell Signaling Technology, Frankfurt, Germany), anti-GFAP (1:200; Cell 
Signaling Technology, Frankfurt, Germany). Next, the cells were incubated with secondary 
antibodies, DyLight 488 and 650 conjugates (1:200; Thermo Fisher Scientific, Darmstadt, 
Germany) for 2 h in blocking solution, before counterstaining the nucleus with 4',6-diamidino-
2-phenylindol (DAPI; 1:1000 in PBS) for 5 min and mounting the coverslips on object slides 
(Aqua-Poly/Mount; Polysciences Inc., Warrington, PA, USA). Images were acquired using a 
Leica DMI6000 B microscope at 10x magnification and LAS X software (Leica, Wetzlar, 
Germany). 
 
3.3.9 Statistical analysis 
Pooled data from independent experiments are presented as single values with mean ± SD. 
For the comparison of two groups, two-tailed unpaired t-tests were used. Multiple 
comparisons were performed by one-way ANOVA followed by Fisher’s LSD post-hoc test. 
Representative experiments with 3-6 technical replicates are displayed as mean values with 
SD and were statistically analyzed by one-way ANOVA and Scheffé’s-test. Statistical 
parameters were calculated using the WinSTAT statistics Add-In for Microsoft Excel (R. Fitch 
Software, Bad Krozingen, Germany). A p-value < 0.05 was considered statistically significant. 
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3.4 Primary rat microglia 
Primary glial cultures were prepared from brain tissue of postnatal day (PND) 1 rat pups. For 
detailed information concerning the constitutive Cacna1c rat model used as well as the 
genotyping procedure see Chapter 3.2 and 3.3.1. The PND 1 pups were separated from their 
mother and, using scissors, their heads were quickly decapitated after treating the cutting site 
shortly with 70% ethanol. The dissection of cortico-hippocampal regions from both brain 
hemispheres was performed as described previously (Figure 5). In separate tubes for each pup, 
the dissected brain tissues were instantly placed in cold HBSS (Thermo Fisher Scientific, 
Darmstadt, Germany; supplemented with 9 mM HEPES sodium salt, 100 U/ml penicillin, and 
100 µg/ml streptomycin; pH 7.2), washed once with fresh HBSS, and subsequently incubated 
with trypsin (1 mg/ml in HBSS) for 15 min at 37°C to allow enzymatic disaggregation. DNase 
(100 µg/ml) was added for 30 sec at room temperature, followed by another washing step and 
a 2 min-incubation with trypsin inhibitor (1 mg/ml in HBSS). The brain tissues were washed 
once again and then carefully triturated 15-20x using a P1000 pipette, before adding 1 ml 
culture medium (DMEM F-12 Ham complemented with 2 mM glutamine, 10% (v/v) FBS 
(Biochrom, Berlin, Germany), 100 U/ml penicillin, and 100 µg/ml streptomycin). Next, the cell 
suspensions were centrifuged at 1000 rpm for 5 min (Heraeus fresco 17; Thermo Fisher 
Scientific, Darmstadt, Germany). After removing the supernatant, the cell pellets were each 
resuspended in 12 ml DMEM F-12 Ham, transferred to T-75 cell culture flasks, and incubated 
at 37°C in a humidified 5% CO2 atmosphere. Every 3 days, the culture medium was completely 
replaced by 12 ml fresh, pre-warmed DMEM F-12 Ham. 
After 10-14 DIV, the astrocyte layer reached 100% confluence and microglia were growing on 
top, microscopically visible as bright, small, rounded cells. Then, the microglial cells were 
separated from the mixed glial cultures by shaking the flasks at 200 rpm, 37°C for 1 h on an 
orbital shaker (Dual-Action Shaker KL 2; Edmund Bühler GmbH, Bodelshausen, Germany). 
Subsequently, the supernatant of all flasks was pooled per genotype (Cacna1c+/+, Cacna1c+/-) and 
the containing microglia were pelleted by centrifugation (1000 rpm, 5 min). After resuspension 
in culture medium (500 µl per flask), cell numbers were quantified (Neubauer Zählkammer; 
Brand, Wertheim, Germany), and the purified microglia seeded at a density of 80-140 
×103 cells/cm2 in culture plates pre-coated with poly-L-lysine (PLL). The coating was realized 
on the day of purification by incubation of the respective cell culture plates with PLL 
hydrobromide (0.1 mg/ml in PBS) for 1 h at room temperature, 3x washing with PBS, and 
exposure to UV light (30 min) for sterilization. The astrocyte-containing flasks were refilled 1:1 
with fresh and conditioned medium respectively, and cultured for another 4-5 days before 
microglia cells were isolated again. This process was repeated up to three times. The purity of 
the microglial cultures was ~99% as confirmed by immunostaining using the specific microglia 
marker CD11b/c and the astrocyte marker GFAP (Figure 9). 
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Figure 9. Primary microglia cultures from PND1 rat pups 
a Schematic workflow of the culturing procedure. Primary glial cultures were prepared from the cortex 
and hippocampus of 1-day-old neonatal Cacna1c+/- rat pups and their wildtype littermates. After 10-14 
DIV, when astrocytes reach 100% confluence, microglia were separated from the underlying astrocyte 
layer by shaking the flasks for 1 h on an orbital shaker. LPS-treatment was performed 24 h after the 
seeding of pure microglia in PLL-coated plates. b Control and LPS-stimulated (100 ng/ml, 24 h) wildtype 
cultures were fixated and stained for the microglia marker CD11b/c (Green, A488), the astrocyte marker 
GFAP (Red, A650), and the nucleus (DAPI; blue). Scale bar, 100 µm. 
 
3.4.1 Treatment with LPS and nimodipine 
Pure primary microglia were cultured for 1-2 days before treating them with the inflammatory 
stimulus LPS (100 ng/ml, 24 h; unless otherwise stated). The DHP LTCC blocker nimodipine 
(Cayman Chemical, Ann Arbor, MI, USA) was applied as co-treatment in a final concentration 
of 25 µM (for chemical structure see Figure 8). 
 
3.4.2 Quantitative PCR 
RNA isolation and reverse transcription qPCR were performed as specified in Chapter 3.3.3. 
In addition to Cacna1c, Cacna1d, and U6 the following primer pair was employed to evaluate 
Nos2 mRNA levels: forward 5’-TGG TGA GGG GAC TGG ACT TTT-3’ and reverse 5’-GCA 
CCA ACT CTG CTG TTC TC-3’. 
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3.4.3 Protein analysis 
Protein isolation and Western blot were conducted as detailed previously (Chapter 3.1.2). To 
this end, 7.5% SDS-polyacrylamide gels, 30 µg protein per sample, and anti-iNOS (1:2,000; BD 
Biosciences, Franklin Lakes, NJ, USA) as well as anti-Vinculin (1:20,000) antibodies were used. 
 
3.4.4 Real-time assessment of changes in cellular morphology 
The xCELLigence RTCA instrument (Roche Diagnostics, Mannheim. Germany) monitors and 
quantifies cell size and shape by measuring electrical impedance in real time, thereby 
providing a sensitive readout for morphology changes associated with immune cell activation. 
In this regard, 30,000-40,000 cells per well were seeded in 96-well E-Plates containing gold 
microelectrodes fused to the bottom surface. Cell size enlargement leads to an increase in 
electrical impedance reported as normalized cell index. 
 
3.4.5 Cell bioenergetics measurement 
OCR and ECAR of primary rat microglia were determined using a Seahorse XFe96 Analyzer 
(Agilent Technologies, Waldbronn, Germany). For that purpose, 40,000-50,000 cells per well 
were assayed in DMEM supplemented with 143 mM sodium chloride, 25 mM glucose, 1 mM 
sodium pyruvate, 2 mM glutamine, and 0.04% (w/v) bovine serum albumin (pH 7.35). LPS 
(100 ng/ml) was either injected to each well via the first port or added 24 h prior to the 
measurement. Further mitochondrial stressor compounds used were as follows: 2 µM 
oligomycin, 2 µM FCCP, and 0.5 µM rotenone together with 1 µM antimycin A (Figure 4). 
After assay completion, the data was normalized to total protein amount per well (for details 
see Chapter 3.3.6) using the Seahorse Wave software 2.6 (Agilent Technologies, Waldbronn, 
Germany). 
 
3.4.6 Determination of nitrite concentration in cell culture supernatant 
To investigate NO formation, nitrite (NO2ˉ), a stable breakdown product of NO, was measured 
in the supernatant of microglial cultures by utilizing the Griess Reagent System (Promega, 
Mannheim, Germany) in accordance with the manufacturer’s instructions. This system is 
based on a chemical diazotization reaction, which forms a magenta-colored azo compound in 
the presence of nitrite. A reference curve with nitrite standards ensured the accurate 
quantitation of NO2ˉ levels. Absorbance was determined at 530/10 nm with a FLUOstar 
OPTIMA reader (BMG Labtech, Ortenberg, Germany). 
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3.4.7 Rat cytokine and chemokine immunoassay 
Cytokine and chemokine concentrations in the cell culture supernatant of primary microglia 
were assessed by Felix Picard in the lab of Prof. Holger Garn (Institute of Laboratory Medicine 
and Pathobiochemistry, University of Marburg, Germany) using the Bio-Plex Pro Rat Cytokine 
Assay (24-Plex panel; BioRad Laboratories, Hercules, CA, USA). This magnetic bead- and 
antibody-based multiplex immunoassay allows for the simultaneous detection of multiple 
signaling proteins in a 96-well format. Each individual sample was measured in duplicates. 
Cytokine levels were calculated from standard curves and are indicated as absolute 
concentration in ng/ml. Data acquisition and analysis was performed with Bio-Plex Manager 
software (BioRad Laboratories, Hercules, CA, USA). 
 
3.4.8 Immunocytochemistry 
Fixated cells were stained with anti-CD11b/c (1:100; BioLegend, San Diego, CA, USA), anti-
GFAP (1:1,000; Dako, Glostrup, Denmark) and DAPI (1:1,000) as described before (Chapter 
3.3.8). Images were acquired using an inverted fluorescence microscope (DMI6000 B; Leica 
Microsystems, Wetzlar, Germany) at 10x magnification. Confocal images were acquiredwith 
a 40x/1.0 oil objective at a Zeiss LSM700 microscope (Carl Zeiss Microscopy GmbH, Jena, 
Germany). 
 
3.4.9 Statistical analysis 
Data from independent preparations are presented as single values with mean ± SD. For 
statistical comparisons between two groups, two-tailed unpaired t-tests were used. Multiple 
comparisons were performed by one-way ANOVA followed by Fisher’s LSD post-hoc test. 
Representative experiments with 3-10 technical replicates are displayed as means with SD and 
were statistically analyzed by one-way ANOVA and Scheffé’s-test. Parameter calculations 
were realized with the WinSTAT statistics Add-In for Microsoft Excel (R. Fitch Software, Bad 
Krozingen, Germany). A statistically significant difference was assumed at p < 0.05. 
 
3.5 Isolated mitochondria from adult rat brain 
This project was realized in collaboration with Prof. Rainer Schwarting and Markus Wöhr as 
well as with the help of Prof. Amalia Dolga, Moria Braun, Theresa Kisko, Özge Sungur, Ina 
Eisenbach, Katharina Elsässer, Goutham Ganjam, Lena Hoffmann, Birgit Honrath, Anja 
Jelinek, Rukhshona Kayumova, Malena Rabenau, Tobias Redecker, and Dominik Seffer. 
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3.5.1 Animals and breeding 
A constitutive heterozygous Cacna1c+/- rat model was used as detailed in Chapter 3.2. 
Genotyping was performed from rat tail snips (PND 5 ± 1) by Prof. Marcella Rietschel and 
Stephanie Witt (Department of Genetic Epidemiology in Psychiatry, Central Institute for 
Mental Health, Mannheim, Germany) as reported before (37). 
As published previously, a heterozygous breeding protocol was used to obtain offspring from 
both genotypes (37). To this aim, Sprague-Dawley females (Charles River, Sulzfeld, Germany) 
and male Cacna1c+/- rats were paired for breeding. Sprague-Dawley females were used because 
breeding efficacy is reduced in female Cacna1c+/- rats. In order to avoid litter effects, only litters 
with both genotypes present were included in the experiments. Breeding was performed at 
the Faculty of Psychology, University of Marburg, Germany. Approximately two weeks after 
pairing for breeding, females were individually housed and inspected daily for pregnancy and 
delivery. The day of birth was considered as postnatal day (PND) 0. Rats were identified by 
paw tattoo using non-toxic animal tattoo ink (Ketchum permanent tattoo inks green paste; 
Ketchum Manufacturing Inc., Brockville, Canada). The ink was inserted subcutaneously 
through a 30-gauge hypodermic needle tip into the center of the paw on PND 5 ± 1. Rats were 
housed under standard laboratory conditions (22 ± 2°C and 40-70% humidity) with free access 
to standard rodent chow and water. 
 
3.5.2 Gene-environment study 
To study the effects of a gene-environment interaction (GxE) on brain mitochondrial 
bioenergetics, a 2x3 design was applied and male Cacna1c+/- rats and Cacna1c+/+ littermate 
controls were exposed to one of three experimental housing conditions for four consecutive 
weeks after weaning on PND 21, i.e. between PND 22 and 50 ± 1 (Figure 10). From each litter, 
six rats were included in the experiment whenever possible with a pair of Cacna1c+/- and 
Cacna1c+/+ siblings each being exposed to (A) post-weaning social isolation (Iso), (B) standard 
housing (Stand), or (C) social and physical environmental enrichment (Enr). 
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Figure 10. Experimental design 
Shortly after birth, the genotypes of the rats (Cacna1c+/+ vs Cacna1c+/-) were determined. With three 
weeks of age (PND 21), the rats were separated from their mothers and allocated to one of three 
experimental housing conditions, i.e. post-weaning social isolation (Iso), standard housing (Stand), and 
social and physical environmental enrichment (Enr), where they spend four weeks before their brains 
were removed (PND 50 ± 1) and the mitochondria were isolated from the prefrontal cortex (PFC) and 
the hippocampus (HC). 
 
(A) Post-weaning social isolation (Iso) in a Makrolon type III cage (425 x 265 x 150 mm, plus 
high stainless-steel covers; Tecniplast Deutschland GmbH, Hohenpeißenberg, Germany), 
housed alone, applying a previously established protocol (55). 
(B) Standard housing (Stand) in a polycarbonate Macrolon Type IV cage (580 x 380 x 200 mm, 
plus high stainless-steel covers; Tecniplast Deutschland GmbH, Hohenpeißenberg, Germany), 
housed in groups of six rats, consistent with previously applied control conditions (55). 
(C) Social and physical environmental enrichment (Enr) in a large commercial rat cage 
(AniOne Remus, 104 x 59 x 107 cm; MultiFit Tiernahrungs GmbH, Krefeld, Germany) 
containing three wooden platforms connected by ramps, two metal food dispensers, and an 
assortment of cage accessories and places to hide, applying a modified protocol previously 
established (58). The initial cage setup comprised six hiding places (2x Rodent Retreats red, 
Bio-Serv, Flemington, NJ, USA; 2x AniOne Grasnest Size L, MultiFit Tiernahrungs GmbH, 
Krefeld, Germany; 1x AniOne Grastunnel, MultiFit Tiernahrungs GmbH, Krefeld, Germany; 
1x empty cardboard box, Dallmayr capsa, Munich, Germany), six wooden sticks for the 
animals to chew on, and two petri dishes with water in addition to the water bottle affixed to 
the cage wall. Twice a week, various accessories were either added to the cage (e.g. 2x wire 
feeding balls stuffed with paper tissue, Food-Ball Ø 12 cm, Trixie Heimtierbedarf GmbH, Tarp, 
Germany; 3x marbles; 2x empty toilet paper rolls) or exchanged, in the case of hiding places 
(1x wooden rat house, Jesper Eckhaus Size M, Trixie Heimtierbedarf GmbH, Tarp, Germany; 
1x JR Farm Heuhaus 85 g, JR FARM GmbH, Holzheim-Pessenburgheim, Germany). During 
social and physical environmental enrichment, rats further received two servings of six pieces 
of sweetened puffed wheat cereal (Kellogg’s Smacks; Kellogg Deutschland, Hamburg, 
Germany), which were hidden within the cage. 
In standard housing and social and physical environmental enrichment conditions, two 
siblings were always housed with two further pairs of Cacna1c+/- and Cacna1c+/+ siblings from 
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different litters. To avoid age differences between litters, all rats included in the experiment 
were born within a four-day time window. In total, 54 rats were included in the experiment, 
with n = 9 per genotype and experimental housing condition (Cacna1c+/+-Iso, Cacna1c+/+-Stand, 
Cacna1c+/+-Enr, Cacna1c+/--Iso, Cacna1c+/--Stand, Cacna1c+/--Enr; short: +/+ Iso, +/+ Stand, +/+ Enr, 
+/- Iso, +/- Stand, +/- Enr). One Cacna1c+/- rat housed under social and physical environmental 
enrichment conditions died before the end of the experiment and was excluded from data 
analysis. PFC and HC of the right brain hemispheres were removed on three consecutive days 
immediately following the four weeks of exposure to the experimental housing conditions at 
~2 months of age. All subsequent analyses were conducted blinded to genotype and 
environmental background. 
 
3.5.3 Supplementary genotype studies 
Besides the GxE study, two additional studies were performed. In the first supplementary 
study, it was tested whether brain mitochondrial bioenergetics differs in Cacna1c+/- rats and 
Cacna1c+/+ littermate controls depending on brain hemisphere. In this study, six male Cacna1c+/- 
rats and six male Cacna1c+/+ littermate controls exposed to standard housing conditions were 
included. Brains were removed at ~2 months of age. The second supplementary study 
evaluated whether brain mitochondrial bioenergetics differs in Cacna1c+/- rats and Cacna1c+/+ 
littermate controls depending on age and sex. In this study, eight male Cacna1c+/- rats and eight 
male Cacna1c+/+ littermate controls as well as eight female Cacna1c+/- rats and eight female 
Cacna1c+/+ littermate controls exposed to standard housing conditions were included. Brains 
were removed at ~10 months of age (Figure 10). Rats included in the supplementary studies 
were used before weaning to study isolation-induced ultrasonic vocalizations, developmental 
milestones, and somatosensory reflexes ((154); not shown). 
 
3.5.4 Brain extraction 
For brain removal, rats were first deeply anesthetized with isoflurane (Baxter, 
Unterschleißheim, Germany), and then decapitated and their brains were quickly extracted. 
The HC was identified and removed as described previously (155), following the gross 
anatomical criteria established before (156). To expose the dorsal part of the HC, the cerebral 
cortex covering it was incised and pulled up. The HC was then separated from cortex and 
removed towards the ventral side. Next, using a cold stainless steel adult rat brain matrix 
(Zivic Instruments, Pittsburgh, PA, USA), the brain was divided into left and right 
hemispheres and subsequently the prefrontal cortex was isolated via a coronal cut 
approximately between + 2.5 mm and + 5.0 mm from bregma, using the rat brain atlas as 
anatomical reference (157). 
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3.5.5 Mitochondrial isolation 
 Mitochondria were isolated from both PFC and HC of acutely dissected adult rat brains using 
a pump-controlled cell homogenizer as detailed in Chapter 3.1.3. Before homogenization, fresh 
brain tissue (~50 mg), kept in isolation buffer containing 300 mM sucrose, 5 mM TES, 200 µM 
EGTA, and 1 mM DTT, was coarsely sheared with a 20G Neoject needle (Dispomed, 
Gelnhausen, Germany) and then strained through a 100-µm nylon cell strainer (Corning 
Incorporated, Corning, NY, USA). The resulting cell suspension was then homogenized and 
the emerging crude mitochondrial fraction was slowly resuspended in 500 µl mitochondrial 
isolation buffer (70 mM sucrose, 210 mM mannitol, 5 mM HEPES, 1 mM EGTA, 0.5% (w/v) 
BSA; pH 7.2). All steps were performed on ice. The total protein concentration was determined 
using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Darmstadt, Germany) with 
BSA standards based on mitochondrial isolation buffer. As isolated mitochondria decline in 
their functional quality over time, the present study was strictly littermate-controlled and the 
isolation process was conducted in a randomized order to compensate for potential inter-day 
and time-dependent variability. 
 
3.5.6 Protein analysis 
Protein was extracted from frozen cortical tissue (10 mg) lysed in buffer containing 50 mM 
Tris-HCl, 150 mM NaCl, 5 mM EDTA, 1.0% (w/v) Triton X-100, and 0.5% (w/v) Na-
deoxycholate, freshly supplemented with 2 mM PMSF, 1 mM Na3VO4, and 10 mM NaF. Tissue 
lysis was succeeded by a homogenization step using a T10 basic Ultra-Turrax (IKA-Werke, 
Staufen, Germany) for 10 sec. The homogenates were then centrifuged for 15 min at 13,000 xg 
and 4°C resulting in the protein-comprising supernatants (Heraeus Fresco 17; Thermo Fisher 
Scientific, Darmstadt, Germany). In addition, the collected fractions from the isolation 
procedure, i.e. total lysate, cytosolic and mitochondrial fraction, were also used for protein 
quantitation. Protein quantification, SDS-PAGE, and Western blot were performed according 
to the standard procedures described in Chapter 3.1.2. The following antibodies were used: 
Cav1.2 (1:1,000; Alomone Labs, Jerusalem, Israel), Vinculin (1:20,000), Lamin A/C (1:1,000; Cell 
Signaling Technology, Frankfurt, Germany), α-Tubulin (1:10,000), Tim23 (1:2,000; BD 
Bioscience, Heidelberg, Germany), Mitofusin 2 (Mfn2; 1:1,000; Cell Signaling Technology, 
Frankfurt, Germany), and MitoProfile Total OXPHOS Rodent WB Antibody Cocktail (1:250; 
Abcam, Cambridge, UK). 
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3.5.7 Mitochondrial bioenergetics measurement 
The OCR as an indicator of mitochondrial respiration was measured with a Seahorse XFe96 
Analyzer (Agilent Technologies, Waldbronn, Germany). The coupling assay was performed 
according to existing protocols (158). Briefly, 6 µg of freshly isolated mitochondrial protein per 
well were assayed in mitochondrial assay solution containing 70 mM sucrose, 220 mM 
mannitol, 10 mM KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1 mM EGTA, and 0.2% (w/v) fatty-
acid-free BSA, with an adjusted pH of 7.2 and supplemented with the complex II substrate 
succinate (10 mM) and the complex I inhibitor rotenone (2 µM). The consistent adherence of 
the mitochondria to the well ground was ensured by centrifugation of the whole plate at 
2,000 xg for 20 min at 4°C (Heraeus Megafuge 40R; Thermo Fisher Scientific, Darmstadt, 
Germany). The Seahorse system allows for the consecutive injection of different modulators 
of the electron transport chain. The compounds and final concentrations used are as follows: 
4 mM ADP, 2.5 µg/ml oligomycin, 4 µM FCCP, 4 µM antimycin A. Data analysis and 
parameter calculation were conducted as described previously (159) and in Table 2. 
Table 2. Seahorse parameter calculations 
Parameter Rate measurement equation 
Anti A Minimum rate measurement after antimycin A injection 
Basal Last rate measurement before first injection - Anti A 
State 3 Maximum rate measurement after ADP injection - Anti A 
State 4o Minimum rate measurement after oligomycin injection - Anti A 
State 3u Maximum rate measurement after FCCP injection - Anti A 
RCR Respiratory control ratio = State 3 / State 4o 
 
3.5.8 Flow cytometry 
Freshly isolated mitochondrial protein was suspended in mitochondrial assay solution at a 
concentration of 50 µg/ml. The probes were stained with fluorescent dye and incubated on ice 
for 15 min protected from light. Mitochondrial superoxides were detected by incubation with 
1.25 µM MitoSOX Red indicator (Thermo Fisher Scientific, Darmstadt, Germany). Changes in 
mitochondrial membrane depolarization were determined using MitoPT TMRE Kit (0.2 µM; 
ImmunoChemistry Technologies, Hamburg, Germany) and with 10 mM succinate and 2 µM 
rotenone added to the buffer. The samples were measured with a total count of 50,000 events 
utilizing a Guava easyCyte 6-2L flow cytometer (Merck Millipore, Darmstadt, Germany). 
Analysis and gating were performed with GuavaSoft 3.1.1 software. 
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3.5.9 Rhodamine 123 
Mitochondrial membrane potential (ΔΨm) integrity was assessed over time (40 min) by 
rhodamine 123 (Thermo Fisher Scientific, Darmstadt, Germany) fluorescence quenching, as 
previously reported (160). Isolated mitochondrial protein samples (75 µg/well) were 
resuspended in 200 mM sucrose, 10 mM MOPS-Tris, 5 mM succinate, 1 mM Pi (H3PO4), 10 µM 
EGTA, and 2 µM rotenone (pH 7.3) and dyed with 125 nM rhodamine 123 in a black 96-well 
plate. Injection of the depolarizing reagent FCCP (500 nM) at the end of the measurement 
served as internal positive control leading to a complete loss of ΔΨm. The resulting 
fluorescence signals were detected with a FLUOstar OPTIMA reader (Ex 485/12 nm, Em 
530/10 nm; BMG Labtech, Ortenberg, Germany). 
 
3.5.10 Microscopy 
To visualize mitochondria, the enriched fractions resulting from the isolation procedure were 
incubated with 0.2 µM MitoTracker Deep Red (Cell Signaling Technology, Frankfurt, 
Germany) for 15 min. Thereafter, images were acquired using a fluorescence microscope with 
a HCX PL Fluotar L 40.0x/0.60 dry objective (DMI6000 B; Leica Microsystems, Wetzlar; 
Germany). 
 
3.5.11 Statistical analysis 
Statistical analyses were performed by Thomas Möbius (research group of Prof. Astrid 
Dempfle; Institute of Medical Informatics and Statistics, Kiel University, Germany). Data is 
presented as single values together with their mean and SD. Analysis of PFC and HC were 
performed separately. The outcome variables studied in the statistical analysis were CaV1.2 
protein levels, body weight, the parameters of the mitochondrial bioenergetics measurements 
(Basal, State 3, State 4o, State 3u, Anti A, and RCR), MitoSOX, and TMRE fluorescence. Besides 
genotype (Cacna1c+/+/Cacna1c+/-), explanatory variables included in the analysis were housing 
(Iso, Stand, and Enr), brain hemisphere (left/right), age (2/10 months), and sex (male/female). 
Each of these factors was fully crossed with the genotype, but none of them were crossed with 
any of the other explanatory variables. Hence, a separate analysis of each of these variables on 
the respective outcome variables was performed. 
In the case of CaV1.2, body weight, MitoSOX, and TMRE, a preliminary explorative data 
analysis evaluated the general shapes and locations of the individual distributions in a fully 
saturated, two-factorial design including interactions. All respective residual distributions 
were assessed. Standard ordinary least squares techniques were used, where suitable, in order 
to study the outcome variables in their respective 2x3 factorial designs. In the presence of 
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variance heteroscedasticity, which was the case for MitoSOX and TMRE, weighted least 
squares techniques were used instead including Lagrange multiplier tests to assess statistical 
significance in these cases. Model selection was performed via backwards selection, where the 
aim of the first test was always to exclude or establish the existence of gene-interaction. Only 
if gene-interactions could be excluded, the analysis proceeded with the study of the main 
effects. If interactions were present, the analysis was stratified. 
To study the existence of possible gene or gene-interaction effects on either of the bioenergetic 
parameters, the littermate-controlled design was exploited by first studying the paired 
differences of the respective measures between Cacna1c+/+ and Cacna1c+/- rat littermate pairs. 
This analysis strategy was able to counteract potential litter effects or confounding factors that 
were due to differences in the isolation process when evaluating the existence of gene or gene-
interaction effects. Furthermore, variances of these confounding factors were reduced that 
might have otherwise overlaid gene or gene-interaction effects, thereby increasing statistical 
power. Analyzing Cacna1c+/+/Cacna1c+/--paired differences resulted in single factor designs, in 
which the main effect corresponds to gene-interaction and differences from zero correspond 
to main gene effects on the outcome variable. If gene-interactions were present, the respective 
analysis was stratified. 
All p-values are reported up to four digits of significance and were considered statistically 
significant at p < 0.01. The analysis was carried out using Python (Version 3.5.2; Python 
Software Foundation, Beaverton, OR, USA) and the Python module Statsmodels (Version 
0.9.0). Figures were created with GraphPad Prism (Version 7; GraphPad Software, La Jolla, 
CA, USA). 
Type II error considerations 
In a comparable study using a mouse model of chronic mild stress, Gong et al. reported an 
average reduction of Basal OCR from 95 to 50 nmol/min/mg protein with a maximal standard 
deviation of 25 nmol/min/mg protein (161). The power to detect such an effect at 1% 
significance with eight animals per group is 96%. Further, a significant drop of 3.5 in RCR 
under stress with a SD of 1.2 was reported. The chance to detect this effect with 8 animals per 
group at 1% significance is 88% implying that the present study was well powered to detect 
differences in the respective parameters. 
 
3.6 Human PBMCs 
Whole blood for the isolation of PBMCs was collected and processed in the psychiatric 
departments of the university hospitals in Marburg and Münster (Germany) under the 
direction of Prof. Tilo Kircher, Prof. Udo Dannlowski, and Prof. Petra Pfefferle. 
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3.6.1 Subjects 
Three homogeneous proband subgroups were selected from a larger sample recruited in the 
Marburg/Münster Affective Disorders Cohort Study (MACS). Study approval was obtained 
from the local ethics committee and all participants provided informed written consent. 
Exclusively women, aged between 18 and 50, with no personal history of any psychiatric 
disorder were included to eliminate possible gender-specific differences in respiratory activity 
(162). The three extreme groups comprise healthy subjects with genetic risk (GR, n = 20), 
environmental risk (ER, n = 21), and no risk (NR, n = 20) as age-matched control cohort. The 
genetic risk group consists of people having at least one first degree relative with a lifetime 
diagnosis of schizophrenia, major depression, or bipolar disorder. The environmental risk 
group implies study participants, which experienced at least two forms of childhood 
maltreatment such as sexual abuse, physical or emotional abuse/neglect. These traumatic early 
life experiences were retrospectively assessed using the German version of the Childhood 
Trauma Questionnaire (CTQ) (163, 164). Individuals with no family history of psychiatric 
disorders and with no CTQ subscale reaching the threshold for maltreatment form the no risk 
control group. 
 
3.6.2 Isolation and preparation 
Human PBMCs were isolated from venous whole blood by Ficoll density gradient 
centrifugation using BD Vacutainer Cell Preparation Tubes with sodium heparin (Becton, 
Dickinson and Company, Franklin Lakes, NJ, USA). The structured and quality-controlled 
PBMC separation, cryopreservation and storage in liquid nitrogen was performed by the 
Comprehensive Biomaterial Bank Marburg (CBBMR). 
On the day of experiments, frozen 2 ml-aliquots were semi-thawed in the water bath and 
diluted in 5 ml pre-warmed DMEM supplemented with 10% FBS (Biochrom, Berlin, 
Germany), 20 mM HEPES, 100 units/ml penicillin, 100 µg/ml streptomycin, and 2 mM 
glutamine. After centrifugation at 2,000 rpm for 5 min (Heraeus Megafuge 11R; Thermo Fisher 
Scientific, Darmstadt, Germany), the resulting cell pellet was resuspended in 500 µl assay 
medium containing DMEM, 143 mM sodium chloride, 25 mM D-glucose, 2 mM glutamine, 
and 1 mM sodium pyruvate with an adjusted pH of 7.35. Subsequently, total cell number and 
viability were determined using a CASY TT cell counter (OMNI Life Science, Bremen, 
Germany) and a cut-off diameter of 5.4 µm to exclude cell debris and thrombocytes with the 
help of Felix Picard in the laboratory of Prof. Holger Garn (Institute of Laboratory Medicine 
and Pathobiochemistry, University of Marburg, Germany). 
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3.6.3 Flow cytometry 
The isolated PBMCs were examined by flow cytometry with a total count of 10,000 cells per 
sample utilizing a Guava easyCyte 6-2L flow cytometer (Merck Millipore, Darmstadt, 
Germany). By plotting the side against the forward scatter, potential differences in cell type 
composition between samples were assessed. To selectively analyze mitochondrial 
superoxides, the probes were stained with the fluorescent dye MitoSOX (1.25 µM; Thermo 
Fisher Scientific, Darmstadt, Germany) and incubated for 30 min at 37°C protected from light. 
After centrifugation at 10,000 rpm for 5 min (Heraeus fresco 17, Thermo Fisher Scientific, 
Darmstadt, Germany), the emerging pellet was suspended in PBS to yield a concentration 
between 1,000 and 4,000 cells/µl. Data analysis and gating were performed with the GuavaSoft 
3.1.1 software. 
 
3.6.4 Mitochondrial OCR measurement 
To characterize mitochondrial bioenergetic function in human PBMCs, the OCR was 
quantified with a Seahorse XFe96 Analyzer (Agilent Technologies, Waldbronn, Germany). 
Therefore, PBMCs were suspended in 180 µl assay medium per well (DMEM supplemented 
with 143 mM sodium chloride, 25 mM D-glucose, 2 mM glutamine, and 1 mM sodium 
pyruvate; pH = 7.35). After centrifugation at 50 xg (ACC 5/DEC 5), the plate was turned 180° 
and centrifuged again at 300 xg (Heraeus Megafuge 40R; Thermo Fisher Scientific, Darmstadt, 
Germany) to ensure cell adhesion and formation of an evenly distributed monolayer. Three 
basal and three measurements after each injection were recorded. Prior to experiments, the 
optimal cell density, FCCP and oligomycin concentration were determined as detailed in 
Figure 11. An optimal seeding density is reflected in basal OCR values ranging between 60 
and 120 pmol/min. Even though 300,000 cells showed an average basal OCR rate of 
60 pmol/min compared to 40 pmol/min with 200,000 cells per well, all subsequent 
measurements were performed using 250,000 viable PBMCs/well due to the limited amount 
of cells provided per sample. The maximal reaction upon FCCP addition was reached after the 
third/fourth injection of 0.4 µM each, resulting in an optimal concentration of 1.5 µM. 
Furthermore, 2 µM oligomcin, which correlates with its second injection (1 µM each), showed 
maximal OCR reduction. In summary, the following final parameters were employed: 250,000 
viable PBMCs/well, 2 µM oligomycin, 1.5 µM FCCP, 1 µM rotenone, and 1 µM antimycin A. 
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Figure 11. Titration of optimal Seahorse assay conditions for PBMCs 
The oxygen consumption rates (OCRs) of PBMCs using two cell densities (200k vs. 300k per well) as 
well as different FCCP (0.1-1.6 µM) and oligomycin (1-4 µM) concentrations are compared. k, × 103; 
Oligo, oligomycin. 
 
Assay parameter calculations were performed using the Seahorse XF Cell Mito Stress Test and 
the Bioenergetic Health Index (BHI) Report Generators (Agilent Technologies, Waldbronn, 
Germany) as outlined in Table 3. 
Table 3. Seahorse parameter equations 
Parameter Rate measurement equation 
Non-mitochondrial 
Respiration Minimum rate measurement after rotenone/antimycin A injection 
Basal Respiration Last rate measurement before first injection - Non-mitochondrial Respiration 
ATP Production Last rate measurement before first injection - Minimum rate measurement after oligomycin injection 
Proton Leak Minimum rate measurement after oligomycin injection - Non-mitochondrial Respiration 
Maximal Respiration Maximum rate measurement after FCCP injection - Non-mitochondrial Respiration 
Spare Capacity Maximal Respiration - Basal Respiration 
Spare Capacity (%) (Maximal Respiration / Basal Respiration) × 100 
Coupling Efficiency (%) (ATP Production / Basal Respiration) × 100 
Bioenergetic Health 
Index 
log (Spare Capacity × ATP Production) / (Non-mitochondrial 
Respiration × Proton Leak) 
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3.6.5 Statistical analysis 
All data are presented as single values with mean ± SD. Comparisons of the three groups NR, 
GR, and ER were performed by one-way analysis of variance (one-way ANOVA) followed by 
Fisher’s Least Significant Difference (LSD) post-hoc test. Monotonic associations between BHI 
and mitochondrial ROS levels were assessed by Spearman rank correlation. A statistical 
significant correlation was assumed at p < 0.05 (*). Statistical analyses were realized using the 
WinSTAT statistics Add-In for Microsoft Excel (R. Fitch Software, Bad Krozingen, Germany). 
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4 Results 
4.1 Effects of Cacna1c knockdown on oxidative stress in HT22 cells 
In order to study the effects of Cacna1c depletion on mitochondrial parameters, the siRNA-
mediated knockdown was first validated at the level of mRNA and protein. As shown in 
Figure 12a, Cacna1c siRNA significantly reduced mRNA expression by ~75% compared to 
control and siScr. In line with this finding, the immunoblot revealed a pronounced 
downregulation of CaV1.2 protein levels in siRNA-transfected HT22 cells (Figure 12b). A 
comparable knockdown was also achieved using another Cacna1c siRNA sequence 
(siCacna1c 3; Figure 13). 
Downregulation of Cacna1c preserved mitochondrial morphology and function 
independent of glutathione depletion in glutamate-challenged HT22 cells 
To investigate the effects of Cacna1c gene silencing on the mechanisms of glutamate-induced 
oxidative stress, GSH levels and lipid peroxidation were next analyzed in HT22 cells exposed 
to glutamate. Total glutathione levels were determined 2, 4, and 6 h after the onset of 
glutamate treatment (Figure 12c). Loss of GSH marks the initial step in oxidative glutamate 
toxicity and, in fact, a steady decline in GSH concentration over time was observed (117). 
Notably, there were no significant differences in GSH depletion between Cacna1c siRNA-
transfected HT22 cells and controls. Glutathione depletion leads to the accumulation of lipid 
peroxides, which was evaluated here 8 h post-glutamate treatment using the fluorescent dye 
BODIPY followed by flow cytometric analysis (112). The results revealed that the initial rise in 
lipid peroxidation upon glutamate exposure was largely prevented in HT22 cells transfected 
with Cacna1c siRNA indicating a partial action upstream of mitochondria in the considered 
oxidative stress cascade (Figure 12d,e). 
 
 
 
Figure 12. siRNA-mediated knockdown of Cacna1c prevented lipid peroxidation, but not 
glutathione depletion following glutamate exposure 
a Cacna1c mRNA levels were analyzed 24 h after siRNA transfection with 20 and 40 nM. Gapdh served 
as internal control. b Protein samples were collected 48 h after transfection with 40 nM siRNA and the 
CaV1.2 expression levels were then identified by Western blot. Vinculin was used as loading control. c 
Total glutathione levels were calculated from three replicates per condition after 0, 2, 4, and 6 h of 
glutamate treatment (10 mM). Data are provided as mean + SD. d,e Lipid peroxidation in HT22 cells 
was determined using BODIPY staining after an 8-hour incubation with 9 mM glutamate. The dot plots 
show representative replicates and the bar graph summarizes the associated experiment where three 
replicates per sample are shown as percentage of cells in the upper right quarter (mean + SD; 10,000 
cells per replicate). Ctrl, control; siScr, scrambled siRNA; siCacna1c, Cacna1c siRNA; Glut, glutamate. 
***p < 0.001; ns (not significant) compared to glutamate-treated ctrl (ANOVA, Scheffé’s-test). 
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Figure 13. Effects of Cacna1c siRNA transfection on Cacna1c mRNA and protein levels 
a Cacna1c mRNA levels from three different Cacna1c siRNAs were analyzed 24 h after siRNA 
transfection using Gapdh as internal control. b Protein samples were collected 48 h after transfection 
with 40 nM siRNA and the CaV1.2 expression levels were then identified by Western blot. Vinculin and 
Tubulin are used as loading control. 
 
Then, the present work focused on specific parameters of mitochondria, since these organelles 
play a crucial role in the employed paradigm of oxidative stress (165). As displayed in Figure 
14a, a pronounced increase in mitochondrial fragmentation was found in the control and siScr-
transfected cells after glutamate treatment. In contrast, Cacna1c siRNA-transfected cells mostly 
maintained their tubular, elongated morphology despite the glutamate challenge. The 
mitochondrial morphology was quantified by means of a classification into three different 
categories (111). Briefly, cells containing healthy mitochondria with an elongated, tubule-like 
structure were defined as Category 1; while dying cells show strongly fragmented 
mitochondria accumulating around the nucleus and were classified as Category 3. Based on 
this classification system, the systematic quantification confirmed that Cacna1c gene silencing 
preserved mitochondrial morphology at Category 1 also after glutamate exposure (Figure 
14b). 
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Figure 14. Cacna1c gene silencing preserved the morphology of healthy mitochondria 
in glutamate-challenged HT22 cells 
a Changes in mitochondrial morphology were visualized after 15 h of glutamate exposure using 
MitoTracker Deep Red. Epifluorescence images of representative HT22 cells are shown with details 
enlarged by 300% at the bottom right. Scale bar, 10 µm. b Five hundred cells per condition were 
classified into three categories of mitochondrial fragmentation (Category 1: elongated; Category 2: 
intermediate; Category 3: fragmented) and quantified as percentage of counted cells (n = 3, 
mean + SD). ***p < 0.001 compared to glutamate-treated ctrl (ANOVA, Scheffé’s-test). 
 
To substantiate these results, the expression of mitochondrial fission and fusion proteins as 
well as mitochondrial biogenesis and mitophagy markers were additionally evaluated (Figure 
15). While the total levels of mitofusin 2 (Mfn2), a protein that regulates the fusion of the outer 
mitochondrial membrane, were not significantly altered, changes in the expression of the 
mitochondrial fission proteins Drp1 and Fis1 were observed. During mitochondrial fission, 
cytosolic dynamin-related protein 1 (Drp1) is recruited to the mitochondrial outer membrane 
where it interacts with mitochondrial fission protein 1 (Fis1) leading to constriction and 
fragmentation of the organelles. Upon glutamate challenge, the levels of both Drp1 and Fis1 
were increased in the control conditions, whereas in the siCacna1c-transfected cells their levels 
remained unchanged. In addition to the rather moderate differences in the actual levels of the 
related fission and fusion proteins, it is likely that mitochondrial fragmentation is also 
regulated by modifications in their activity. 
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Figure 15. Cacna1c gene silencing led to diminished mitochondrial fission and 
increased mitochondrial biogenesis following glutamate challenge 
After 16 h of glutamate treatment, the expression levels of the mitochondrial fusion protein Mfn2 (a), the 
fission proteins Drp1 and Fis1 (b,c), the mitochondrial biogenesis marker PGC1α (d) and the mitophagy 
indicators p62 and LC3B-II (e,f) were identified by Western blot. One representative immunoblot per 
protein is shown (left panel). The bar graphs (right panel) were obtained by densitometric quantification 
of the Western blot data and normalization to α-Tubulin. Data is presented as mean + SEM (n = 3-4). 
Ctrl, control; siScr, scrambled siRNA; siCacna1c, Cacna1c siRNA; Glut, glutamate. **p < 0.01; 
*p < 0.05; ns (not significant) compared to glutamate-treated ctrl (ANOVA, Scheffé‘s-test). 
 
The peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC1α) is a 
transcription factor that regulates genes involved in mitochondrial biogenesis. In glutamate-
treated HT22 cells, Cacna1c knockdown led to elevated PGC1α levels, contrary to controls 
showing slightly decreased levels. Sequestosome 1 (p62) is involved in the recruitment of 
autophagosomal membranes to the mitochondria and interacts with the microtubule-
associated protein light chain 3 isoform B (LC3B). During autophagy LC3B-I (16 kDa) is 
converted to LC3B-II (14 kDa) through lipidation. The expression of p62 and LC3B-II was 
increased after 16 h of glutamate treatment in Cacna1c siRNA-transfected and control cells 
alike. However, silencing of Cacna1c induced already a considerable increase in basal levels of 
both p62 and LC3B-II compared to controls. This finding is consistent with earlier studies 
stating that decreases in cytosolic Ca2+ can induce autophagy (166). The present results indicate 
that Cacna1c downregulation stimulates mitochondrial biogenesis under oxidative stress 
without affecting mitophagic processes, thereby promoting the turnover of mitochondria and 
preventing the accumulation of dysfunctional mitochondria in HT22 cells. 
At the functional level, the concentration of cellular ATP was determined next, which provides 
the energetic basis for neuronal plasticity, viability, and function. In line with the previous 
findings on mitochondrial morphology, the downregulation of Cacna1c blocked the loss of 
ATP levels in response to glutamate (Figure 16a). To further confirm the protective effects of 
Cacna1c knockdown in this model of oxytosis, the OCR was analyzed as a measure of 
mitochondrial respiration. As illustrated by the OCR graphs shown in Figure 16b, the basal 
respiration, represented by the OCR before injection of oligomycin (Oligo), was considerably 
higher in Cacna1c siRNA-transfected cells compared to controls after glutamate treatment. In 
line with this observation, the maximal mitochondrial respiration, detected after FCCP 
injection, was also significantly higher in glutamate-exposed cells with Cacna1c depletion 
versus controls. Here, the mitochondrial uncoupler FCCP mimics an increased energy demand 
as, for example, present in times of stress and, thereby, allows for the evaluation of the 
respiratory reserve. The present findings imply that mitochondrial dysfunction attributed to 
oxidative glutamate toxicity leads to decreased stress adaptation, which is prevented by a 
knockdown of Cacna1c. 
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Figure 16. Downregulation of Cacna1c gene expression mediated protection of 
mitochondrial function against glutamate-induced oxidative stress 
a A luciferase-based assay was used to determine ATP levels in glutamate-exposed (8 mM) HT22 cells. 
Values from eight replicate wells per condition are displayed as mean + SD. The luminescence under 
control conditions is set as 100%. b After 16 h of glutamate challenge, the oxygen consumption rate 
(OCR) was analyzed with a Seahorse XFe96 Analyzer. Data of 3-7 replicate wells per condition are 
given as mean ± SD. Oligo, oligomycin; FCCP, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone; 
Rot, rotenone; AA, antimycin A. c Mitochondrial superoxide formation was investigated by flow 
cytometry using the fluorescent dye MitoSOX. HT22 cells were treated with 9 mM glutamate for 18 h. d 
Flow cytometric analysis of the mitochondrial membrane potential was realized via TMRE staining after 
18 h of glutamate treatment. CCCP (carbonyl cyanide 3-chlorophenylhydrazone, 50 µM) is a 
mitochondrial membrane depolarizer and serves as positive control. c,d Each bar chart depicts one 
representative experiment with three replicates per sample (mean + SD; 10,000 cells per replicate). 
***p < 0.001; **p < 0.01 compared to glutamate-treated ctrl (ANOVA, Scheffé’s-test). 
 
Besides the effects of Cacna1c downregulation after glutamate challenge, differences in the 
OCR between untreated conditions and Cacna1c siRNA-transfected cells can be observed, 
which may be functionally relevant. Compared to untreated controls, silencing of Cacna1c led 
to a lower basal and maximal OCR without a compensatory increase in glycolysis, as measured 
by the ECAR (Figure 17a). Thus, consistent with the slightly decreased basal ATP levels, 
depletion of Cacna1c resulted in a reduced metabolic potential suggesting in particular a 
constitutively inhibited respiratory chain (Figure 16a and Figure 17b). Reportedly, the activity 
of the electron transport complex IV is disinhibited by increases in cytosolic calcium 
concentration ([Ca2+]i) and is thereby presumably dependent on Cacna1c function. 
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Consequently, Cacna1c knockdown may act as a form of preconditioning that prevents 
glutamate toxicity via complex IV inhibition and concurrent decrease in mitochondrial ROS 
production (167). 
 
 
Figure 17. Extracellular acidification rate and cell energy phenotype 
a After 16 h of glutamate challenge, the extracellular acidification rate (ECAR) was determined with a 
Seahorse XFe96 Analyzer. Data of 3-7 replicate wells per condition are given as mean ± SD. Oligo, 
oligomycin; FCCP, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone; Rot, rotenone; AA, 
antimycin A. b In the cell energy phenotype graph the OCR is plotted against the ECAR. The baseline 
phenotype (open square) represents the OCR and ECAR of HT22 cells at starting assay conditions. 
The stressed phenotype (filled square) displays the OCR and ECAR under an induced energy demand, 
i.e. in the presence of the two stressors oligomycin and FCCP. The resulting metabolic potential (dashed 
line) reflects the ability to meet an induced energy demand. 
 
As described previously, the mitochondrial ETC is the major source of ROS in this paradigm 
of glutamate-induced stress. Therefore, mitochondrial superoxide levels were detected by 
MitoSOX Red staining (117). Figure 16c demonstrates that mitochondrial ROS formation was 
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significantly elevated in glutamate-challenged HT22 cells, but not in the Cacna1c siRNA-
transfected cells. 
 
 
Figure 18. Only a pronounced knockdown of Cacna1c mediated protective effects 
against glutamate toxicity in HT22 cells 
a Mitochondrial superoxide formation was assessed by flow cytometry using 1.25 µM MitoSOX. The bar 
graph shows one representative experiment with three replicates per sample (mean + SD; 10,000 cells 
per replicate). b xCELLigence measurements were conducted after the treatment with 10 mM 
glutamate. Three to six replicate wells per condition are displayed as mean ± SD. c Cell viability was 
evaluated in glutamate-challenged HT22 cells by measuring MTT formazan absorbance (9 mM, 17 h). 
Eight replicate wells per condition are displayed as mean + SD. The absorbance under control 
conditions is set as 100%. ***p < 0.001; **p < 0.01; ns (not significant) compared to glutamate-treated 
ctrl (ANOVA, Scheffé‘s-test). 
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This protective effect was confirmed by another siRNA sequence (siCacna1c 3; comparable 
62% reduction of CaV1.2 protein levels versus control), whereas a further siRNA (siCacna1c 2; 
only 21% reduction of CaV1.2 protein levels compared to controls) did not provide sufficient 
knockdown to affect mitochondrial ROS levels in glutamate-treated cells (Figure 18a). These 
results suggest that the functional effects of Cacna1c siRNA transfection strongly correlate with 
the extent of reduction in mRNA and protein levels (Figure 13). Another common feature of 
apoptotic and metabolically stressed cells is the collapse of the mitochondrial membrane 
potential (ΔΨm) (119). According to Figure 16d, the breakdown of ΔΨm in response to 
glutamate is indicated by a loss in TMRE fluorescence and this was visibly attenuated in 
Cacna1c-silenced cells.  
 
 
Figure 19. Assessment of ΔΨm hyperpolarization after glutamate treatment 
The mitochondrial membrane potential was analyzed by flow cytometry using the voltage-sensitive 
fluorescent dye TMRE. In the histograms, the dark grey graphs represent the untreated conditions, the 
white graphs the glutamate-treated samples, and the light grey areas the overlay of both graphs. CCCP 
(carbonyl cyanide 3-chlorophenylhydrazone; 50 μM) is a mitochondrial membrane depolarizer and 
serves as positive control. Mitochondrial membrane depolarization leads to a left shift in TMRE 
fluorescence, whereas ΔΨm hyperpolarization results in a right shift. The bar graph shows one 
representative experiment with three replicates per sample (mean + SD). ***p < 0.001 compared to 
glutamate-treated ctrl (ANOVA, Scheffé‘s-test). 
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Furthermore, Cacna1c siRNA-transfected HT22 cells exhibited significantly less ΔΨm 
hyperpolarization in the surviving cell population after glutamate damage (Figure 19). A 
lower ΔΨm results from a decreased [Ca2+]i and is accompanied by less mitochondrial 
superoxide formation (Figure 16c) (168). These results further substantiate the findings from 
the OCR measurements and assist in elucidating the protective mechanisms of Cacna1c 
downregulation. 
 
 
Figure 20. Depletion of Cacna1c attenuated the glutamate-induced rise in mitochondrial 
calcium concentration 
a The mitochondria-specific dye dihydrorhod-2 AM was used for the flow cytometric calcium 
measurements. The dark grey graphs represent the untreated controls, the white graphs the glutamate-
treated samples, and the light grey areas the overlay of both graphs. b Here, the right shift in Rhod-2 
fluorescence in response to 11 mM glutamate was quantified. The bar graph shows one representative 
experiment with three replicates per sample (mean + SD; 10,000 cells per replicate). ***p < 0.001 
compared to glutamate-treated ctrl (ANOVA, Scheffé’s-test). 
 
Importantly, the detrimental mitochondrial Ca2+ overload constitutes a central event during 
programmed cell death and is tightly coupled to excessive mitochondrial ROS production 
(124). Here, mitochondrial calcium concentrations were assessed using the fluorescent dye 
rhodamine-2. The fluorescence intensity of rhodamine-2 increases upon binding calcium and 
the quantification of gated cells displays that the glutamate-induced rise in mitochondrial 
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calcium was fully blocked in Cacna1c siRNA-transfected cells compared to the controls (Figure 
20a,b). This effect of Cacna1c siRNA could be attributed to lower levels of CaV1.2 in the cell 
membrane, which may contribute to a reduced influx of exogenous Ca2+, thereby positively 
influencing the deregulated calcium homeostasis in this model of oxidative stress (169). 
 
 
Figure 21. The L-type calcium channel blocker nimodipine ameliorated mitochondrial 
function and cell survival under glutamate treatment 
a Mitochondrial calcium levels were investigated by flow cytometry using Rhod-2. HT22 cells were co-
treated with 100 µM nimodipine and 6 mM glutamate for 16 h. The bar graph depicts one representative 
experiment with three replicates per sample (mean + SD; 10,000 cells per replicate). b Cell viability was 
assessed after 16 h of glutamate and nimodipine exposure by a colorimetric MTT assay. Six replicate 
wells per condition are displayed as mean + SD. The absorbance under control conditions is set as 
100%. c The bar graph shows the percentage of annexin V and AV/PI positive cells after 16 h of 
glutamate (7 mM) and nimodipine (100 µM) co-treatment. One representative experiment with three 
replicates per sample is depicted (mean + SD; 10,000 cells per replicate). DMSO concentration in all 
experiments was 0.1%. Nim, nimodipine; AV, annexin V; PI, propidium iodide. ***p < 0.001; ns (not 
significant) compared to glutamate-treated ctrl (ANOVA, Scheffé‘s-test). 
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This conclusion was further supported by the effects of the DHP calcium channel blocker 
nimodipine, which protected HT22 cells against glutamate-induced mitochondrial calcium 
overload at a concentration of 100 µM similar to the effects achieved by Cacna1c knockdown 
(Figure 21a). 
 
 
Figure 22. CaV1.2 localization and MCU expression levels 
a CaV1.2 protein expression levels in the total lysate, the cytosolic and the mitochondrial fraction of HT22 
cells were identified by Western blot. α-Tubulin was used as cytosolic marker protein. The inner 
mitochondrial membrane protein Tim23 served as indicator for mitochondrial enrichment. b The MCU 
expression levels in both Cacna1c siRNA-transfected and nimodipine-treated HT22 cells after 16 h of 
glutamate exposure were assessed by Western blot. One representative immunoblot per treatment 
condition is shown. c The relative MCU protein abundance was densitometrically quantified and α-
Tubulin-normalized. Data is presented as mean + SEM (n = 4-5). Ctrl, control; siScr, scrambled siRNA; 
siCacna1c, Cacna1c siRNA; Glut, glutamate. ***p < 0.001; *p < 0.05 compared to glutamate- treated 
ctrl (ANOVA, Scheffé‘s-test). 
 
To further investigate the mechanisms linking Cacna1c downregulation to mitochondrial 
calcium load, the cellular localization of CaV1.2 in HT22 cells was assessed next (Figure 22a). 
Consistent with existing evidence describing a plasma membrane localization of voltage-gated 
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calcium channels, the present study confirmed that CaV1.2 was mostly present in the total 
lysate and to a lesser extent in the cytosolic fraction. As expected, CaV1.2 was not appreciably 
expressed in the mitochondrial fraction rather excluding a direct effect of Cacna1c gene 
silencing on mitochondrial calcium concentration. Therefore, it was then evaluated if Cacna1c 
knockdown indirectly affects the expression of the mitochondrial calcium uniporter (MCU; 
Figure 22b,c). The MCU is an inner mitochondrial membrane transport protein and essential 
for the regulation of calcium uptake. Under control conditions, oxidative glutamate toxicity 
caused an increase in MCU levels after 16 h. This glutamate-induced rise in MCU expression 
was significantly abolished in both Cacna1c siRNA-transfected and nimodipine-treated cells, 
thereby correlating well with the findings from the Rhod-2 calcium measurements. 
Furthermore, these results are in line with a previous study showing that knockdown of MCU 
in mouse neurons reduces NMDA-induced increases in mitochondrial calcium resulting in 
resistance to excitotoxicity (170). Overall, these results demonstrate that both Cacna1c gene 
silencing and pharmacological inhibition of LTCCs provided a consistent protection of 
different mitochondrial parameters in paradigms of oxidative glutamate neurotoxicity. 
Knockdown of Cacna1c mediated protection against glutamate-induced cell death 
The positive effects of Cacna1c depletion in the applied model of oxidative stress were also 
reflected at the level of cell morphology and viability. Representative images of glutamate-
treated controls showed characteristic features of dying cells, which were shrinking, rounding 
up, and detaching from the culture dish. In contrast, healthy and viable cells appeared 
elongated and well attached to the well bottom, as detected in the untreated control and 
glutamate-exposed siCacna1c conditions (Figure 23a). 
Finally, cell proliferation and viability were investigated in real time via continuous electrical 
impedance readout and it was found that, compared to controls, Cacna1c siRNA-transfected 
cells showed a significantly lower proliferation rate under basal conditions (Figure 23b). As 
cell proliferation is tightly coupled to energy metabolism, this effect may be due to the before 
mentioned siCacna1c-mediated inhibition of the mitochondrial ETC (171). However, Cacna1c 
silencing mediated persistent protection of HT22 cells from glutamate toxicity. On the 
contrary, in the glutamate-treated controls a fast decrease in the normalized cell index was 
observed after 12 to 15 h of glutamate administration indicating cell death. In line with this 
result from real time impedance measurements, the protective effect of the Cacna1c siRNA was 
also detected in the MTT reduction assay after 16 h of glutamate exposure (Figure 23c). Both 
findings were independently confirmed by an additional siRNA sequence (siCacna1c 3; Figure 
18b,c). Accordingly, flow cytometric measurements using annexin V and propidium iodide 
(PI) provided concurrent results. The two dyes stain early apoptotic and late apoptotic/necrotic 
cells respectively (Figure 23d,e). The quantification presented in Figure 23d indicates a 
significantly enhanced resistance against glutamate-induced cell death in Cacna1c siRNA-
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transfected cells. Supporting these results, nimodipine (100 µM) also protected the cells from 
glutamate toxicity as shown by the MTT assay and annexin V/PI staining (Figure 21b,c). 
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Figure 23. Cacna1c silencing protected HT22 cells from glutamate-induced cell death 
a Representative phase-contrast images of glutamate-treated HT22 cells illustrate changes in cell 
morphology. Scale bar, 25 µm. b A representative real time cell impedance measurement over 30 h 
after the treatment with 8 mM glutamate is shown. Eight replicate wells per condition are displayed as 
mean ± SD. c Before cell viability was determined by MTT assay, HT22 cells were challenged with 8 mM 
glutamate for 16 h. Values from 8 wells per condition are presented as mean + SD. The absorbance 
under control conditions is set as 100%. d The bar graph shows the percentage of annexin V and AV/PI 
positive cells. One representative experiment with three replicates per sample is depicted (mean + SD; 
10,000 cells per replicate). e In addition, the dot plots exemplify the subdivision into AV (lower right 
quarter) and AV/PI positive cells (upper right quarter). AV, annexin V; PI, propidium iodide. ***p < 0.001 
compared to glutamate-treated ctrl (ANOVA, Scheffé’s-test). 
 
4.2 Effects of Cacna1c haploinsufficiency on excitotoxicity in PCNs 
Following the promising effects of Cacna1c downregulation on glutamate-induced oxidative 
stress in neuronal HT22 cells, cell viability, mitochondrial bioenergetics, ATP and Ca2+ levels 
were next investigated in a model of glutamate-mediated excitotoxicity using heterozygous 
Cacna1c primary cortical neurons (PCN). First, potential acute impacts of Cacna1c 
haploinsufficiency on neuronal calcium influx directly after glutamate stimulation (25 µM) 
were assessed by ratiometric Fura 2 calcium imaging. As evident from Figure 24, glutamate 
addition triggered an immediate increase in [Ca2+]i irrespective of the neuronal genotype. 
However, no differences in the intracellular free calcium concentration, both basal and after 
glutamate injection, were observed between wildtype and heterozygous Cacna1c cultures. 
Even further depolarization with potassium chloride (KCl, 50 mM) led to a similar increase in 
the 340/380 nm ratio. These findings suggest that either CaV1.2 is not involved in the initial 
early Ca2+ influx after glutamate stimulation, or CaV1.2 function is compensated by another 
calcium channel such as CaV1.3, or wildtype and heterozygous Cacna1c neurons exhibit the 
same surface expression levels of CaV1.2. 
Next, delayed long-term effects on mitochondrial bioenergetics and cell viability were 
evaluated 24 h after continuous glutamate exposure (25 µM). Glutamate-challenged wildtype 
and Cacna1c heterozygous neurons both showed a marked decrease in basal (before the first 
injection) and most notably maximal (after FCCP addition) mitochondrial respiration (OCR) 
as well as glycolysis (ECAR) compared with untreated controls (Figure 25a,b). This was also 
reflected in a reduced metabolic potential of the cortical neurons following sustained 
glutamate treatment (Figure 25c). The metabolic potential is a measure of the cells’ ability to 
meet an induced energy demand via respiration and glycolysis. As illustrated by Figure 25c, 
untreated control cells clearly featured this energetic ability, whereas prolonged glutamate 
excitotoxicity resulted in a completely quiescent phenotype. However, the present 
bioenergetic measurements did not reveal any significant differences in OCR and ECAR 
between the glutamate-challenged wildtype Cacna1c+/+ and heterozygous Cacna1c+/- rat 
neuronal cultures. 
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Figure 24. Acute effects of glutamate and depolarization on intracellular calcium 
concentration in primary neuronal cultures 
Intracellular calcium concentrations were assessed using the ratiometric Fura 2 dye. a Exemplary 
images of the calcium signal intensity (Jet LUT) were acquired at 20x magnification, 340 nm excitation 
and different time points. b A representative measurement of the Fura 2 ratio (340/380 nm) in the soma 
of Cacna1c+/+ and Cacna1c+/- cortical neurons is depicted as mean ± SD (dotted line). The bar graphs 
summarize the c mean basal, d mean glutamate-induced (25 µM) and e maximal KCl-evoked (50 mM) 
intracellular calcium levels. Pooled data of n = 3 littermate cultures per genotype, each with 6-10 cells 
per measurement are shown (ns; two-tailed unpaired t-test). +/+, wildtype Cacna1c+/+; +/-, heterozygous 
Cacna1c+/-; Glut, glutamate. 
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Figure 25. Assessment of mitochondrial bioenergetics, ATP levels and cell viability in 
Cacna1c+/+ and Cacna1c+/- neuronal cultures following glutamate-induced excitotoxicity 
A representative measurement of a the oxygen consumption rate (OCR) and b the extracellular 
acidification rate (ECAR) is shown including injections of the ATP synthase inhibitor oligomycin (Oligo), 
the uncoupling agent FCCP, the complex I inhibitor rotenone (Rot), the complex III inhibitor antimycin A 
(AA), and the glycolysis inhibitor 2-deoxy-D-glucose (2-DG). c To visualize the cells’ energy phenotype, 
the OCR was plotted against the ECAR. The baseline phenotype (open square) represents the OCR 
and ECAR at starting assay conditions. The stressed phenotype (filled square) displays the OCR and 
ECAR in the presence of the two stressor compounds oligomycin and FCCP. The resulting metabolic 
potential (dashed line) reflects the cells’ ability to meet an induced energy demand. Three to six replicate 
wells are presented as mean ± SD. d ATP levels were determined using a luminescence-based assay 
in a 96-well plate format (mean ± SD; +/+, n = 18; +/-, n = 16). e Cell viability was assessed by the 
colorimetric MTT assay (mean ± SD; +/+, n = 16; +/-, n = 11). d,e Each value is related to its individual 
untreated control, which is set as 100%. Differences between glutamate-treated Cacna1c+/+ and 
Cacna1c+/- cortical neurons were not significant (ns; two-tailed unpaired t-test) a-e After 9 DIV, the PCN 
cultures were treated with 25 µM glutamate in EBSS and assayed 24 h later. +/+, wildtype Cacna1c+/+; 
+/-, heterozygous Cacna1c+/-; Glut, glutamate. 
 
These findings were further confirmed by an unaltered, and thereby genotype-independent, 
reduction of ATP levels (mean +/+ 60.6%; +/- 60.3%) as well as cell viability (mean +/+ 51.5%; 
+/- 55.7%) in response to persistent glutamate stimulation for 24 h and compared to untreated 
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controls (100%; Figure 25d,e). Subsequently, Cacna1c expression was analyzed and verified the 
heterozygous knockout model by substantiating a ~40% reduction on mRNA and protein level 
in Cacna1c+/- versus wildtype neurons (Figure 26). Moreover, the results demonstrated 
comparably decreased Cacna1c mRNA as well as CaV1.2 protein levels upon 24 h glutamate 
exposure in both Cacna1c heterozygous and wildtype cells. With reductions by ~45% in mRNA 
and ~75% in protein expression compared to untreated wildtype controls, these were even 
more pronounced than the genotype effect, which may explain the identical mitochondrial 
bioenergetics and cell death rates of Cacna1c+/+ and Cacna1c+/- neurons after glutamate 
treatment. Interestingly, Cacna1c downregulation was not accompanied by a compensatory 
increase in Cacna1d mRNA, which encodes the other LTCC in the brain CaV1.3 (Figure 26b). 
CaV1.2 degradation after activation of glutamate receptors might therefore constitute a 
negative feedback mechanism and an attempt to protect the cell from Ca2+ overload. 
 
 
Figure 26. Cacna1c, Cacna1d mRNA and CaV1.2 protein levels of rat cortical neurons in 
response to glutamate excitotoxicity 
Relative a Cacna1c and b Cacna1d mRNA levels normalized to the reference gene U6 were determined 
by quantitative PCR (mean ± SD; n = 5). CaV1.2 protein expression levels were analyzed by Western 
blot. c One representative immunoblot is shown. d The bar graph was obtained by densitometric 
quantification of the Western blot data. The values were normalized to the loading control vinculin and 
presented as fold of Cacna1c+/+ (mean ± SD; n = 5). After 9 DIV, the PCN cultures were treated with 
25 µM glutamate in EBSS for 24 h followed by mRNA and protein isolation respectively. +/+, wildtype 
Cacna1c+/+; +/-, heterozygous Cacna1c+/-; Ctrl, untreated control; Glut, glutamate; ***p < 0.001; 
**p < 0.01 compared to untreated +/+ (ANOVA, Fisher’s LSD-test). 
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Figure 27. Effects of different L-type calcium channel modulators on excitotoxic cell 
death in PCN cultures 
a,b Absolute absorbance values (570-630 nm) of two representative cell viability experiments resulting 
from the NADH-dependent reduction of MTT to a purple-colored formazan product are depicted. The 
bar graphs present 5-6 technical replicates as mean + SD. Statistical significance was tested by ANOVA 
and Scheffé’s post-hoc test. The results of c n = 13 and d n = 9 MTT assays using wildtype cultures 
treated either with the LTCC activator Bay K8644 (10 µM), the DHP LTCC blockers isradipine (10, 
20 µM) and nimodipine (12.5, 25 µM), or, as positive control, the NMDA receptor antagonist MK-801 are 
summarized. e The bar graph displays the combined effects of nimodipine treatment (25 µM) and 
Cacna1c+/- deficiency on cell viability in glutamate-exposed cortical rat neurons (mean ± SD; +/+, n = 14; 
+/-, n = 16). c-e Each value is related to its individual untreated control, which is set as 100% 
(mean ± SD; ANOVA, Fisher’s LSD-test). The PCN cultures were co-treated with 25 µM glutamate and 
the respective modulating substance for 24 h in EBSS and assayed after 10 DIV. ***p < 0.001; *p < 0.05; 
ns (not significant) compared to glutamate-treated controls (Ctrl, DMSO 0.2%, +/+); Ctrl, wildtype 
control; Isra, isradipine; Nim, nimodipine; +/+, wildtype Cacna1c+/+; +/-, heterozygous Cacna1c+/-. 
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Besides studying the effects of Cacna1c haploinsufficiency in a model of glutamate 
excitotoxicity, the impact of different pharmacological LTCC modulators on cell viability was 
tested in wildtype rat cortical neurons treated with glutamate. Initially, as displayed in Figure 
27a,b, the substance concentrations used showed no basal effect on neuronal metabolic 
activity. Co-treatment of 25 µM glutamate with the LTCC activator Bay K8644 for 24 h had a 
slightly negative effect on cell viability compared to glutamate-treated controls, whereas the 
DHP LTCC blockers isradipine and nimodipine led to a trend towards and to a significant 
protection from glutamate-induced cell death respectively (Figure 27a-d). These results are in 
contrast to the non-protective findings from the heterozygous Cacna1c neuronal cultures 
indicating a dose-dependent effect on CaV1.2 activity and function, which was also observed 
in the HT22 cells (Figure 13 and Figure 18). In this regard, the combination of Cacna1c 
haploinsufficiency and nimodipine treatment had no synergistic protective effect on cell 
viability in glutamate-exposed cortical rat neurons though (Figure 27e). By validating a full 
protection of the non-competitive NMDA receptor antagonist MK-801 (Figure 27b,d), the 
present measurements further confirmed that NMDA receptors are the primary triggers of 
exicitotoxic cell death, but, by identifying a moderate protective effect of nimodipine (~20%), 
they also strengthen the, at least, partial role of LTCCs in this process. 
In summary, heterozygous Cacna1c knockout in primary cortical neurons had no impact on 
either initial increase in [Ca2+]i, or delayed perturbations in mitochondrial bioenergetics and 
cell viability after glutamate treatment. Furthermore, Cacna1c mRNA and protein expression 
levels were strongly regulated in this paradigm of glutamate-induced neuronal excitotoxicity. 
Finally, partial neuroprotection against long-term glutamate toxicity by pharmacological 
blockade of LTCCs may highlight a potential dose-effect-dependency and the involvement of 
LTCCs in the present cell death pathway. 
 
4.3 Effects of Cacna1c haploinsufficiency on inflammation in microglia 
Using primary rat microglia cultures, the potential impact of Cacna1c haploinsufficiency on 
cell morphology and bioenergetics as well as on secretion of inflammatory mediators was 
examined in a model of LPS-mediated neuroinflammation. First, as evident from Figure 28a, 
the expression of Cacna1c in rat microglial cells was validated by qPCR and, furthermore, a 
significant ~50% reduction at the level of mRNA was confirmed in heterozygous Cacna1c 
microglia compared to wildtype. Cacna1d mRNA levels, on the other hand, were unchanged 
highlighting the specificity of the Cacna1c knockout model (Figure 28b). 
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Figure 28. LPS-induced morphological alterations were diminished in Cacna1c+/- 
microglia 
Relative a Cacna1c and b Cacna1d mRNA levels normalized to the reference gene U6 were evaluated 
in heterozygous Cacna1c+/- and wildtype microglia by qPCR (mean ± SD; n = 3). *p < 0.05 (two-tailed 
unpaired t-test). c,d Morphological alterations after LPS treatment were monitored in real time via 
electrical impedance measurements (45/25 h). Two representative experiments using different LPS 
concentrations (10, 100, 200 ng/ml) are shown. Three to 10 replicate wells per condition are displayed 
as mean ± SD. e Confocal images of representative PFA-fixated microglial cells, which were 
immunostained for the microglia marker protein CD11b/c (Green, A488) and the nucleus (DAPI, blue), 
additionally illustrate the LPS-induced morphology changes. Scale bar, 25 µm. +/+, wildtype Cacna1c+/+; 
+/-, heterozygous Cacna1c+/-. 
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LPS-induced morphological alterations were diminished in Cacna1c+/- microglia 
In vitro, primary microglial cells changed their morphology from spindle-shaped to ameboid-
like structures in response to bacteria-derived LPS as illustrated by Figure 28e. These LPS-
induced morphological alterations were monitored and quantified in real time via electrical 
impedance readout resulting in characteristic kinetic profiles of microglial activation (Figure 
28c,d). In detail, LPS addition led to an initial increase in the normalized cell index, which 
correlates with morphological cell expansion, followed by a decline ~10 h after LPS 
stimulation. This decrease to basal cell indices was succeeded by a steady rise over time, whose 
extent was LPS concentration- and Cacna1c genotype-dependent. While cellular impedance 
increased with rising LPS concentrations (10, 100, 200 ng/ml), this trend was consistently less 
pronounced in Cacna1c+/- microglial cultures compared to wildtype (Figure 28c,d). Cacna1c 
haploinsufficiency had no effect on basal, unstimulated cellular impedance levels. Based on 
these findings, the majority of further experiments were conducted after a 24 h-treatment with 
100 ng/ml LPS (Figure 28d,e); a concentration also relating to clinical conditions (172). 
Cacna1c+/- as well as nimodipine-treated microglia displayed reduced bioenergetic 
capacities in response to LPS 
LPS-mediated microglial activation also involved changes in cellular energy metabolism, 
which were next studied by assessing the OCR, a measure of mitochondrial respiration, and 
the ECAR, an indicator of glycolysis. After acute injection of LPS, the OCR remained stable 
over the measurement period of 7 h, whereas LPS provoked a rapid glycolytic burst shortly 
after its application (Figure 29a,b). This continuous increase in ECAR was significantly lower 
in LPS-treated Cacna1c+/- versus Cacna1c+/+ microglia (Figure 29b). From Figure 29a it can be 
observed that basal respiration (before oligomycin addition) and mitochondrial reserve 
capacity (OCR increase in response to FCCP) were at the same level as untreated controls after 
LPS stimulation for 7 h. After a 24 h-treatment with LPS, however, the microglial cells showed 
a decrease in basal respiration and were unresponsive to the different mitochondrial stressors 
oligomycin, FCCP, rotenone, and antimycin A indicating an impaired mitochondrial function 
(Figure 29c). The observed inhibition of mitochondrial metabolism was accompanied by a 
compensatory increase in glycolysis ensuring the rapid and sufficient generation of ATP to 
meet the energy demands of LPS-induced microglial activation (Figure 29d). This glycolytic 
shift was less prominent in LPS-challenged heterozygous Cacna1c microglia compared to 
wildtype, which was also reflected in a reduced metabolic potential in response to an induced 
energy demand, i.e. in the presence of the two stressor compounds oligomycin and FCCP 
(Figure 29e). Furthermore, the present measurements confirm a two-stage activation process 
upon LPS stimulation (90). Initially, primary rat microglia were capable of utilizing both 
oxidative and glycolytic metabolism (Figure 29a,b), followed by a second phase in which 
microglial energy metabolism switched to almost exclusively rely on glycolysis for cell 
survival (Figure 29c-e). 
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Figure 29. Cacna1c+/- microglia displayed reduced bioenergetic capacities in response 
to LPS 
An exemplary measurement of a OCR and b ECAR following the acute injection of LPS (100 ng/ml) is 
presented. c OCR, d ECAR, and e the cells’ energy phenotype were determined in heterozygous 
Cacna1c versus wildtype microglia 24 h after the treatment with 100 ng/ml LPS. The energy phenotype 
profile summarizes the relative utilization of the two energy pathways oxidative phosphorylation and 
glycolysis and was determined under baseline and stressed conditions. The baseline phenotype (open 
square) represents the OCR and ECAR at starting assay conditions. The stressed phenotype (filled 
square) demonstrates the OCR and ECAR in the presence of oligomycin and FCCP. The increases in 
stressed over baseline rates reflect the cells’ metabolic potential. a-e Three to 8 replicate wells per 
condition are given as mean ± SD. +/+, wildtype Cacna1c+/+; +/-, heterozygous Cacna1c+/-; O/Oligo, 
oligomycin; F, FCCP; R/Rot, rotenone; A/AA, antimycin A. 
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Figure 30. Combined effects of Cacna1c haploinsufficiency and pharmacological LTCC 
blockade on cellular bioenergetics in LPS-treated microglial cells 
After a 24-h-treatment with 100 ng/ml LPS, a OCR, b ECAR, and c energy phenotype profile were 
assessed using a Seahorse XFe96 Analyzer. The DHP LTCC blocker nimodipine (25 µM) was applied 
as co-treatment together with LPS. Data of 4-8 technical replicates are presented as mean ± SD. +/+, 
wildtype Cacna1c+/+; +/-, heterozygous Cacna1c+/-; Oligo, oligomycin; Rot, rotenone; AA, antimycin A; 
Nim, nimodipine. 
 
Figure 31. Cacna1c haploinsufficiency was associated with reduced NO and cytokine 
release in LPS-stimulated primary microglia 
a Relative Nos2 mRNA levels normalized to the reference gene U6 were examined by qPCR 
(mean ± SD; n = 3). b Inducible nitric oxide synthase (iNOS) protein expression levels were evaluated 
by Western blot. One exemplary Western blot as well as the densitometric quantification of 4 
independent blots are depicted (mean ± SD). The values were normalized to the loading control vinculin 
and presented as fold of Cacna1c+/+. c LPS-mediated NO production was assessed in the supernatant 
of microglial cells using a colorimetric assay based on the Griess reaction. Three to 7 technical replicates 
are shown as mean + SD (ANOVA, Scheffé’s-test). a-c The primary microglia cultures were challenged 
with 200 ng/ml LPS for 24 h. Concentrations of the following pro- and anti-inflammatory cyto- and 
chemokines were quantified in the culture supernatant by a magnetic bead-based multiplex 
immunoassay: d IL-1α, e IL-1β, f IL-6, g TNF-α, h IL-10, i IL-18, j MCP-1, and k MIP-3α. d-k 100 ng/ml 
LPS for 24 h; n = 3-4; mean ± SD; ANOVA, Fisher’s LSD-test. ***p < 0.001, not significant (ns) 
compared to LPS-treated Cacna1c+/+; +/+, wildtype Cacna1c+/+; +/-, heterozygous Cacna1c+/-. 
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Additionally, the present findings regarding the influence of Cacna1c haploinsufficiency on 
glycolytic energy flux in LPS-stimulated microglia were further supported by pharmacological 
LTCC blockade with the DHP nimodipine (25 µM). As detailed in Figure 30, treatment of 
Results 
68 
wildtype cells with nimodipine already led to a stronger reduction in ECAR compared to 
Cacna1c+/- after 24 h of LPS exposure. Moreover, nimodipine-treated heterozygous Cacna1c 
primary microglia even showed an additive reducing effect on LPS-induced glycolysis. 
Unstimulated OCR and ECAR remained unaffected by both Cacna1c haploinsufficiency and 
nimodipine treatment. 
Cacna1c haploinsufficiency and pharmacological LTCC blockade was associated with 
reduced NO and cytokine release in LPS-stimulated primary microglia 
Reportedly, microglial activation is also associated with a massive secretion of NO as well as 
inflammatory cytokines (79). Nonexistent under resting conditions, microglial expression of 
Nos2 (mRNA) and iNOS (protein) was substantially induced in response to LPS (Figure 31a,b). 
This marked, LPS-mediated increase of Nos2/iNOS expression levels was considerably 
prevented in heterozygous Cacna1c microglial cultures. Inducible nitric oxide synthase (iNOS) 
catalyzes the synthesis of NO, which was assessed via detecting nitrite, a stable reaction 
product of NO, in the culture supernatant by Griess reaction. Consistently, Cacna1c 
haploinsufficiency significantly inhibited the LPS-induced nitrite release into the microglia 
culture medium (Figure 31c). These results were further substantiated by the treatment of LPS-
stimulated primary microglia with nimodipine, which also resulted in a reduced NO 
production compared to control (Figure 32a). In addition, NO inhibits oxidative 
phosphorylation at ETC complex IV, thereby contributing to the glycolytic switch observed in 
activated microglia (140). 
Besides the release of NO, stimulation of microglial cells with the TLR agonist LPS for 24 h 
involves the production and secretion of inflammatory mediators such as cytokines and 
chemokines. In the present study, the concentrations of eight different cyto-/chemokines were 
determined in the culture supernatant of activated rat microglia using a multiplex 
immunoassay. Among these, the levels of key pro-inflammatory cytokines including IL-1α, 
IL-1β, IL-6, and TNF-α were analyzed. LPS-mediated extracellular accumulation of all four 
cytokines was significantly reduced in both heterozygous Cacna1c (Figure 31d-g) and 
nimodipine-treated (Figure 32b-e) microglia compared to wildtype. 
 
Figure 32. Additive effects of Cacna1c haploinsufficiency and nimodipine treatment on 
NO and cytokine release in LPS-challenged rat microglia 
a NO release was determined in the culture supernatant using the Griess reagent. A representative 
measurement with 4-9 technical replicates is presented (mean ± SD; ANOVA, Scheffé’s-test). The 
levels of b IL-1α, c IL-1β, d IL-6, e TNF-α, f IL-10, g IL-18, h MCP-1, and i MIP-3α from 3-4 independent 
experiments were pooled and are displayed as mean ± SD. Data was statistically analysed by one-way 
ANOVA followed by Fisher’s LSD post-hoc test. a-i The microglia cultures were co-treated with 
100 ng/ml LPS and 25 µM nimodipine for 24 h prior to experiments. ***p < 0.001 compared to LPS-
treated Cacna1c+/+; ###p < 0.001, ##p < 0.01 compared to LPS-treated Cacna1c+/-; +/+, wildtype 
Cacna1c+/+; +/-, heterozygous Cacna1c+/-; Nim, nimodipine. 
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The same applies to the LPS-induced generation of the anti-inflammatory cytokine IL-10, 
which was also diminished by Cacna1c haploinsufficiency (Figure 31h) as well as 
pharmacological LTCC blockade (Figure 32f). In the collected culture supernatants of activated 
rat microglia, IL-10, whose LPS-evoked expression has been reported before (173), was present 
in a much lower absolute concentration than IL-1α, IL-1β, IL-6, and TNF-α. Moreover, 
nimodipine treatment had a significantly stronger inhibitory impact on IL-6 and IL-10 release 
than Cacna1c haploinsufficiency in LPS-challenged microglia underlining a certain dose-
dependency of the effects (Figure 32d,f). Pro-inflammatory IL-18 as well as the chemokines 
monocyte chemoattractant protein 1 (MCP-1, CCL2) and macrophage inflammatory protein 
3α (MIP-3α, CCL20) were constitutively, in the case of MIP-3α hardly, expressed in primary 
rat microglia and remained unchanged irrespective of genotype (Figure 31i-k) and treatment 
condition (Figure 32g-i). 
Collectively, the present findings with regard to morphological appearance, metabolic status, 
and secretion of inflammatory mediators revealed a reduced activation pattern, bioenergetic 
capacity as well as inflammatory immune response upon LPS stimulation in both 
heterozygous Cacna1c and nimodipine-treated primary rat microglia compared to wildtype. 
These results suggest that Cacna1c might play an important role in the activation of microglia, 
the resident immune cells of the CNS. 
 
4.4 Effects of gene-environment interactions in isolated mitochondria 
In order to study the combined effects of heterozygous Cacna1c knockout and different 
environmental influences on brain mitochondria, first the reduction of CaV1.2 levels in 
Cacna1c+/- rats was validated, the mean body weight per group compared, and the functional 
integrity of the isolated mitochondria verified. As evident from Figure 33a,b, the CaV1.2 
protein content is decreased by around 50% in the PFC of Cacna1c+/- rats compared to their 
Cacna1c+/+ littermates, irrespective of the environmental condition. In turn, the housing 
condition had an impact on the body weight of the two-month-old rats. Compared to social 
isolation and standard housing, social and physical environmental enrichment led to 
significantly decreased weight in both Cacna1c+/- rats and their Cacna1c+/+ littermates. Further, 
a trend towards reduced body weight of heterozygous Cacna1c rats versus wildtype can be 
observed in the social isolation as well as the standard housing group (Figure 33c). The 
previously established isolation of mitochondria from fresh brain tissue using a speed- and 
pressure-controlled cell rupture system including a Balch-style homogenizer with a defined 
clearance constitutes a fast, efficient, and replicable method (148), which ensured the 
separation of a crude fraction of functional active mitochondria from nuclear and cytosolic 
parts (Figure 34). 
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Figure 33. CaV1.2 protein levels in rat prefrontal cortex and body weight 
CaV1.2 protein expression levels in the right prefrontal cortex of two-month-old male Cacna1c+/- rats and 
Cacna1c+/+ littermate controls from the different environmental conditions were analyzed by Western 
blot. a One representative immunoblot is shown. b The bar graph was obtained by densitometric 
quantification of the Western blot data. The values are normalized to the loading control vinculin and 
presented as fold of Cacna1c+/+-Stand (mean ± SD, n = 6). Statistical analysis found no evidence for a 
gene-environment interaction (GxE, p = 0.6632) or for an environmental effect (E, p = 0.4050), but 
revealed a significant genetic effect (G, p < 0.0001). The average relative CaV1.2 level in Cacna1c+/+ 
was 0.94 (95% CI 0.87,1.01) and thereby approximately doubled compared to the mean CaV1.2 level in 
Cacna1c+/- of 0.47 (95% CI 0.41,0.54). c Whole body weight was determined after the four-week 
exposure to the experimental housing conditions at ~2 months of age (mean ± SD, n = 8-9). There was 
no evident GxE (p = 0.4421; omnibus test) or G effect (p = 0.0573). However, animals housed in a social 
and physically enriched environment weighed on average 33.1 g (95% CI 28.4,37.9) less than animals 
from the social isolation or standard housing group (p = 0.0035). +/+, wildtype Cacna1c+/+; +/-, 
heterozygous Cacna1c+/-; Iso, isolation; Stand, standard housing; Enr, enrichment. 
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Figure 34. Quality of the isolated mitochondria from rat brain tissue 
a The fractionation quality was evaluated by Western blot using the total lysate, the cytosolic and the 
mitochondrial fraction of hippocampal brain tissue. Lamin A/C was used as nuclear and α-Tubulin as 
cytosolic marker. The inner mitochondrial membrane protein Tim23 served as indicator for mitochondrial 
enrichment. b To visualize mitochondria, the enriched mitochondrial fraction was stained with 
MitoTracker Deep Red. One representative image is shown. Scale bar, 10 μm. Mitochondria from c the 
right PFC and d the right HC of male Cacna1c+/+-Stand and Cacna1c+/--Stand rats were stained with 
rhodamine 123 (R123) to test their constant integrity after the isolation procedure. Positively charged 
R123 accumulates in mitochondria with intact membrane potential (ΔΨm) leading to a time stable 
fluorescence quenching over 30 min. This is also evident from the constant FCCP to control ratios after 
zero and 30 min (t = 0, t = 30) (PFC, p = 0.0235; HC, p = 0.0117; two-sided, two-sample t-test with 
paired observations). The injection of FCCP (0.5 µM) as internal control dissipates the ΔΨm resulting in 
an increase in R123 fluorescence. Mean ± SD, n = 8; PFC, prefrontal cortex; HC, hippocampus; RFU, 
relative fluorescence units; +/+, wildtype Cacna1c+/+ (grey bars); +/-, heterozygous Cacna1c+/- (clear 
bars). 
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Mitochondrial bioenergetics and respiratory chain complex levels 
To compare brain bioenergetics in the GxE study using extracellular flux analysis, 
mitochondria were isolated from PFC and HC of Cacna1c+/- rats and wildtype littermates, 
which were each exposed to one of the three experimental housing conditions, i.e. post-
weaning social isolation, standard housing, or social and physical environmental enrichment 
during the critical developmental period of adolescence (Figure 10). As cellular regulation of 
mitochondrial function was removed during isolation, energy demand and substrate 
availability can be specifically modulated to identify site-specific changes in mitochondrial 
activity and to examine the degree of coupling between the ETC and the oxidative 
phosphorylation machinery. In the performed coupling experiments, respiratory states, 
indicative of mitochondrial function, were measured as absolute oxygen consumption rate 
(respiration), normalized to protein content (Figure 35). 
 
 
Figure 35. Key steps in oxidative phosphorylation and representative oxygen 
consumption rate measurement with isolated mitochondria from rat brain 
a The scheme illustrates the electron transport chain with its five different complexes. Modulating 
compounds used in the Seahorse mitochondrial coupling assay are highlighted in red. b An exemplary 
measurement of the oxygen consumption rate (OCR) from isolated rat brain mitochondria is shown 
together with key parameters of mitochondrial respiration, which were calculated from the data. Five 
technical replicates are displayed as mean ± SD. IMS, intermembrane space; MM, mitochondrial 
membrane; OCR, oxygen consumption rate; Oligo, oligomycin; AA, antimycin A. 
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Figure 36. Indices of mitochondrial function calculated from the OCR measurements 
Individual parameters of the bioenergetics measurements with isolated mitochondria from rat right 
prefrontal cortex (PFC; a,c,e,g,i) and right hippocampus (HC; b,d,f,h,j) are specified. a,b With rotenone 
and succinate present in the assay buffer, the Basal rate implies the ADP-independent, complex II-
mediated respiration (E; PFC, p = 0.5066; HC, p = 0.7683). c,d The State 3 OCR is initiated with the 
injection of ADP and accounts for the phosphorylating respiration (E; PFC, p = 0.5777; HC, p = 0.8343). 
e,f State 4o is induced by the addition of the ATP synthase inhibitor oligomycin and stands for the non-
phosphorylating respiration (E; PFC, p = 0.1364; HC, p = 0.8159). g,h FCCP uncouples the oxygen 
consumption from ATP production and is used to assess State 3u, which represents the maximal 
respiratory activity (E; PFC, p = 0.4133; HC, p = 0.8917). i,j The Anti A rate constitutes the OCR 
response to antimycin A which inhibits the mitochondrial respiration (E; PFC, p = 0.3915; HC, 
p = 0.8581). The parameter values are calculated as absolute oxygen consumption rate in 
pmolO2/min/6 µg mitochondrial protein. The data of n = 8-9 two-month-old male rats per group are 
presented as mean ± SD and showed no effect of the heterozygous Cacna1c genotype in any of the 
three different environmental conditions (G; PFC, p = 0.9890; HC, p = 0.8567). OCR, oxygen 
consumption rate; +/+, wildtype Cacna1c+/+ (grey bars); +/-, heterozygous Cacna1c+/- (clear bars); Iso, 
isolation; Stand, standard housing; Enr, enrichment. 
 
To assess the Basal respiration state, mitochondria were initially incubated with the complex 
II substrate succinate and, to prevent reverse electron flow, with the complex I inhibitor 
rotenone (Figure 36a,b). Then, ADP was added to induce phosphorylation and ATP synthesis 
(State 3; Figure 36c,d). Both parameters did not differ significantly among the six groups, 
neither in the PFC nor in the HC, thereby excluding an effect on ATP turnover. Next, State 4o 
was initiated by the injection of oligomycin to inhibit the ATP synthase (complex V). This state 
allows to assess proton leak and was not affected by either the genotype or the environment 
in both brain regions studied (Figure 36e,f). After oligomycin addition the protonophore FCCP 
was injected to dissipate the proton gradient leading to enhanced oxygen consumption, which 
is not coupled to phosphorylation. Thus, the achieved State 3u is exclusively controlled by 
substrate oxidation. Here, the genotype, the environment, and their interaction also showed 
no effect on State 3u respiration of mitochondria isolated from PFC or HC (Figure 36g,h). The 
final injection of the complex III inhibitor antimycin A was used to correct all parameters for 
non-mitochondrial respiration, which was consistently low in all conditions as cytosolic 
oxidases were eliminated during the isolation process (Figure 36i,j). 
In line with previous studies investigating brain region-specific differences in mitochondrial 
bioenergetics (174), all respiration rates in the HC were lower compared to the PFC with no 
effect on the respiratory control ratio (Figure 36 and Figure 37). The respiratory control ratio 
(RCR) is defined as the oxygen consumption in State 3 divided by that in State 4o. This 
internally normalized parameter provides combined information on substrate oxidation 
capacity, ATP turnover, and proton leakage making it a potent overall marker of energetic 
dysfunction (175). In mitochondria from the right PFC (mean RCR 2.97; 95% confidence 
interval (CI) 2.80,3.13) as well as from the right HC (mean RCR 3.42; 95% CI 3.19,3.64) of two-
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month-old male rats constant RCR values were obtained for all the six groups compared 
(Figure 37). 
 
 
Figure 37. Respiratory control ratio (RCR) as indicator for mitochondrial integrity 
The RCR was determined from isolated mitochondria of a the right prefrontal cortex and b the right 
hippocampus of two-month-old male Cacna1c+/- rats and Cacna1c+/+ littermate controls which were each 
kept in one of the three different environmental conditions. The State 3 to State 4o ratio (RCR) is a 
measure of the coupling quality between respiration and phosphorylation (mean ± SD, n = 8-9). There 
was no GxE interaction (PFC, p = 0.3852; HC, p = 0.4914), no genetic (PFC, p = 0.2614; HC, 
p = 0.7892), and no environmental effect (PFC, p = 0.9640; HC, p = 0.9275) on RCR in both PFC and 
HC. PFC, prefrontal cortex; HC, hippocampus; +/+, wildtype Cacna1c+/+ (grey bars); +/-, heterozygous 
Cacna1c+/- (clear bars); Iso, isolation; Stand, standard housing; Enr, enrichment. 
 
To control for potential brain hemisphere-, age-, or sex-related effects, mitochondrial RCRs 
were also evaluated in right versus left hemisphere, in two- versus ten-month-old animals, 
and in female versus male, using Cacna1c+/- rats and Cacna1c+/+ littermate controls exposed to 
standard housing conditions in two supplementary studies (Figure 38). The present 
measurements did not reveal any significant differences in male PFC RCR between both brain 
hemispheres and/or genotypes (Figure 38a). Interestingly, in the PFC of ten-month-old 
normally housed male Cacna1c+/- rats, the RCR was moderately, but significantly elevated by 
0.45 (95% CI 0.28,0.62) compared to the 3.90 average RCR (95% CI 3.67,4.13) of Cacna1c+/+ 
littermate controls (Figure 38b). However, no genotype effect on RCR of ten-month-old 
animals was observed in male HC (mean 4.50; 95% CI 4.12,4.89), female PFC (mean 4.32; 95% 
CI 3.94,4.69), and female HC (mean 4.35; 95% CI 4.21,4.49) respectively (Figure 38c-e). Further, 
male HC RCRs were significantly higher (p < 0.0001) in the ten- compared with the two-
month-old animals (Figure 38c). 
In addition to the functional assessment, the expression levels of the five ETC complexes were 
quantified by Western blot. Consistently, these showed no changes in relation to genotype 
and/or environment (Figure 39). 
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Figure 38. Respiratory control ratio of mitochondria isolated from rats with differing age, 
sex and from both brain hemispheres 
Respiratory control ratios (RCR) calculated from the OCR measurements using isolated mitochondria 
from: a right and left PFC of two-month-old male Cacna1c+/+-Stand and Cacna1c+/--Stand rats, b the 
right PFC and c the right HC of two- versus ten-month-old male Cacna1c+/- rats and Cacna1c+/+ littermate 
controls, which were kept under standard housing conditions, d the right PFC and e the right HC of ten-
month-old male and female Cacna1c+/+-Stand and Cacna1c+/--Stand rats (mean ± SD, pooled data). a 
There was neither a gene-hemisphere interaction (p = 0.5210), nor an effect of the genotype 
(p = 0.0934) or the hemisphere (p = 0.2874) on RCR alone. b Statistical analysis revealed a strong 
effect of the genotype on RCR in the PFC of ten-month-old male animals (p < 0.0001) indicating a gene-
age interaction. c No gene-age interaction (p = 0.3524) as well as no genetic effect (p = 0.8602) exists 
for the RCR of hippocampal mitochondria, but there was a main age effect (p < 0.0001). d Differences 
in PFC RCR between sexes were statistically significant (p < 0.0001) implying a gene-sex (GxS) 
interaction. Compared to males, no genotype effect was found for PFC RCR in females (p = 0.4259). e 
On the contrary, no GxS interaction (p = 0.0748), no genetic effect (female; p = 0.8742) and no sex 
effect (p = 0.2708) on HC RCR were observed. +/+, wildtype Cacna1c+/+ (grey bars); +/-, heterozygous 
Cacna1c+/- (clear bars). 
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Figure 39. Protein levels of the five electron transport chain complexes in right 
prefrontal cortex 
Relative protein levels of the five electron transport chain complexes (CI-CV) were assessed in isolated 
PFC mitochondria from two-month-old male rats. a One representative immunoblot and b-f the 
densitometric quantification of the individual complexes (CI-CV) are depicted. The values are 
normalized to the mitochondrial outer membrane protein Mfn2 and presented as fold of Cacna1c+/+-
Stand (mean ± SD, n = 4). There was no gene-environment interaction in any of the complexes 
(p = 0.5143). Moreover, neither genotype (p = 0.7529), nor environment (p = 0.3509) had an effect on 
complex expression levels. +/+, wildtype Cacna1c+/+ (grey bars); +/-, heterozygous Cacna1c+/- (clear 
bars); Iso, isolation; Stand, standard housing; Enr, enrichment. 
 
 
Figure 40. Exemplary histograms and quantifications of flow cytometric measurements 
with isolated mitochondria from rat prefrontal cortex 
Freshly isolated mitochondria were stained with a MitoSOX (1.25 μM) and b TMRE (0.2 μM). Antimycin 
A (Anti A, 10 μM) and CCCP (50 µM) respectively were used as validating positive control. The complex 
III inhibitor antimycin A increased the formation of superoxide leading to a rightward shift in MitoSOX 
fluorescence. Incubation of mitochondria with CCCP resulted in a decrease in membrane potential, 
which is visible as a left shift of the peak, indicating a loss of TMRE fluorescence. The histograms (left 
panel) illustrate that the gate (red) was set at the inflection point of the reference graph (Cacna1c+/+-
Stand, dark grey). The clear graphs with the dotted line represent the unstained controls. The dark grey 
graphs constitute the control samples, the light grey graphs the Anti A/CCCP-treated samples, and the 
grey areas the overlay of both graphs. The bar graphs (right panel) display the percentage of 
mitochondria within the gate (n = 1). 
 
Mitochondrial superoxide levels and membrane potential 
To further substantiate the results from the bioenergetics analyses, associated mitochondrial 
parameters were measured including ROS levels and membrane potential (ΔΨm) by using 
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flow cytometry (176). The fluorescent dye MitoSOX is rapidly targeted to mitochondria where 
it is selectively oxidized by superoxide (O2•ˉ) producing red fluorescence (Figure 40a). O2•ˉ is 
increasingly formed upon perturbations in the electron flow across the respiratory chain. 
Moreover, superoxide generation is strongly dependent on the mitochondrial membrane 
potential, which, in turn, is particularly important for the regulation of ATP synthesis, 
indicating that all these processes are closely interconnected. The slow-responding cationic 
dye TMRE accumulates within the mitochondria in a membrane potential-dependent manner 
and is thereby well suited for measuring pre-existing ΔΨm (Figure 40b). 
 
 
Figure 41. Assessment of mitochondrial superoxide levels and membrane potential 
Flow cytometric measurements were conducted with isolated mitochondria from right PFC (a,c) and 
right HC (b,d) of two-month-old male rats using (a,b) the mitochondrial superoxide indicator dye 
MitoSOX and (c,d) the mitochondrial membrane potential sensitive dye TMRE. The data was gated to 
the reference condition Cacna1c+/+-Stand in each group of six and is displayed as mean ± SD (n = 8-9). 
While showing no gene-environment interaction (p = 0.9608) and no genetic effect (p = 0.6410), 
mitochondrial ROS levels were significantly higher in the PFC of enriched animals (E, p = 0.0050). No 
statistical significant differences were observed in hippocampal mitochondrial superoxide levels (mean 
8.12; 95% CI 6.83,9.40; GxE, p = 0.9349; G, p = 0.9309; E, p = 0.1700) as well as in the membrane 
potential of mitochondria isolated from PFC (mean 17.57; 95% CI 16.55,18.59; GxE, p = 0.7319; G, 
p = 0.0127; E, p = 0.5439) and HC (mean 18.90; 95% CI 17.71,20.09; GxE, p = 0.5196; G, p = 0.1260; 
E, p = 0.6433). +/+, wildtype Cacna1c+/+ (grey bars); +/-, heterozygous Cacna1c+/- (clear bars); Iso, 
isolation; Stand, standard housing; Enr, enrichment. 
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As detailed in Figure 41 and consistent with the previous findings, both superoxide levels and 
ΔΨm of mitochondria isolated from PFC and HC remained unaltered in response to Cacna1c 
haploinsufficiency and different environmental situations with the exception of physical and 
social enrichment. Here, significantly higher mitochondrial ROS levels (mean 10.85; 95% CI 
9.02,12.68) were found versus isolation and standard housing (mean 6.27; 95% CI 5.01,7.53), 
but only in mitochondria isolated from PFC and not from HC. 
In summary, genotype and environment alone or in interaction did not have a substantial 
effect on overall mitochondrial bioenergetics in brain regions that are affected in psychiatric 
disorders (PFC, HC). Furthermore, the functional profile of the isolated brain mitochondria 
was completed by the evaluation of respiratory chain complex levels, superoxide formation, 
and membrane potential also not providing evidence for mitochondrial impairment associated 
with the investigated conditions. 
 
4.5 Effects of genetic and environmental risk on mitochondria in PBMCs 
Before studying the possible effects of psychiatric disease-relevant genetic or environmental 
risk factors on mitochondrial function in human PBMCs, the quality of the frozen PBMC 
samples after thawing was evaluated with regard to viability, purity, and total number of cells. 
Without considering cell debris, dead cells, and platelets, the absolute cell count of viable 
PBMCs per 2 ml-aliquot ranged from 30,000 to 6.7 million and was not significantly different 
among the three groups NR, GR, and ER (Figure 42a). The same applies to the percentage of 
viable PBMCs, which ranged between 8 and 71% (Figure 42b) and is exemplary depicted in 
Figure 42c. The, in part, limiting amount of viable PBMCs (< 500,000/sample) led to the 
exclusion of 3-5 samples per group from the subsequent mitochondrial respiration 
measurements. 
Furthermore, based on the characteristic light-scattering properties of the different blood cells, 
these can be distinguished by flow cytometry (Figure 43). This allows to include (green) and 
exclude (red) particular cell populations for further flow cytometric analyses. Besides a 
contamination with cell debris and thrombocytes, most of the present samples (~85%) 
contained low-granular mononuclear cells, i.e. lymphocytes and monocytes. The remaining 
~15% additionally manifested a certain contamination with larger and more complex 
granulocytes. 
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Figure 42. Cell count and viability of the frozen PBMC samples after thawing 
a The graph depicts the total number of viable PBMCs per sample excluding cell debris, dead cells, and 
thrombocytes with a diameter < 5.4 µm. The dotted line marks the minimal cell count for respiration 
measurements (500,000 viable cells). b Viable PBMCs are displayed as percentage of total counts 
ranging from 8 to 70%. a,b Data is shown as mean with single values (NR, n = 20; GR, n = 20; ER, 
n = 21). Differences between the three groups are not significant (ns; ANOVA, Fisher’s LSD-test). NR, 
no risk; GR, genetic risk; ER, environmental risk. c Exemplary images of two PBMC samples with good 
and poor quality respectively (upper vs lower picture) were captured in differential interference contrast. 
Scale bar, 20 µm. 
 
 
 
Figure 43. Representative flow cytometric dot plots 
The dot blots illustrate the three different identified distributions of cells based upon size (FSC) and 
granularity (SSC). The first scatter plot displays two distinct populations, cell debris and thrombocytes 
(1) as well as lymphocytes (2). In addition, the second exemplary distribution also includes monocytes 
(3). Together these two compositions account for ~85% of all samples. The remaining ~15% contain 
lymphocytes (2), monocytes (3), and, besides cell debris and thrombocytes (1), a pronounced 
granulocytes (4) contamination. In all samples, these contaminations (1,4) were excluded from further 
flow cytometric analyses. 
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Assessment of mitochondrial ROS levels in human PBMCs 
Mitochondria are the major site of superoxide generation in cells. Particularly at complex I and 
III of the respiratory chain, the leakage of single electrons to O2 results in the formation of 
superoxide. If their levels exceed the capacity of the antioxidant defense system, reactive 
oxygen species cause molecular and functional damage to DNA, lipids, and proteins. Thus, an 
increased superoxide production can be indicative of mitochondrial dysfunction. However, 
mitochondrial perturbations may also be associated with decreased ROS levels, depending on 
the site and cause of the dysfunction (177). 
 
 
Figure 44. Assessment of mitochondrial ROS levels by flow cytometry 
a PBMC samples were stained with the fluorescent dye MitoSOX. A right shift in MitoSOX Red 
fluorescence indicates an increase in superoxide levels. As demonstrated by three exemplary 
histograms two fixed gates at 60 and 400 separate the three occurring peaks representing PBMC 
populations with low, intermediate, and high mitochondrial ROS levels. b The bar graph quantifies the 
amount of PBMCs with intermediate and high ROSm (gate at 60) as percentage of all PBMCs in each 
sample. c Here, the percentages of PBMCs with high ROSm (gate at 400) in each sample are 
summarized. b,c Data is displayed as mean ± SD with single values (NR, n = 20; GR, n = 20; ER, 
n = 21). One-way ANOVA and Fisher’s LSD post-hoc test revealed no significant (ns) differences 
between the three groups. ROSm, mitochondrial reactive oxygen species; NR, no risk; GR, genetic risk; 
ER, environmental risk. 
 
In the present study, mitochondrial superoxide levels in human PBMCs were investigated by 
flow cytometry using the fluorescent dye MitoSOX. MitoSOX is rapidly and selectively 
targeted to mitochondria, where it is oxidized by superoxide producing red fluorescence. As 
evident from the exemplary histograms in Figure 44a, all investigated PBMC samples were 
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subdivided by two fixed gates at 60 and 400 into three populations termed PBMCs with low, 
intermediate and high mitochondrial ROS levels. Figure 44b,c summarizes the percentages of 
PBMCs with intermediate and high ROS (gate at 60) as well as high ROS only (gate at 400) of 
each individual probe. Both quantifications showed a tendency to slightly lower 
mitochondrial ROS levels in the ER samples, but did not reveal any statistically significant 
differences between the three groups NR, GR, and ER. 
Measurement of cellular bioenergetics in human PBMCs 
To investigate different aspects of mitochondrial function in more detail, extracellular flux 
analyses were performed including all samples with sufficient amount of viable PBMCs (NR, 
n = 17; GR, n = 15; ER, n = 16). The successive injection of different inhibitors of oxidative 
phosphorylation allows a bioenergetic profile to be measured in cells. As illustrated in Figure 
45a, specific respiratory parameters were analyzed as absolute oxygen consumption rate 
(respiration) normalized to cell number (175). First, the basal respiration was assessed, which 
is mainly controlled by cellular ATP demand and partly by mitochondrial proton leak and 
substrate oxidation (Figure 45b). Then, the rate of mitochondrial ATP production was 
estimated from the decrease in respiration upon inhibition of the ATP synthase with 
oligomycin (Figure 45c). The remaining OCR in the presence of oligomycin is a direct measure 
of the proton leak rate across the inner mitochondrial membrane and is therefore sensitive to 
uncoupling (Figure 45d) (178). None of these three parameters differed significantly among 
the three groups studied. However, a trend towards higher mean values and variation in the 
GR as well as the ER group compared to the NR control can be observed indicating increased 
proton leak accompanied by elevated ATP demand to maintain organelle integrity. Next, 
maximal respiration was stimulated by addition of the uncoupler FCCP, which simulates an 
artificial energy demand and is dependent on the maximum activity of electron transport, 
substrate oxidation and supply to meet this metabolic challenge (Figure 45e). 
 
 
Figure 45. Exemplary OCR measurement and subsequently calculated key parameters 
of mitochondrial respiration 
a A representative OCR measurement including injections of the ATP synthase inhibitor oligomycin, the 
uncoupler FCCP, the complex I inhibitor rotenone, and the complex III inhibitor antimycin A is shown 
together with key parameters of mitochondrial bioenergetics derived from the measured data. Four 
replicate wells are displayed as mean ± SD. The specific parameters are depicted as follows: b basal 
respiration, c ATP production, d proton leak, e maximal respiration, f non-mitochondrial respiration, g 
spare capacity, and h coupling efficiency. b-h Data is shown as mean ± SD with single values (NR, 
n = 17; GR, n = 15; ER, n = 16). Differences between the three groups were not significant (ns; ANOVA, 
Fisher’s LSD-test). Oligo, oligomycin; Rot, rotenone; AA, antimycin A; NR, no risk; GR, genetic risk; ER, 
environmental risk. 
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Finally, the combined injection of the complex I inhibitor rotenone and the complex III 
inhibitor antimycin A leads to a complete inhibition of the mitochondrial respiratory chain. 
The persisting OCR was subtracted from all other rates to correct these for non-mitochondrial 
respiration (Figure 45f). In leukocytes, non-mitochondrial respiration is typically attributed to 
oxygen-consuming pro-inflammatory enzymes such as cyclo-oxygenases, lipoxygenases, or 
NADPH oxidases (179). Neither maximal nor non-mitochondrial respiration were 
significantly affected in isolated PBMCs from individuals with genetic or environmental risk 
respectively. 
In addition, two ratios were calculated, which have the advantage of combining the 
information of two parameters as well as being internally normalized and thereby 
independent of cell number, size and mitochondrial content. The spare capacity is a measure 
of the cell’s ability to respond to an increased energy demand and indicates how closely a cell 
is operating to its bioenergetic limit (see Figure 45g for equation) (175). There were no 
statistical significant differences between the NR, GR, and ER groups. As evident from Figure 
45g, however, the genetic risk group tended to have a lower average spare capacity comprising 
a subpopulation of six samples that exhibited a lack of spare respiratory capacity (72-122%) 
revealing a mitochondrial dysfunction that was not apparent under basal conditions. The 
coupling efficiency constitutes the fraction of basal respiration that is used for ATP production 
and is susceptible to changes in proton permeability (see Figure 45h for equation) (175). With 
mean values ranging between 85 and 92%, the coupling efficiency was consistently high in all 
three groups (Figure 45h). 
Furthermore, the Bioenergetic Health Index (BHI) was evaluated, which condenses the 
mitochondrial respiration profile into a single value making it a strong overall indicator of 
cellular metabolic function. The BHI was introduced in 2014 by Chacko et al. as dynamic 
prognostic biomarker measured in circulating PBMCs, which are particularly sensitive and 
responsive to early systemic metabolic and inflammatory changes associated with 
neurodegeneration, diabetes, and cardiovascular disease (179). As shown in Figure 46a, the 
BHI equation captures positive aspects of bioenergetic function such as spare capacity and 
ATP production and contrasts these with potentially detrimental parameters including non-
mitochondrial respiration and proton leak. In conformity with its individual components, the 
BHI showed no significant alterations between the three groups. On average, PBMCs from the 
genetic risk group had lower Bioenergetic Health Indices and higher data variability compared 
to the NR and ER samples. Additionally, both mean and SD in each group remained practically 
unchanged when excluding samples with granulocytes contamination and high platelets 
content/poor amount of viable PBMCs (< 20%; Figure 46b). 
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Figure 46. Bioenergetic Health Index (BHI) as indicator of mitochondrial function in 
PBMCs 
a The BHI combines positive aspects of bioenergetic function including spare capacity and ATP 
production and contrasts these with potentially deleterious parts such as non-mitochondrial respiration 
and proton leak. The bar graph summarizes the individual BHI values highlighting samples with 
granulocytes contamination in red and samples with less than 20% viable PBMCs in blue. Data is shown 
as mean ± SD with single values. Using one-way ANOVA and Fisher’s LSD post-hoc test, no significant 
(ns) differences between the three groups were detected. b The table lists the mean BHI, SD, and n of 
all samples in each group compared to an adjusted cohort excluding samples with granulocytes 
contamination (- G) and less than 20% viable PBMCs (- V < 20%). NR, no risk; GR, genetic risk; ER, 
environmental risk. 
 
Correlation of mitochondrial ROS levels and BHI 
To determine a potential relationship between mitochondrial ROS levels and BHI, data of all 
samples (n = 45) were merged. Figure 47a reveals a significant, moderate, negative monotonic 
correlation between the BHI and intermediate and high mitochondrial ROS levels (r = -0.35, 
p = 0.01) indicating that an increase in ROS levels is partly related to a decreased BHI and vice 
versa. This suggests that mitochondrial superoxide generation amplifies mitochondrial 
damage, thereby having a negative impact on the cell’s bioenergetic health. The association 
between the BHI and the high risk portion was smaller and not significant (r = -0.23, p = 0.06; 
Figure 47b). The total correlation tendency was always reflected in the individual correlations 
of the NR and ER group, but not the GR group, which showed correlation coefficients near 
zero. 
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Figure 47. Correlation of mitochondrial ROS and BHI 
Overall and individual group correlations (All, n = 45; NR, n = 17; GR, n = 13; ER, n = 15) of the BHI 
with intermediate and high ROS (a) as well as high ROS only (b) are shown together with the resulting 
Spearman correlation coefficients (r) and correlating p-values. **p < 0.01; *p < 0.05; p > 0.05 ns (not 
significant); NR, no risk; GR, genetic risk; ER, environmental risk. 
 
Overall, neither psychiatric disease-relevant genetic nor environmental risk factors had a 
significant effect on superoxide levels and mitochondrial bioenergetics in PBMCs from healthy 
subjects. However, there seems to be a tendency towards reduced spare respiratory capacity 
as well as BHI in the GR group. Moreover, the correlation analysis confirmed a significant 
inverse relation between mitochondrial ROS levels and BHI in human PBMCs. 
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5 Discussion 
5.1 Effects of Cacna1c knockdown on oxidative stress in HT22 cells 
As summarized in Figure 48, the present study found that both siRNA-mediated 
downregulation and pharmacological inhibition of Cacna1c in neuronal HT22 cells mediated 
substantial protective effects on lipid peroxidation, mitochondrial integrity and function, and 
cell viability in a model of glutamate-induced cell death. These results suggest that, in 
paradigms of oxidative stress, Cacna1c is significantly involved in mechanisms of neuronal 
damage. 
 
 
Figure 48. Cacna1c downregulation preserved mitochondrial function in glutamate-
challenged neuronal HT22 cells 
As mouse hippocampal HT22 cells do not express functional ionotropic glutamate receptors, glutamate 
toxicity is mediated via an oxidative stress-dependent pathway including inhibition of the 
glutamate/cystine antiporter, a subsequent depletion of glutathione and a consecutive impairment of 
mitochondrial function, which ultimately leads to neuronal cell death (left panel). This glutamate-induced 
cascade is positively affected by Cacna1c knockdown (siRNA) and pharmacological LTCC inhibition 
(nimodipine), which both mediate substantial protective effects on lipid peroxidation, mitochondrial 
integrity and function, and cell viability (right panel). XCˉ, glutamate/cystine antiporter; CaV1.2, voltage-
gated L-type calcium channel; MCU, mitochondrial calcium uniporter; ROS, reactive oxygen species; 
ΔΨm, mitochondrial membrane potential; ATP, adenosine triphosphate. 
 
These findings may also be of potential relevance in human diseases, since hippocampal and 
cortical atrophy, which are closely associated with abnormalities in neuronal plasticity and 
reduced resilience to cellular stress, have been frequently reported in patients with psychiatric 
disorders and early-life adverse experiences (53, 180). Furthermore, recent studies revealed 
that healthy subjects carrying the CACNA1C risk variant rs1006737 also show decreased 
prefrontal cortex activation and hippocampal dysfunction (30, 31). Even though it is not 
consistently observed (25, 181), the majority of evidence suggests that the non-coding risk SNP 
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rs1006737 is associated with enhanced CACNA1C expression and a gain of CaV1.2 function (26, 
28, 182) suggesting deregulated Ca2+ signaling in the affected population and a significantly 
increased probability of psychiatric diseases (17). These findings are further confirmed by 
several animal studies demonstrating that, besides an increase in anxiety-associated behavior 
(183), Cacna1c heterozygous and forebrain-specific knockout mice exhibit an antidepressant-
like phenotype, resilience to chronic stress, and a protective phenotype against mania-related 
behavior (33–35, 184). In addition to the data based on genetic modifications, the 
pharmacological inhibition of L-type calcium channels has repeatedly been linked to anti-
stress and antidepressant-like effects, and reduced despair-like behavior in rodents (185–187). 
Moreover, dihydropyridine compounds with good CNS penetration, such as nimodipine 
showed promising mood stabilizing effects in humans with affective disorders, suggesting 
that LTCC antagonists represent an additional option in the pharmacotherapy of psychiatric 
diseases, and especially patients carrying the CACNA1C risk SNP could benefit from this 
alternative treatment strategy (17, 182, 188). Elevated cytosolic calcium levels, which may be 
associated with the CACNA1C risk SNP rs 1006737, represent a major upstream pathway that 
impairs mitochondrial function in BD (74). In this regard, it has been reviewed recently that 
systemic administration of the DHP isradipine suppresses cytosolic calcium transients, 
increases mitochondrial mass and lowers mitophagy in dopaminergic neurons (189). These 
findings in vivo are in line with the present results in vitro, revealing an enhanced resistance 
against oxidative stress and beneficial effects on mitochondrial function in conditions of 
reduced Cacna1c expression and LTCC blockade with nimodipine. 
As reported previously, impaired cellular adaptation to environmental stress constitutes 
another major trigger in the pathophysiology of psychiatric disorders (9). In particular, it has 
been demonstrated in animal models that psychosocial stress results in depression-like 
behavior through the activation of oxidative and apoptotic mechanisms, including increased 
ROS levels, lipid peroxidation, reduced Bcl-2 expression, and increased caspase-3 (48). 
Additionally, in human post-mortem studies a downregulation of several antioxidant genes 
and an increase in protein oxidation have been observed in the hippocampus and prefrontal 
cortex of patients with BD (190, 191). Hence, the applied model of glutamate-induced oxidative 
stress in hippocampal HT22 cells constitutes a suitable system reflecting a common cellular 
response to environmental stress in the development and course of psychiatric illnesses. 
It has been repeatedly proposed that interactions between genetic and environmental risk 
factors significantly contribute to the complex and heterogeneous clinical manifestations of 
affective disorders (9). The present study provides valuable insights into a gene-stress 
interaction by showing that reduced Cacna1c expression, which represents a beneficial genetic 
factor, mediated neuroprotective effects against oxidative stress, particularly at the level of 
mitochondria. Mitochondrial function is essential for cellular resilience and adaptation to 
oxidative stress. Here, siRNA-mediated knockdown of Cacna1c preserved mitochondrial 
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morphology, ATP values, respiration, membrane potential, and calcium homeostasis, and, 
furthermore, diminished excessive ROS formation in the employed model of oxidative 
glutamate toxicity. These findings are highly relevant as increasing evidence suggests a crucial 
role for mitochondrial dysfunction and related key determinants of cellular stress, such as 
intracellular Ca2+ deregulation and ROS formation in the development of mood disorders (71). 
Furthermore, the present findings indicate a possible link between Cacna1c expression and 
mitochondrial function in oxytosis. In this paradigm of oxidative cell death, both Cacna1c gene 
silencing and pharmacological inhibition of LTCC using nimodipine were found to 
significantly diminish the glutamate-induced rise in mitochondrial calcium levels. It is 
concluded that this effect was attributed to a reduced cellular calcium influx, thereby leading 
to a mild inhibition of complex IV and also affecting the downstream mitochondrial Ca2+ 
influx. It has been shown previously, however, that Ca2+ influx through the plasma membrane 
only partially contributes to mitochondrial damage and cell death in the applied model of 
glutamate-induced oxidative stress (192). Based on the pronounced protective effects of 
Cacna1c knockdown and LTCC blockade, it has to be taken into consideration that, beyond its 
influence on calcium homeostasis at the plasma membrane, Cacna1c is possibly involved in 
further regulatory pathways at the level of mitochondria. For example, the calcium-dependent 
cytosolic phosphatase calcineurin dephosphorylates Drp1, thereby promoting its translocation 
to mitochondria and triggering detrimental mitochondrial fission; a process that is likely 
inhibited by Cacna1c gene silencing (193). Moreover, both Cacna1c knockdown and LTCC 
blockade probably lead to altered CaV1.2-dependent gene transcription regulation and may 
suppress toxic mitochondrial Ca2+ uptake via transcriptional repression of enhanced MCU 
expression following glutamate treatment in HT22 cells (170). Conversely, it has been 
described in arterial myocytes that mitochondria stimulate NF-κB-dependent CaV1.2 
expression via elevated mitochondrial calcium concentration and subsequently induced 
mitochondrial ROS generation (194). In this regard, it is suggested that silencing of Cacna1c 
possibly counteracts the respective feed-forward signaling cascade. In mast cells, however, 
Cacna1c knockdown augmented apoptosis after IgE stimulation by disrupting mitochondrial 
integrity emphasizing that the maintenance of an appropriate mitochondrial calcium 
concentration is also essential for cell survival (195). The present study also revealed that 
Cacna1c downregulation led to a reduced formation of lipid peroxides in HT22 cells upon 
glutamate exposure indicating a partial action upstream of mitochondria. But since 
mitochondrial damage acts as an amplification factor of lipid peroxidation, mitochondria 
might still represent the main point of action of Cacna1c silencing in this model of oxidative 
glutamate toxicity (112). 
Overall, the present findings suggest that the GWAS-confirmed psychiatric risk gene 
CACNA1C plays a major role in oxidative stress pathways with particular impact on 
mitochondrial integrity and function. However, the precise molecular mechanisms underlying 
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the effects of CACNA1C regulation on mitochondrial performance in neurons and the 
emerging link to neuronal plasticity, maintenance and function in the context of affective 
disorders remain to be elucidated. 
 
5.2 Effects of Cacna1c haploinsufficiency on excitotoxicity in PCNs 
In an in vitro model of neuronal excitotoxicity, heterozygous Cacna1c primary rat cortical 
cultures were continuously activated by 25 µM glutamate for 24 h before the cells’ energy 
phenotype and viability were analyzed. As reported previously in cerebellar granule cells 
(127) and mouse cortical neurons (128), mild insults with low micromolar concentrations of 
glutamate triggered acute early necrosis in a very small proportion of cells, but predominantly 
induced delayed-onset apoptotic cell death after 24 h. 
In the present study, Cacna1c haploinsufficiency in dissociated cortical neurons had no impact 
on the acute immediate increase in [Ca2+]i after glutamate stimulation. This result corresponds 
to prior evidence showing that during the initial phase of excitotoxicity Ca2+ influx was 
primarily mediated by stimulated NMDA receptors and only secondary by other calcium 
channels such as CaV1.2 (196, 197). However, further depolarization with 50 mM KCl, thereby 
fully activating all voltage-sensitive channels including LTCC, also resulted in equal [Ca2+]i 
elevations in both wildtype and constitutively heterozygous Cacna1c cultures. In this context, 
it has been identified before that chronic genetic loss of CaV1.2 channels in the CNS of mice led 
to a compensatory upregulation of Ca2+-permeable AMPA receptors, but not CaV1.3 channels, 
thereby providing an alternative source of ligand-gated calcium signaling to maintain normal 
neuronal functioning (198). 
Consequently, when focusing on the delayed long-term excitotoxic disturbances, the 
conducted measurements did not reveal any significant differences in respiratory and 
glycolytic rate, ATP levels as well as cell viability between the glutamate-treated wildtype 
Cacna1c+/+ and heterozygous Cacna1c+/- neurons. Moreover, the neuronal cultures showed a 
strong, genotype-independent reduction in both Cacna1c mRNA and CaV1.2 protein levels 
after 24 h of glutamate exposure. These results, which highlight the tight regulation of CaV1.2, 
are in line with previous studies indicating rapid, dynamic calcium- and voltage-dependent 
inactivation mechanisms for CaV1.2 (23, 199) and stating that sustained glutamate exposure 
and excessive activation of NMDA receptors caused adaptive internalization and lysosomal 
degradation of CaV1.2 channels in cortical neurons already at subtoxic conditions (200). This 
protective negative feedback mechanism after the activation of ionotropic glutamate receptors 
has also been described for CaV1.3 in salamander retinal neurons, additionally identifying the 
endocytotic internalization process to be dynamin- and actin-dependent (201). Stronger 
stimulation, however, overrode this protective mechanism and the neurons underwent 
excitotoxicity (200) consistent with the current findings. 
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In accordance with the present study, the neurotoxic impact of pharmacological LTCC 
activation (202) and the, in turn, excitotoxic cell death reducing effect of LTCC blockade by 
dihydropyridines in vitro (200, 203, 204) and in vivo (197, 205) have been repeatedly 
demonstrated earlier. The protective effect of DHPs, which reversibly stabilize and induce 
inactivated channel states (18), underline the contribution of Ca2+ influx through CaV1.2 to 
neuronal death during glutamate-induced excitotoxicity. However, the multiplicity of 
conditions including substance concentrations, treatment combinations, time points, 
functional assays, culture characteristics, and in vivo models used, makes specific overall 
comparisons difficult. As mentioned before, differences between genetically and 
pharmacologically achieved effects may result from an adaptive compensation for the genetic 
loss of CaV1.2, thereby sustaining neuronal excitability (198, 206, 207). 
In conclusion, the present findings from the heterozygous Cacna1c cortical rat cultures did not 
replicate the effects of the siRNA-mediated Cacna1c knockdown in hippocampal HT22 cells 
suggesting the need for a stronger, CNS-specific homozygous Cacna1c knockout to reach 
significance, the involvement of different glutamate-induced signaling cascades, and/or the 
complex regulation of CaV1.2 expression in primary neurons to be potential reasons. Future 
research may additionally focus on psychiatric disease-relevant model systems for example 
patient-derived (26) or CRISPR-edited (208) induced neurons carrying the intronic risk SNP 
rs 1006737 with special emphasis on changes in mitochondrial respiratome, proteome, and 
function in combination with cellular stress. Besides glutamate, other primarily ROS 
generating stressors such as RSL3, H2O2, tert-butyl hydroperoxide, or menadione (209) might 
be studied, also evaluating the effect of pharmacological LTCC blockade in these settings. A 
further promising future task might be the investigation of neuronal network activity in 
cultures or acute brain slices with genetic or pharmacological CaV1.2 modifications by using 
multielectrode array (MEA) recordings (210). In addition, this technique would allow for 
assessing the effects of neuron-glia interaction and inflammatory stimuli on neuronal circuit 
function; mechanisms that are also significantly involved in the pathophysiology of 
psychiatric disorders (76, 77). 
 
5.3 Effects of Cacna1c haploinsufficiency on inflammation in microglia 
In the present study, primary rat microglial cultures were stimulated in vitro with the bacterial 
endotoxin LPS mimicking a gram-negative infection and inducing an inflammatory, 
neurotoxic phenotype (211). Exposure to LPS activates microglial TLRs and initiates signal 
transduction cascades including NF-κB and NLRP3 leading to the transcription, synthesis, 
processing, and secretion of inflammatory cytokines, chemokines, and NO (77). Increasing 
evidence suggests that LPS-induced microglial activation is associated with a sustained 
increase in basal [Ca2+]i, which is evident as early as 1 h after LPS application (212) and thereby 
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coincides with the rise in glycolysis observed in the present work. It has been reported 
previously that the chronic elevation of basal calcium after LPS treatment (100 ng/ml, 24 h) 
constitutes a central regulatory element in the activation of mouse microglia, since chelation 
of intracellular Ca2+ strongly attenuated LPS-stimulated cytokine release (143). However, a rise 
in [Ca2+]i alone failed to trigger any cytokine production on its own suggesting that increased 
[Ca2+]i is necessary, but by itself not sufficient to induce the release of NO and cytokines (143). 
Dolga et al. further showed that the influx of extracellular calcium was a prerequisite for LPS-
induced microglial activation in mouse primary cultures (213). Moreover, several studies 
indicate the involvement of LTCCs in mediating this Ca2+ entry (144). Even though 
controversially discussed (214, 215) with limited data available, mounting evidence, including 
the findings from the present study, supports the expression of voltage-gated calcium 
channels in non-excitable cells such as microglia (144, 216, 217). Reportedly, stimulation of 
human fetal microglia with chemokines (218, 219) or amyloid-β fragments (220) evoked a 
voltage-insensitive, DHP-sensitive Ca2+ influx. While another study detected a small, voltage-
dependent, DHP-sensitive inward calcium current in cultured neonatal rat microglia 
potentiating superoxide production stimulated by phorbol 12-myristate 13-acetate (221). 
Further complicating the situation, specific immune splice variants of LTCCs have been 
described, which are voltage-insensitive and truncated, and might, thus, be differently 
activated compared to excitable cells and function, besides through ion transport, particularly 
via transcriptional regulation (217). 
The present work demonstrated the expression of the LTCC isoform CaV1.2 at mRNA level. In 
line with this, a prior study even found an activation-dependent increase in α1C subunit 
expression in stimulated rat microglia and murine BV2 cells treated with LPS and interferon-
γ (IFN-γ) (144). Moreover, this publication showed that pharmacological LTCC blockade with 
nimodipine diminished the depolarization-induced increase in [Ca2+]i as well as the release of 
TNF-α and NO in LPS + IFN-γ activated BV2 microglia. The inhibitory effect of nimodipine 
on LPS-stimulated microglial secretion of NO, TNF-α, and IL-1β was also observed in mixed 
cultures with dopaminergic neurons (222). Besides confirming the anti-inflammatory impact 
of nimodipine in LPS-challenged primary rat microglia, the present study adds specific genetic 
evidence by showing that Cacna1c haploinsufficiency attenuated, but not completely 
prevented, microglial activation, which resulted in a decreased downstream release of NO, IL-
1α, IL-1β, IL-6, IL-10, and TNF-α after 24 h. It seems likely that a reduced elevation in [Ca2+]i 
after LPS stimulation mediated the anti-inflammatory effects in both heterozygous Cacna1c 
and nimodipine-treated microglial cells. Rather than being the only control element for 
microglial activation, these findings furthermore indicate a more modulatory role for CaV1.2 
in calcium-dependent inflammatory immune responses, also suggesting the involvement of 
other Ca2+ influx routes such as P2X7 and store-operated Ca2+ entry (223). Since both mediator 
systems, NO and cytokine production, were affected, it could be assumed that CaV1.2 is 
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possibly engaged in more proximal steps of the induction cascades instead of interfering with 
the later phases of release performance. 
Increasing evidence also points to a key role of metabolic reprogramming in the regulation of 
the innate immune response (90). In accordance with previous studies, it was observed that, 
upon stimulation with the TLR agonist LPS, microglia switch from oxidative metabolism 
towards glycolysis. This LPS-induced elevation in glycolytic activity seems essential for the 
inflammatory response by providing energy and metabolic resources necessary for the 
associated microglial proliferation and cytokine production (224). Indeed, blockade of 
glycolysis using 2-DG resulted in a reduced TNF-α and IL-6 production in sevoflurane-
stimulated primary mouse microglia (225) and LPS-activated human PBMCs (226) 
respectively. Additionally, mitochondrial ROS, generated in the course of microglial metabolic 
reprogramming, further assists in the activation of redox-sensitive signaling pathways 
including NF-κB and NLRP3 and could thereby represent an important intermediate step in 
pro-inflammatory gene expression (227). As shown previously, blocking the LPS-induced ROS 
generation with rotenone inhibited pro-inflammatory IL-1β secretion in mouse macrophages 
(228). Mitochondrial ROS production can be promoted through the LPS-mediated rise in 
cytosolic Ca2+, which is dynamically stored in mitochondria, where it enhances electron flow 
into the ETC via TCA stimulation as well as inhibits complex IV via NO synthase activation 
(229). In the present study, Cacna1c haploinsufficiency led to an early and long-lasting 
reduction in glycolytic metabolism compared to wildtype upon LPS treatment. This blunted 
bioenergetic adaptation to an immune stimulus in heterozygous Cacna1c microglia is 
presumably linked to reduced cytosolic Ca2+ levels and might, to some extent, account for the 
observed decrease in the expression of several inflammatory markers including NO, IL-1β, IL-
6, and TNF-α. Overall, these results strengthen the emerging role of CaV1.2 in regulating the 
TLR-mediated, calcium-dependent activation of microglia. However, in order to further 
elucidate the underlying molecular mechanisms, the specific effects of Cacna1c 
haploinsufficiency on [Ca2+]i, ROS generation, NADPH oxidase activity, expression of genes 
involved in the glycolytic switch, e.g. HIF-1α and c-Myc, as well as on critical convergent 
signaling pathways such as NF-κB activation and NLRP3 inflammasome formation remain to 
be investigated (90). In addition, co-cultures of activated microglia with neurons or even 
astrocytes would shed more light on related neuronal stress responses in respect of the Cacna1c 
genotype-dependent microglial susceptibility to LPS. 
A wide variety of studies have identified microglial activation in psychiatric disorders 
including schizophrenia, BD, and MDD (77, 94, 230). Since isolated culture systems cannot 
reflect the heterogeneity of microglia and the complexity of their responses in the physiological 
environment, future studies may focus on the impact of Cacna1c haploinsufficiency and 
pharmacological LTCC blockade on microglial activation in an in vivo rat model of 
neuroinflammation, additionally assessing its effect on anxiety- and depressive-like behaviors. 
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This would also provide an opportunity to correlate the cytokine profiles of brain microglia 
and PBMCs in order to establish these as potential peripheral biomarkers reflecting the 
severity of microglial activation and depressive symptoms/behaviors. Furthermore, it should 
be considered that the bacterial endotoxin LPS stimulates microglia only on a single receptor, 
which may lead to findings not transferable to the signaling cascades involved in vivo. 
In conclusion, the present findings suggest that the GWAS-confirmed psychiatric risk gene 
CACNA1C plays a significant role in neuroinflammatory processes with particular impact on 
microglial activation and bioenergetics. Moreover, a dual mode of action might be assumed, 
since reduced Cacna1c expression and DHP treatment had neuroprotective as well as anti-
inflammatory effects on glutamate-challenged neuronal HT22 cells and LPS-stimulated 
microglia, respectively. Thus, modulating L-type calcium signaling may offer an effective 
therapeutic strategy in psychiatric disorders, where neuronal atrophy and inflammation both 
contribute to disease onset and progression. 
 
5.4 Effects of gene-environment interactions in isolated mitochondria 
In contrast to the initial evidence-based hypothesis, no major differences in brain 
mitochondrial performance could be detected between constitutive haploinsufficient 
Cacna1c+/- rats and wildtype littermates irrespective of the environmental condition, i.e. post-
weaning social isolation, standard housing, and social and physical environmental 
enrichment. By studying different aspects of mitochondrial function such as respiration, ROS 
production, ΔΨm, and ETC complex protein levels, it was repeatedly confirmed that there is 
no genotype effect, no distinct environment effect, and also no GxE interaction, emphasizing 
the robustness and reliability of the present (negative) results. A potential link between altered 
expression of the psychiatric risk gene Cacna1c and cerebral mitochondrial function has not 
been investigated in vivo so far. It is well known, however, that the respiratory chain is 
regulated by the cytosolic calcium concentration (231), which, in turn, is very likely dependent 
on the level of CaV1.2 at the cell membrane. Despite a ~50% reduction in brain CaV1.2 levels in 
the present rat model, the heterozygous Cacna1c genotype consistently had no effect on PFC 
and HC bioenergetics compared to wildtype littermates, independent of the hemisphere and 
environmental condition studied. One possible reason might be that developmental Cacna1c 
heterozygosis either is not sufficient to perceive detectable changes, or induces adaptive 
mechanisms facilitating alternative calcium influx routes. In this regard, it has been reported 
previously that chronic genetic loss of CaV1.2 in the CNS of mice leads to a compensatory 
upregulation of calcium-permeable AMPA receptors, thereby maintaining appropriate 
intracellular calcium concentrations and normal neuronal plasticity (198). 
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In the context of GxE interactions, it has been shown in Chapter 4.1 that Cacna1c 
downregulation mediates cellular resilience against oxidative stress in neuronal HT22 cells 
particularly at the level of mitochondria (232). Furthermore, using different Cacna1c siRNAs, 
these previous findings indicate that a sufficiently strong knockdown of at least 62% in CaV1.2 
expression is essential to achieve significant protective effects in mouse hippocampal HT22 
cells exposed to oxidative stress including the maintenance of ATP production, respiration, 
and ΔΨm as well as the prevention of excessive ROS formation (232, 233). Consistently, several 
animal studies have confirmed that modified Cacna1c expression modulates stress 
susceptibility in adult male mice (29, 234). However, in these previous studies, mitochondrial 
parameters were not analyzed. For example, the region-specific deletion of Cacna1c in the 
nucleus accumbens was associated with increased stress sensitivity in mice exposed to chronic 
social defeat for ten days (234). Accordingly, Cacna1c depletion in forebrain glutamatergic 
neurons during embryonic development promoted susceptibility to chronic stress in mice 
subjected to social defeat for three weeks (29). Conversely, four weeks of chronic unpredictable 
stress induced depressive- and anxiety-like behavior in both Cacna1c heterozygous mice and 
their wildtype littermates when assessed 1-2 days following stress (34). Similar to this 
unchanged performance in PFC-dependent behavioral tasks, Cacna1c haploinsufficiency did 
not interact with four-week early life social isolation stress to affect PFC or HC mitochondrial 
bioenergetics in the present rat study. Discrepancies in the above-mentioned findings might 
be related to different species, sites of the genetic modification, age, stress paradigms and 
duration, or readouts. Environmental enrichment was initially intended for rescuing potential 
adverse genotype effects on mitochondrial performance and had neither a combined gene-
environment impact, nor a beneficial influence on its own in the current experiments. 
However, physical and social environmental enrichment showed a general effect on the rats’ 
biometric characteristics and ROS generation. In line with prior studies, environmentally 
enriched animals had significantly lower body weights than their non-enriched controls, 
possibly attributed to a higher physical activity and most likely influenced by the type and 
duration of enrichment (235). Moreover, four weeks of environmental enrichment resulted in 
significantly increased mitochondrial ROS levels in the rats’ prefrontal cortex, which 
constitutes a common response of tissues to physical exercise (236). 
Compared to Cacna1c-associated effects, the impact of chronic stress alone on brain 
mitochondrial function has already been examined in a number of rodent studies (for review 
see (61, 237)). Traditional chronic stress paradigms, including chronic unpredictable stress 
(CUS) for six weeks and chronic restraint stress (CRS) for two to three weeks, are established 
animal models of depression. Published findings indicate that CUS in adult male rats is 
accompanied by inhibited activities of the mitochondrial respiratory chain complexes I, III, 
and IV in whole tissue homogenates from cerebral cortex and cerebellum, but not from PFC 
and HC (238). Under the same conditions, another study described decreased complex I and 
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IV activities in isolated PFC and HC mitochondria (239). Opposing results, however, showed 
increased complex I, II, and III activities in PFC tissue of adult Wistar rats exposed to CUS 
(240). In mice, CUS led to a reduced respiratory control ratio in isolated mitochondria from 
cortex and HC (161). Using the CRS model, further research revealed decreases in enzyme 
activity of complex I-III without affecting complex IV activity, oxygen consumption, and ATP 
production in isolated cortical rat mitochondria (110). CRS in mice caused complex IV 
inhibition in mitochondria isolated from HC (241) and diminished complex I-driven State 3 
respiration in isolated forebrain mitochondria (242). Collectively, variations in stress induction 
paradigms, brain region selection, tissue processing, method application, and parameter 
evaluation probably contribute to the diverging and in part conflicting results regarding the 
impact of chronic stress on mitochondrial outcomes. Furthermore, existing studies largely 
focused on ETC complex activity measurements and observed in most cases decreased 
activities with effects ranging between 30 and 70% (237). However, it has been demonstrated 
in isolated non-synaptic rat mitochondria that complex I, III and IV activities could be reduced 
by more than 60% before respiration and ATP synthesis are considerably affected (243). This 
suggests that moderate changes in candidate complex activities have little effect on the overall 
capability of mitochondria to maintain brain energy homeostasis, which is dependent on the 
integrity of many processes. On the contrary, the oxygen consumption and RCR, which were 
measured in the present and some previous studies, represent a more comprehensive and 
revealing option to detect bioenergetic dysfunction in isolated mitochondria (175). 
With four weeks of post-weaning social isolation, the present work used a different model of 
environmental stress and found no changes in mitochondrial respiration, membrane potential, 
ROS formation, or protein levels of the ETC complexes in rat PFC and HC compared to the 
socially reared littermate controls. Such chronic social isolation represents a mild and more 
natural stressor than CUS and CRS, which still evokes a variety of neurobehavioral changes in 
rodents comparable to those observed in patients with psychiatric disorders, including anxiety 
and depression (244). As reported previously, four weeks of juvenile social isolation stress led 
to decreased ATP and elevated ROS levels in the HC of male mice (245). Post-weaning social 
isolation for eight weeks also resulted in reduced ATP accumulation in the frontal cortex, but 
not in the striatum of male Sprague-Dawley rats (246). In addition, male Wistar rats showed 
slightly increased complex IV activity as well as unchanged mitochondrial membrane 
potential and ROS production in the PFC after one-week social isolation during the pre-
pubertal period (247). All these parameters, which were used as measures of mitochondrial 
function, were assessed from whole frozen tissue, whereas the present experiments were 
predominantly conducted with isolated fresh mitochondria. Thus, the published 
measurements are solely normalized to the total protein content in the tissue homogenates, 
making it impossible to distinguish if the existent findings are based on altered mitochondrial 
quantity or quality. Whilst the meaningful normalization to mitochondrial protein in the 
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present study allowed to specifically evaluate the functional status of brain mitochondria. 
Besides varying stress duration and assays used, this apparent difference in the normalization 
procedure might be a further explanation for the inconsistent findings and additionally 
impedes the comparability of the studies. 
PFC and HC are among the most frequently studied brain regions in neuropsychiatric 
disorders based on their documented stress sensitivity, especially during the juvenile 
developmental period and their particular implication in disease-relevant neuronal circuits 
(248). Nonetheless, while providing brain-region-specific analyses of PFC and HC 
mitochondria, the present work did not differentiate between cells or cell subtypes, sharing 
this limitation also with all relevant prior studies. Mitochondria isolated from brain tissue 
originate from different cell types including neuronal and glial cells. This heterogeneous 
composition of cells could mask potential cell type-dependent variations in stress 
susceptibility and changes in the glia-neuron ratio. Furthermore, the expression of CaV1.2 
varies between excitable and non-excitable cells (249), which might, thus, be differently 
affected by the heterozygous Cacna1c knockout. The investigation of cell type-specific 
mitochondrial bioenergetics therefore constitutes a key challenge for future studies. 
Although brain mitochondrial function was not affected or adaptive mechanisms were not yet 
exhausted in the particular risk GxE setting studied, i.e. Cacna1c haploinsufficiency and post-
weaning social isolation, mitochondria might still represent an important intersection point 
between genetic alternations, psychosocial experiences and abnormalities in cerebral energy 
metabolism, synaptic plasticity in psychiatric disorders (59). The overall inconsistent findings 
in this research field highlight the complexity and heterogeneity of those illnesses and suggest 
that study results are strongly dependent on many factors, such as animal species, 
experimental design, and analysis methods. Hence, additional investigations are required to 
determine the disease-relevant effects on bioenergetics also including long-term studies of 
gene-environment interactions in both sexes, since the present study found a significant effect 
of Cacna1c haploinsufficiency on mitochondrial respiration in the PFC of ten-month-old male, 
but not female rats, which was not evident in the two-month-old animals. The extent of this 
observed genotype effect under standard housing conditions might further vary in 
combination with different environmental situations and may overall contribute to our 
understanding of the pathophysiology of neuropsychiatric disorders. 
 
5.5 Effects of genetic and environmental risk on mitochondria in PBMCs 
In the present study mitochondrial ROS levels and respiratory parameters in PBMCs of 
healthy females with either a family history of psychiatric disorders or an experience of 
maltreatment during childhood were compared to those of a no risk control group. Both, the 
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genetic and the environmental component, are strong risk factors for the development of 
neuropsychiatric illnesses, which, reportedly, are also associated with mitochondrial 
dysfunction (59). However, significant alterations in mitochondrial ROS formation, ATP 
production, proton leak, basal, maximal, and non-mitochondrial respiration were not yet 
evident in the cryopreserved PBMCs of healthy subjects with genetic or environmental risk. 
Consistent with these results from the GR and ER group, a recent study found unchanged 
mitochondrial complex I-V function using monocytes of individuals that were at clinical high 
risk for psychosis and already showed prodromal symptoms (250). Nevertheless, complex III 
function was inversely associated with the severity of prodromal negative symptoms such as 
social anhedonia (251). In contrast to these findings, mitochondrial perturbations were 
detected in PBMCs of patients with an established psychiatric disorder (107–109). Decreased 
complex I, but not complex II and III activity was found in frozen mitochondria isolated from 
PBMCs of chronic schizophrenic patients (107). These changes in complex I activity were 
accompanied by increased levels of lipid peroxidation, but not protein oxidation in blood 
plasma. PBMCs of euthymic BD patients revealed no differences in the respective parameters 
though. Fresh intact platelets of depressive patients in partial remission showed decreased 
basal and maximal respiration, whereas the ratio of both values remained unchanged 
compared to healthy controls (108). Besides basal and maximal respiration, ATP production, 
spare capacity, and coupling efficiency were significantly lower in cryopreserved PBMCs of 
female patients with a current diagnosis of major depression (109). In the present study, a 
trend towards reduced mitochondrial spare capacity was also observed in PBMCs from the 
genetic risk group. By focusing on environmental risk factors for psychiatric disorders, it has 
been shown recently that frozen PBMCs of chronically stressed females caring for a child with 
an autism spectrum disorder exhibited decreased complex II and IV activity per unit of 
mitochondria (252). Conversely, increased ratios of basal, ATP-linked, and non-mitochondrial 
respiration over maximal respiration were identified in cryopreserved PBMCs of females, 
which experienced severe maltreatment during childhood, also including individuals with 
psychiatric diagnoses (52). This higher physiological activity was accompanied by increased 
serum ROS levels, unaltered mitochondrial density as well as enhanced spontaneous secretion 
of pro-inflammatory cytokines. In comparison, frozen PBMCs of healthy females with 
environmental risk, i.e. exposed to at least two forms of maltreatment during childhood, 
showed slightly lower mitochondrial ROS levels and unchanged respiratory ratios in the 
present study. Differences in study cohort characteristics, potential antipsychotic medication, 
cell type, cell storage, and measuring method to assess mitochondrial function make overall 
comparability of the reported findings difficult. In most studies, however, reduced ETC 
complex activity or respiration was linked to the risk for or already established psychiatric 
disorders using frozen PBMCs. 
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Since the Bioenergetic Health Index (BHI) comprises several parameters of a person’s 
respiration profile and thereby provides more information than the individual mitochondrial 
function measures (179), it was also calculated in this study. Here, though not significant, a 
trend towards lower BHI in PBMCs of the GR, but not the ER group compared to the no risk 
control was observed. By considering i.a. the spare respiratory capacity, the BHI even has 
predictive value because it can already identify alterations in mitochondrial performance 
before cellular energy failure occurs. Furthermore, it has been demonstrated previously that 
the BHI is dynamically sensitive to acute oxidative stress in human monocytes (253). This 
observation is in line with the present results showing a significant correlation of decreased 
BHI with increasing levels of mitochondrial superoxide. In relation to these findings, 
compromised mitochondrial metabolism often leads to excess superoxide production, thereby 
modulating redox-sensitive inflammatory pathways and inducing oxidative stress, which 
most likely play a role in diverse psychiatric disorders (45, 229). 
The outcomes of this study should be interpreted in view of the following limitations. First, a 
broad range of cell viabilities (8-71%) were encountered after thawing suggesting considerable 
quality differences between the individual PBMC samples. It is known that mononuclear cell 
recovery decreases with increased time delay before PBMC isolation. Furthermore, as tested 
previously, cryogenic storage reduced cell viability of human peripheral blood leucocytes by 
20% (254). Beyond that, cryopreservation also had a time-dependent impact on mononuclear 
cell bioenergetics, including decreased basal respiration, ATP production, and BHI as well as 
increased non-mitochondrial respiration compared to fresh PBMCs. Spare capacity and proton 
leak, however, remained unchanged (226). Freezer storage time should therefore be evaluated 
as potential confounding factor. Second, as supported by the flow cytometric analyses, the 
PBMC samples were probably contaminated with platelets, red blood cells, and/or 
granulocytes to varying extents. Prior research revealed that each type of blood cell is 
characterized by a distinct bioenergetic profile (255). Consequently, the mitochondrial 
function measurements of these mixed populations were weighted averages of the metabolic 
activities of the different cell types included. Subsequent studies should aim for cell type-
specific investigations or the quantitative assessment of PBMC composition to ensure 
conformity among the samples. Lastly, data variation was considerably high, particularly in 
the GR and ER group. In this study, variance of the BHI was not affected by sample quality 
and composition suggesting an involvement of other covariates or a substantial inter-
individual variability. Detecting potential, subtle changes in mitochondrial bioenergetics 
between the psychiatric risk groups might therefore require more specific risk cohorts or a 
larger sample size. 
Further analyses of the existing data could imply correlations with individual subject 
characteristics such as age, body mass index, organic diseases, or smoking status. It has been 
published previously that smoking, for example, leads to a decreased ETC complex IV activity 
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in PBMCs (256), thereby possibly also influencing mitochondrial respiration and ROS levels. 
In addition, a detailed evaluation of the underlying subjects from the observed subpopulation 
in the GR group with particularly low spare capacity might reveal a certain relationship. 
Moreover, a longitudinal follow-up assessment of all probands to check for a potential switch 
from healthy to diseased and associated changes in PBMC mitochondrial bioenergetics would 
enrich the current findings. Beyond that, future studies may include a combined GxE and a 
specific CACNA1C-related risk group as well as MDD, BD, and SZ patients serving as direct 
reference. To substantiate future conclusions, the obtained results should be normalized to 
mitochondrial content per cell by measuring citrate synthase activity (52, 252). Since 
stimulation of the PBMC samples was not feasible due to insufficient amount of cells, studying 
changes in mitochondrial performance in response to either immune-inflammatory challenges 
with LPS and polyinosinic:polycytidylic acid (257) or oxidative stress generated by 2,3-
dimethoxy-1,4-napthoquinone (258) could also be a focus of subsequent investigations. 
In conclusion, mitochondrial bioenergetics and ROS levels in human PBMCs were correlated, 
but alterations in both parameters were not yet evident in the psychiatric disease-relevant 
genetic or environmental risk groups. Consequently, further research is required in order to 
shed more light on the early pathological mechanisms underlying neuropsychiatric disorders. 
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6 Summary 
Affective disorders such as major depression and bipolar disorder are among the most 
prevalent forms of mental illness, and their pathophysiology involves complex interactions 
between genetic and environmental risk factors. However, the underlying mechanisms 
explaining how genetic and environmental alterations affect the risk for psychiatric disorders 
are still largely unknown. Confirmed by several genome-wide association studies over the 
past ten years, CACNA1C represents one of the strongest and most replicable psychiatric risk 
genes. Besides genetic predispositions, environmental influences such as childhood 
maltreatment or chronic stress also contribute to disease vulnerability. In addition, increasing 
evidence suggests a crucial role for mitochondrial dysfunction, oxidative stress, excitotoxicity, 
and neuroinflammation in the development of major neuropsychiatric disorders. 
Furthermore, mitochondrial dysfunction in peripheral blood mononuclear cells (PBMCs) is 
currently being discussed as a potential biomarker for affective disorders supporting early 
diagnosis, control of disease progression, and evaluation of treatment response. 
In a translational setting, the present project focused on the effects of defined gene-
environment interactions on brain mitochondrial integrity and function in order to provide 
new insights into pathophysiological mechanisms of affective disorders and to identify novel 
therapeutic targets with potential relevance for future treatment strategies. 
Using immortalized mouse hippocampal HT22 cells, a well-established model system to 
investigate glutamate-mediated oxidative stress, it was demonstrated that both siRNA-
mediated Cacna1c gene silencing and L-type calcium channel (LTCC) blockade with 
nimodipine significantly prevented the glutamate-mediated rise in lipid peroxidation, 
excessive ROS formation, collapse of mitochondrial membrane potential, loss of ATP, 
reduction in mitochondrial respiration, and ultimately neuronal cell death. Moreover, both 
Cacna1c knockdown and pharmacological LTCC inhibition altered CaV1.2-dependent gene 
transcription, thereby suppressing the glutamate-induced expression of the inner 
mitochondrial membrane calcium uptake protein MCU. Accordingly, downregulation of 
Cacna1c substantially diminished the elevation in mitochondrial calcium levels after glutamate 
treatment. In the employed paradigm of oxidative glutamate toxicity, Cacna1c depletion also 
protected against detrimental mitochondrial fission and stimulated mitochondrial biogenesis 
without affecting mitophagy, thus promoting the turnover of mitochondria and preventing 
the accumulation of dysfunctional mitochondria in neuronal HT22 cells. These data imply that 
upstream genetic modifications, e.g. reduced CACNA1C expression, converge to control 
mitochondrial function, resulting in cellular resilience against oxidative stress. 
In primary cortical rat neurons, heterozygous Cacna1c knockout partially reduced Cacna1c 
expression but had no impact on either initial increase in [Ca2+]i or delayed perturbations in 
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mitochondrial bioenergetics, ATP levels, and cell viability in response to glutamate-mediated 
excitotoxicity. Furthermore, Cacna1c mRNA and protein expression levels were subject to 
strong regulation and degradation in this model of neuronal excitotoxicity. Partial 
neuroprotection against long-term glutamate toxicity by pharmacological LTCC blockade 
highlighted a potential dose-effect-dependency and the involvement of LTCCs in this cell 
death pathway. 
In primary rat microglia cultures, both Cacna1c haploinsufficiency and nimodipine treatment 
were associated with reduced morphological changes and glycolytic metabolism upon 
lipopolysaccharide (LPS) stimulation. The LPS-induced shift from oxidative phosphorylation 
towards glycolysis seems essential for the inflammatory response, since the downstream 
release of NO, IL-1α, IL-1β, IL-6, IL-10, and TNF-α was also decreased in heterozygous Cacna1c 
as well as nimodipine-treated microglial cells. These results indicate a major functional role 
for CaV1.2-dependent signaling in the pro-inflammatory activation of microglia, the innate 
immune cells of the central nervous system. 
By simulating the interaction of psychiatric disease-relevant genetic and environmental factors 
in vivo, the present study additionally evaluated their potential effect on brain mitochondrial 
function using a constitutive heterozygous Cacna1c rat model in combination with a four-week 
exposure to either post-weaning social isolation, standard housing, or social and physical 
environmental enrichment during the juvenile developmental period. In this specific gene-
environment setting, isolated mitochondria from prefrontal cortex and hippocampus, both 
representing particularly susceptible brain regions in neuropsychiatric disorders, did not 
reveal considerable differences in mitochondrial bioenergetics, respiratory chain complex 
protein levels, superoxide formation, and membrane potential between the investigated 
conditions. 
Finally, mitochondrial function was investigated in human PBMCs from probands recruited 
in the Marburg/Münster Affective Disorders Cohort Study (MACS). However, neither a family 
history of psychiatric disorders nor an experience of maltreatment during childhood had a 
significant effect on mitochondrial superoxide levels and respiratory parameters in PBMCs 
from healthy female subjects. Consequently, further research is required in order to shed more 
light on the early pathological mechanisms underlying neuropsychiatric disorders. 
Overall, the present findings suggest that the GWAS-confirmed psychiatric risk gene 
CACNA1C plays a significant role in oxidative stress as well as neuroinflammatory pathways 
with particular impact on mitochondrial integrity and function, thereby adding to a better 
understanding of the intracellular processes likely involved in the pathophysiology of 
CACNA1C-associated disorders. Thus, modulating L-type calcium signaling may offer an 
effective therapeutic strategy in psychiatric disorders, where neuronal atrophy and 
inflammation contribute to disease pathophysiology.  
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7 Zusammenfassung 
Affektive Störungen wie schwere Depressionen und bipolare Störungen gehören zu den 
häufigsten Formen psychischer Erkrankungen. Ihre Pathophysiologie beruht auf komplexen 
Wechselwirkungen zwischen genetischen und umweltbedingten Risikofaktoren. Wie 
genetische und umweltbedingte Veränderungen das Risiko für psychiatrische Erkrankungen 
auf molekularer Ebene beeinflussen, ist jedoch noch weitgehend ungeklärt. Mehrere 
genomweite Assoziationsstudien (GWAS) der letzten zehn Jahre zeigen eindeutig, dass 
CACNA1C zu den bedeutendsten neuropsychiatrischen Risikogenen zählt. Neben genetischen 
Prädispositionen tragen auch Umwelteinflüsse wie Misshandlung in der Kindheit oder 
chronischer Stress zu einer erhöhten Krankheitsanfälligkeit bei. Darüber hinaus gibt es in 
letzter Zeit vermehrt Hinweise darauf, dass mitochondriale Dysfunktion, oxidativer Stress, 
Exzitotoxizität und Neuroinflammation bei der Entwicklung psychiatrischer Störungen eine 
entscheidende Rolle spielen. Zudem werden mitochondriale Funktionsstörungen in 
peripheren mononukleären Blutzellen (PBMCs) derzeit als potentieller Biomarker für 
affektive Störungen diskutiert, die eine frühe Diagnose, eine Beurteilung des 
Krankheitsverlaufs und die Bewertung des Ansprechens auf eine Behandlung unterstützen 
sollen. 
Mit Hilfe eines translationalen Ansatzes, beschäftigte sich die vorliegende Arbeit mit den 
Auswirkungen definierter Gen-Umwelt-Interaktionen auf die Integrität und Funktion von 
Mitochondrien in Neuronen und Mikrogliazellen, um tiefere Einblicke in pathophysiologische 
Mechanismen affektiver Störungen zu gewinnen und neue therapeutische Zielstrukturen mit 
potentieller Relevanz für zukünftige Behandlungsstrategien zu identifizieren. 
In immortalisierten hippokampalen HT22 Mauszellen, einem etablierten Modellsystem zur 
Untersuchung von Glutamat-vermitteltem oxidativem Stress, konnten durch Cacna1c-
Inhibition auf mitochondrialer wie auch auf zellulärer Ebene protektive Effekte aufgezeigt 
werden. Sowohl Cacna1c Knockdown als auch die Blockade von L-Typ-Calciumkanälen 
(LTCC) mit Nimodipin hemmten den Glutamat-induzierten Anstieg der Lipidperoxidation, 
die übermäßige Bildung reaktiver Sauerstoffspezies (ROS), den Abfall des mitochondrialen 
Membranpotentials, den Verlust an ATP, die Verringerung der mitochondrialen Atmung und 
letztlich auch den neuronalen Zelltod. Darüber hinaus führten Cacna1c „Gen-Silencing“ sowie 
pharmakologische LTCC-Hemmung zu einer veränderten CaV1.2-abhängigen Regulation der 
Gentranskription, wodurch die Expression des mitochondrialen Calcium-Uniporters (MCU) 
nach Glutamatschädigung signifikant unterdrückt wurde. Dies führte in den Cacna1c-
defizienten Zellen auch zu einem deutlich verminderten Calciumanstieg in den 
Mitochondrien nach Glutamatexposition. Im verwendeten Modell der oxidativen 
Glutamattoxizität schützte die siRNA-vermittelte Cacna1c Depletion auch vor mitochondrialer 
Fragmentierung und stimulierte die mitochondriale Biogenese, ohne sich auf die Mitophagie 
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auszuwirken, wodurch der mitochondriale Umsatz gefördert und die Akkumulation 
dysfunktionaler Mitochondrien in neuronalen HT22-Zellen vermindert wurde. Dies deutet 
darauf hin, dass die Effekte vorgeschalteter genetischer Modifikationen, wie zum Beispiel 
einer reduzierten CACNA1C Expression, konvergieren und sich auf die mitochondrialen 
Funktionen auswirken, was zu einer erhöhten zellulären Resilienz gegen oxidativen Stress 
beiträgt. 
In primären kortikalen Rattenneuronen reduzierte der heterozygote Cacna1c Knockout die 
Proteinexpression auf etwa die Hälfte der Wildtyp-Level. Nach Glutamat-vermittelter 
Exzitotoxizität war jedoch weder ein Einfluss auf den initialen Anstieg der intrazellulären 
Calciumkonzentration noch auf die zeitverzögerten Störungen der mitochondrialen 
Bioenergetik, der ATP Spiegel oder der Zellviabilität nachzuweisen. Ferner unterlagen die 
Cacna1c mRNA- und Proteinexpressionsspiegel in diesem Modell der neuronalen 
Exzitotoxizität starken Regulations- und Abbaumechanismen. Dagegen unterstreicht die 
partielle Neuroprotektion gegen Glutamattoxizität durch pharmakologische LTCC-Blockade 
mit Dihydropyridinen eine mögliche Dosis-Wirkungs-Abhängigkeit und die Beteiligung von 
LTCCs im Glutamat-vermittelten exzitotoxischen Zelltod. 
In primären Mikroglia-Kulturen der Ratte waren Cacna1c Haploinsuffizienz sowie 
Nimodipin-Behandlung assoziiert mit reduzierten morphologischen Veränderungen und 
einer abgeschwächten glykolytischen Aktivität nach Lipopolysaccharid (LPS)-Stimulation. 
Darüber hinaus scheint die LPS-induzierte Verschiebung vom oxidativen Metabolismus hin 
zur Glykolyse für die weitere Entzündungsreaktion essenziell zu sein, da zusätzlich eine 
verminderte Freisetzung von NO, IL-1α, IL-1β, IL-6, IL-10 und TNF-α sowohl in 
heterozygoten Cacna1c als auch in Nimodipin-behandelten Mikrogliazellen beobachtet wurde. 
Diese Ergebnisse weisen auf eine wichtige funktionelle Rolle CaV1.2-abhängiger Signalwege 
in der pro-inflammatorischen Aktivierung der Mikroglia als zellulärer Bestandteil der 
angeborenen Immunität im zentralen Nervensystem hin. 
Durch die Simulation krankheitsrelevanter Interaktionen genetischer und umweltbedingter 
Faktoren im Tiermodell wurden in dieser Studie zudem ihre potentiellen Effekte auf die 
Funktion zerebraler Mitochondrien evaluiert. Dies wurde mithilfe konstitutiv heterozygoter 
Cacna1c Ratten realisiert, welche während der juvenilen Entwicklungsphase für vier Wochen 
entweder in sozialer Isolation, unter Standardbedingungen oder in sozial und materiell 
angereicherter Umgebung gehalten wurden. Allerdings zeigten isolierte Mitochondrien 
sowohl aus dem präfrontalen Cortex als auch aus dem Hippocampus keine wesentlichen 
Unterschiede zwischen den untersuchten Gen-Umwelt Kohorten im Hinblick auf die 
mitochondriale Bioenergetik, die Proteinkomplexe der Atmungskette, die 
Superoxidproduktion und das Membranpotential. 
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In einem weiteren Teil dieser Studie wurde an humanen PBMCs aus der MACS 
(Marburg/Münster Affective Disorders Cohort Study) Kohorte gezeigt, dass weder eine 
familiäre Vorgeschichte psychischer Störungen noch die Erfahrung von Misshandlung in der 
Kindheit einen signifikanten Effekt auf mitochondriale ROS Level und Parameter der 
mitochondrialen Respiration in PBMCs gesunder weiblicher Probanden hatte. Hierzu sind 
weitere Untersuchungen erforderlich, um die frühen pathologischen Mechanismen besser zu 
verstehen, die neuropsychiatrischen Erkrankungen zugrunde liegen. 
Insgesamt deuten die vorliegenden Forschungsergebnisse darauf hin, dass das durch GWAS 
ermittelte psychiatrische Risikogen CACNA1C eine zentrale Rolle in der Regulation 
mitochondrialer Integrität und Funktion spielt und so auch neuroinflammatorische 
Signalwege und die Resilienz gegen oxidativen Stress beeinflusst. Diese Arbeit trägt damit zu 
einem besseren Verständnis der intrazellulären Prozesse bei, die vermutlich an der 
Pathophysiologie von CACNA1C-assoziierten Erkrankungen beteiligt sind. Die Modulation 
zerebraler LTCC könnte somit eine therapeutische Option bei psychiatrischen Störungen 
darstellen, die sowohl durch neuronale Atrophie als auch durch Entzündungsprozesse 
gekennzeichnet sind. 
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Abbreviations 
2-DG  2-Deoxy-D-glucose 
 
ADP  Adenosine diphosphate 
AIF  Apoptosis inducing factor 
AM  Acetoxymethyl 
AMPA  α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate 
ANOVA Analysis of variance 
ATP  Adenosine triphosphate 
 
BCA  Bicinchoninic acid 
BD  Bipolar disorder 
BHI  Bioenergetic health index 
BID  BH3-interacting domain death agonist 
bp  Base pair 
BSA  Bovine serum albumin 
 
[Ca2+]i  Intracellular calcium concentration 
CCCP  Carbonyl cyanide 3-chlorophenylhydrazone 
CI  Confidence interval 
CNS  Central nervous system 
CRS  Chronic restraint stress 
CTQ  Childhood trauma questionnaire 
CUS  Chronic unpredictable stress 
CytC  Cytochrome C 
 
ΔΨm  Mitochondrial membrane potential 
DAMPs Damage-associated molecular patterns 
DAPI  4′,6-Diamidine-2′-phenylindole 
DHP  Dihydropyridine 
DIV  Days in vitro 
DMEM  Dulbecco’s modified Eagle’s medium 
DMSO  Dimethyl sulfoxide 
DNA  Deoxyribonucleic acid 
DNase  Deoxyribonuclease 
Drp  Dynamin-related protein 
 
EBSS  Earle’s balanced salt solution 
ECAR  Extracellular acidification rate 
ETC  Electron transport chain 
 
FBS  Fetal bovine serum 
FCCP  Carbonyl cyanide-4-(trifluoromethoxy)phenylhydranzone 
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GFAP  Glial fibrillary acidic protein 
GPX  Glutathione peroxidase 
GSH  Glutathione 
GWAS  Genome wide association study 
GxE  Gene-environment interaction 
 
HBSS  Hank’s balanced salt solution 
HC  Hippocampus 
 
IFN  Interferon 
IL  Interleukin 
 
L-Arg  L-Arginine 
LC3B  Light chain 3 isoform B 
LOX  Lipoxygenase 
LPS  Lipopolysaccharide 
LTCC  L-type calcium channel 
 
MACS  Marburg/Müster affective disorders cohort study 
MAP  Microtubule-associated protein 
MCP  Monocyte chemoattractant protein 
MCU  Mitochondrial calcium uniporter 
MDD  Major depressive disorder 
MEA  Multielectrode array 
MEM  Minimum essential medium 
Mfn  Mitofusin 
MIP  Macrophage inflammatory protein 
mPTP  Mitochondrial permeability transition pore 
MTT  3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide 
MW  Molecular weight 
 
NF  Nuclear factor 
NLR  Nucleotide-binding oligomerization domain (NOD)-like receptor 
NLRP  NOD-, leucine-rich repeat (LRR)- and pyrin domain-containing 
NMDA  N-methyl-D-aspartate 
NO  Nitric oxide 
NOS  Nitric oxide synthase 
 
OCR  Oxygen consumption rate 
OXPHOS Oxidative phosphorylation 
 
P2X  ATP-binding purinoceptor 
PAMPs Pathogen-associated molecular patterns 
PBMCs Peripheral blood mononuclear cells 
PBS  Phosphate buffered saline 
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PCN  Primary cortical neurons 
PCR  Polymerase chain reaction 
PEI  Polyethyleneimine 
PET  Positron emission tomography 
PFA  Paraformaldehyde 
PFC  Prefrontal cortex 
PGC  Peroxisome proliferator-activated receptor gamma coactivator 
PI  Propidium iodide 
PLL  Poly-L-lysine 
PND  Postnatal day 
PRR  Pattern recognition receptor 
PVDF  Polyvinylidene difluoride 
 
RCR  Respiratory control ratio 
ROI  Region of interest 
ROS  Reactive oxygen species 
RTCA  Real-time cell analysis 
 
SD  Standard deviation 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SNP  Single nucleotide polymorphism 
 
TCA  Tricarboxylic acid cycle 
TLR  Toll-like receptor 
TNF  Tumor necrosis factor 
TMRE  Tetramethylrhodamine ethyl ester 
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